,,,,,,,,,,,Ames Test,,,,,,,,,,,,,,Mammalian Cell Gene Mutation,,,,,,,,in vitro Micronucleus test ,,,,,,,,in vitro Chromosomal Aberrations test,,,,,,,,,,,in vivo Micronucleus test,,,,,,,in vivo Chromosomal Aberrations test,,,,,,,,,TGR assay,,,,,,,,,in vivo Unscheduled DNA Synthesis ,,,,,,,,,,in vivo DNA damage (COMET or alkaline elution assay),,,,,,,,
,Chemical,CAS No.,InChiKey,Smiles,LogP,AMES CGX,AMES CGX references,AMES ISHL-CSL,AMES ISHL-CSL references,AMES NTP,AMES NTP references,AMES ECHA,AMES ECHA references,AMES EFSA,AMES EFSA references,AMES ISSTox,AMES Literature,AMES Overall,,MCGM CGX,MCGM CGX references,MCGM CSCL-ISHL,MCGM NTP ,MCGM Schisler,MCGM ECHA,MCGM ECHA references,MCGM EFSA,MCGM Literature,in vitro MCGM Overall,MNvit CGX,MNvit CGX references,MNvit CSCL-ISHL,MNvit NTP,MNvit ECHA,MNvit EFSA,MNvit Literature,in vitro MN Overall,CAvit CGX,CAvit CGX references,"CAvit ISHL-CSCL
",CAvit NTP,CAvit NTP references,CAvit ECHA,CAvit EFSA,CAvit Literature,in vitro CA  Overall,,MNvivo CGX,MNvivo CGX references,MNvivo CSCL,MNvivo NTP,MNvivo ECHA,MNvivo EFSA,MNvivo Literature,in vivo MN Overall,CAvivo CGX,CAvivo CGX references,CAvivo CSCL-ISHL,CAvivo NTP,CAvivo ECHA,CAvivo EFSA,CAvivo Literature,in vivo CA Overall,TGR CGX,TGR CGX references,TGR CSCL-ISHL,TGR NTP,TGR ECHA,TGR EFSA,TGR TRAID-DB,TGR Tissues,TGR Literature,TGR Overall,UDS CGX,UDS CGX references,UDS CSCL-ISHL,UDS NTP,UDS ECHA,UDS EFSA,UDS Literature,in vivo UDS Overall,COMET CGX,COMET CGX references,CGX CSCL-ISHL,COMET NTP,COMET ECHA,COMET EFSA,COMET LevyDB,COMET Sasaki,COMET GUMDB,COMET JACVAM,COMET others,COMET Tissues,COMET Literature, in vivo DNA damage Overall
1,Acephate,30560-19-1,YASYVMFAVPKPKE-UHFFFAOYSA-N,COP(=O)(NC(=O)C)SC,"-0,850",[-],[-] mostly but [+] only >5000 ug/plate#Moriya et al 1983,,,,,,,,,,"[-] in TA98, TA100, TA1535, TA1537 and E. coli WP2#ECVAM Review 2016; [-] in TA98, TA100, TA1535, 1537 and E. coli WP2#California EPA 2008; [+] in E. coli WP2 and WP2uvrA, unknown dose acephate (Orthene 755)#Hanna and Dyer 1975;",[-],,,,,,,,,,[-] up to 5 mg/ml#Carver et al 1985; [+] 2429-5000 ug/ml in 2 separate studies#California EPA 2008,[+],,,,,,,,,,,,,,,,[E] in red muntjac cells#He et al 1982,[E],,[+],[+] in chicks#Jena and Bhunya 1994,,,,,"[-] male mice, up to 300 mg/kg, 2 daily doses, oral#Carver et al 1985; [-] male mice, after 2x doses, oral, but too few PCE scored#California EPA 2008; weak [+] in mice, at 2x250 mg/kg, ip#Behera and Bhunya 1989; [+] in chick, bone marrow & blood, ip#Jena and Bhunya 1994; [-] in chick, bone marrow & blood, oral#Jena and Bhunya 1994",[-],[+],[+] chicks#Jena and Bhunya 1994; [+] mice#Behera and Bhunya 1989,,,,,"[-] in mice up to 112 mg/kg oral#Carver et al 1985; [-] in mice#California EPA 2008; [+] in mice, 250 mg/kg, oral, ip & sc#Behera and Bhunya 1989; [+] in chick bone marrow at mid-dose only, ip & oral#Jena and Bhunya 1994",[+],,,,,,,,,,,,,,,,,,,[+],#Rahman et al 2002,,,,,,,,,[+]#Rahman et al 2002,"[+] male mice, in leukocytes, oral",,[+]
2,Acesulfame-K,55589-62-3,WBZFUFAFFUEMEI-UHFFFAOYSA-M,[K+].CC1=CC(=O)[N-]S(=O)(=O)O1,"-0,930",TC [-],#Seifried et al 2006,,,,,[-],"#[-] in TA 98, TA 100, TA 1535, TA 1537, TA 1538 and E. coli WP2 uvrA, w/out S9",,,,"[-] in TA98, TA100, TA1535, TA1537 and E. coli WP2#ECVAM Review 2016",[-],,[U],,,,,[-] ,"[-] in Hprt locus up to 10,000 ug/ml but only without S9",,[-] in Tk locus up to 2000 ug/ml after re-evaluation#Seifried et al 2006,[-],,,,,,,,,,,,,,,, [-] in CHO cells#EC SCF Doc 2000#Mayer et al 1977,[-],,,,,Male [+]; Females [-] in p53+/- mice; Male [-]; Females[-] in Tg:AC mice. Overall [E],"[-] up to 2x4500 mg/kg oral in mice, but sampled only 6 hrs after 2nd dose",,[-] in NMRI mice#EC SCF Doc 2000#Baeder et al  1977,[-],[+],#Mukherjee and Chakrabarti 1997,,,"[-] up to 2250 mg/kg oral, mouse bone marrow; [-] up to 5x4500 mg/kg oral, Chinese hamster bone marrow",,"[+] dose response for CA in mice from 30-2250 mg/kg, single oral doses,but not confirmed#Mukherjee and Chakrabarti 1997; [-] in swiss albino mice#Volker 1998); [-]#Mukhopaddhyay et al 2000",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,[-]#Sasaki et al 2002,"[-] male mice, in stomach, colon, liver, kidney, bladder, lung, brain & bone marrow, oral","[+] in mouse bone marrow, 600 mg/kg oral#Bandyopadhyay et al 2008",[E]
3,Acetaldehyde,75-07-0,IKHGUXGNUITLKF-UHFFFAOYSA-N,CC=O,"-0,340",[-],,[-],"#[-] in TA98, TA100, TA1535, TA1537, TA1538 and E. coli WP2 uvrA, up to 5 mg/plate, w/out S9",[-],"[-] in TA98, TA100, TA1537, TA1535#Mortelmans et al 1986; [-] in TA100, TA102, TA104 with S9",[-]/[+],#[+] and [-] results reported in E. coli ([+] results superceded by robust later studies),,,,"[-] in TA100, TA102, TA104#Dillon et al 1998; [-] in TA102#Aeschbacher et al 1989; [-] in E. coli WP2 uvrA#JETOC 1997",[-],,[+],#Mitchell et al 1997,,,,,,,[+] in Tk locus without S9;  [I] with S9 after re-evaluation#Seifried et al 2006; [+] in Tk locus without S9#Wangenheim and Bolcsfoldi 1988; [+] in Hprt locus in human skin fibroblasts#Grafstroem et al 1994; [+] in Tk locus mutations in TK6 cells without S9#Budinsky et al 2013; [+] in Hprt locus in human lymphocytes  without S9#He and Lambert 1990; [+] in human VH-10 fibroblasts#Lambert et al 1994,[+],,,,,,,[+] in Tk locus6 cells without S9#Budinsky et al 2013#Moeller et al 2013; [+] in MCL-5 cells without S9#Kayani and Parry 2010; [+] in human lymphocytes#Migliore and Nieri 1991; clastogen response#Migliore et al 1996; [+] in V79 cells#Speit et al 2008; [+] in rat skin fibroblasts#Bird et al 1982,[+],[+],#Ishidate et al 1988,"[+] in CHL cells (6-18, 24, 48h treatment without S9 and at 6-18h treatment with S9)",[+],,,,"[+] in CHL cells w/out S9#JETOC 2005; [+] in rat fibroblasts without S9#Ishidate et al 1988; [+] in CHO cells, particularly if deficient in homologous recombination repair#Mechilli et al 2008; [+] in human lymphocytes#Lambert and He 1988#Obe et al 1979; [+] in rat skin fibroblasts#Bird et al 1982",[+],,[+],,,,,,"[+] in blood reticulocytes of aldehyde dehydrogenase-deficient mice#Kunugita et al 2008; [-] in wild type#Kunugita et al 2008; [+] in rat blood reticulocytes, ip admin#Hynes et al 2002; [+] in mouse bone marrow ip#Morita et al 1997; [+] in rat bone marrow and blood#Wakata et al 1998; [+]  mice ip#Ozawa et al 1994",[+],[+],#Dellarco 1988,,,,,[+] in embryonic cells of pregnant female rats dosed intra-amniotically#Barilyak and Kozachuk 1983,[+],,,,,,,,,,,,,,,,,,,,,,,,,[+],,,,,"[+] in stomach, colon, bladder, lung, brain and bone marrow; [-] in kidney and liver of male mice via ip#Sasaki et al 2000",,[+]
4,Acetamide,60-35-5,DLFVBJFMPXGRIB-UHFFFAOYSA-N,CC(=O)N,"-1,260",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537 w/out S9#Haworth et al 1983 ",[-],"#[-] in TA97a, TA98, TA100, TA102, TA1535, up to 5000 ug/plate, w/out S9",,,,"[-] in TA98, TA100, TA1535, TA1537#Benedict et al 1977; [-] in TA102 and E. coli WP2, without S9; [-] in E. coli polA W3110 vs P3478#Leifer et al 1981 EPA data",[-],,,,,,,,,,,,,,,,,,[+] in SHE cells#Fritzenschaf et al 1993 ,[+],,,,,,,,,,,[E],[+]#Chieli et al 1987; [-]#Mirkova 1996; [-]#Morita et al 1997,,,,,"[-] in mouse blood reticulocytes up to 2000 mg/kg ip#De Boeck et al 2005; [-] in mouse bone marrow, single oral dose#Mirkova 1996; [-] in mouse bone marrow and blood after 1x, 2x or 4x ip injections#Morita et al 1997; [+] in mouse bone marrow after single oral dose of only 190 mg/kg#Chieli et al 1987; [-] in oral and ip studies at higher doses make the Chieli et al result highly questionable hence, overall [-]",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,[+],,,,"[+] in stomach, colon, lung and bone marrow#Sasaki et al 2000; [-] in liver, kidney, bladder and brain of male mice via ip#Sasaki et al 2000",,[+]
5,Acetohexamide,968-81-0,VGZSUPCWNCWDAN-UHFFFAOYSA-N,CC(=O)c1ccc(cc1)S(=O)(=O)NC(=O)NC2CCCCC2,"2,440",[-],,,,[-],"[-] in TA97, TA98, TA100, TA1535, TA1537#Haworth et al 1983; [-] in  E. coli  WP2 w/out rat and mouse S9#Dunkel et al 1985

",,,,,,,[-],,[-],,,[-],[U],,,,"[U] in Tk locus#Schisler et al 2018
",[I],,,,,,,,,[+], in CHL cells#Ishidate et al 1988,,[-] ,#up to 3000 or 5000 ug/ml,,,,[E],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
6,Acetaminophen,103-90-2,RZVAJINKPMORJF-UHFFFAOYSA-N,CC(=O)Nc1ccc(O)cc1,"0,460",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537, w/out S9#Haworth et al 1983; [-] in E. coli#IARC vol 50 1990",,,,,,[-]#CPDB;#King et al 1979;#Dybing et al 1984;#Oldham et al 1986;#Haworth et al 1983;#Wirth et al 1980; [-] including TA102#Bartsch et al 1980,[-],,[-],[-] in Hprt locus in V79 cells#IARC vol 50 1990; #Sawada et al 1985,,,,,,,[+] in Tk locus in  L5178Y cells #Clements 1992,[+],[+],[+]in CHL cells#Matsushima et al 1999,,,,,,[+],[+],#Ishidate et al 1988,,,,,,[+] at high concs in multiple papers#Bergman et al 1996,[+],,,,,,,,[-]#King et al 1979; some [+] results at hepatotoxic doses#Bergman et al 1996; weak [+]#Mueller and Kasper 1995; #Bergman et al 1996,[+],,,,,,,[+] results at high doses#Bergman et al 1996; weak [+]#Reddy 1984,[E],,,,,,,[-],[-]  in liver of female rats (525 mg/kg in feed for 13 weeks) ,#Kanki et al 2005,[-],,,,,,,[-]#Bergman et al 1996,[-],,,,,,,[+],,,,#Oshida et al 2008;#El Morsy and Kamel 2015,[+] in liver but [-] in kidney and bone marrow of male mice up to 300 mg/kg via ip; [+] in liver of male rats 2000 mg/kg via gavage,,[+]
7,Acetonitrile (Ethyl nitrile),75-05-8,WEVYAHXRMPXWCK-UHFFFAOYSA-N,CC#N,"-0,340",TC [-],"[-] in TA98, TA100#Wu et al 2009",,,[-],"in TA97, TA98, TA100, TA1535, TA1537#Mortelmans et al 1986",[-],"[-] in TA98, TA100, TA1535, TA1537, TA1538 and E. coli WP2 uvr A, WP2 uvrA/pKM101, up to 5000 ug/plate, w/out S9#Benfenati DB",,,,"[-] in TA98, TA100, TA1535, TA1537#Florin et al 1980; [-] in TA98, TA100#Schlegelmilch et al 1988",[-],,[-],#Mitchell et al 1997; #Rudd et al 1983,,"[-] in Hprt locus up to 30 mg/ml; [-] in Tk locus up to 24 ul/ml (limit concentration, not toxic)",,,,,,[-],,,,,,,,,[E],#Galloway et al 1987,,weak [+],,,,,weak [+],,[+] male; [-] female,,,"[+] male, but <2-fold, [-] female, 90 day study#Witt et al 2000",,,"[+] in males, ip injection at 60% of LD50#Schlegelmich et al 1988; but [-] in marrow and blood, ip injection at MTD#Jones et al 2001",[-],,,,,,,,,,,,,,,,,,,[-],#Madle et al 1994 ,,,,,,[-],,,,,,,,,,,,,,
8,Acetic acid,64-19-7,QTBSBXVTEAMEQO-UHFFFAOYSA-N,CC(=O)O,"-0,170",[-],#Lambert et al 2005,,,,,[-],"[-] in TA92, TA94, TA98, TA100, TA1535, TA1537#Ishidate et al 1984; [-] in TA97, TA98, TA100, TA1535#Zeiger et al 1992",[-],"[-] in TA98, TA100, TA1535, TA1537, TA1538 and E. coli WP2 and WP2 uvrA-, up to 1000ug/ml, w/out S9; plus several other Ames tests#EFSA DAR, 2008",,,[-],,,,,,,[+] in Tk locus in conditions of weak acidity (pH 6.0-6.8) with S9#Cifone et al 1987,,,,[+],,,,,,,,,,,,,,[-] in CHO-K1 but positive at toxic conditions#Morita et al 1990; [-] in CHL without S9#Sofuni 1999, [+] cytogenetic test in CHL cells 2 studies; [-] 1 study#EFSA DAR 2008;#EFSA Journal 10 2012c,,[-],,,,,,,,,,,,,,,,,,[+],#Lambert et al 2005,,,,[+] dermal cell mutation in muta mouse# EFSA DAR 2008,[+],[+] in skin of male mice at an ulcerating dose,,[+],,,,,,,,,,,,,,,,,,,,,,
9,Acetoxime,127-06-0,PXAJQJMDEXJWFB-UHFFFAOYSA-N,CC(=NO)C,"0,120",[-],,,,[-],"[-] in TA97, TA100, TA1535, w/out S9",[-],"[-] in TA98, TA100, TA2637 and E. coli WP2 uvrA/pKM101, at up to 100 µmoles/ plate or a toxic level, by the preincubation assay (37°C, 20 min), w/out S9",,,,,[-],,,,,,,[-],"[-] in Tk locus L5178Y cells, w/out S9, study dossier",,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"[-] in SD rat bone marrow, 6, 24 and 48 hours, gavage, study dossier",,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
10,Acrylamide,79-06-1,HRPVXLWXLXDGHG-UHFFFAOYSA-N,NC(=O)C=C,"-0,670",[E],#Zeiger 1997,,,[-],"[-] in TA97, TA98, TA100, TA1535, w/out S9; [-] in TA98, TA100, TA01535, TA1537, w/out S9#Zeiger et al 1987",[-],"[-] in TA98, TA100, TA1535, TA1537, TA102, w/out S9#Benfenati DB",,,,[-]#Hashimoto and Tanii 1985;#Knaap et al 1988;#Jung et al 1992; [-] including TA102#Mueller et al 1993,[-],,[+],#Mitchell et al 1997,,[+],,,,,[+] in Tk locus without S9 at concs >10 mM#Moore et al 1987; [+] in Hprt locus only at high concs and toxicity#Knaap et al 1988; [+] in Tk locus only at > 10 mM#Mei et al 2008; [-] in Hprt locus up to 10 mM without S9#Baum et al 2005; weak [+] in Tk locus in TK6 cells at >10 mM#Koyama et al 2006,[+],,,,,,,[-] in human lymphocytes with S9#Baum et al 2005; [+] in HepG2 cells at < 2 mM#Jiang et al 2007;#Zhang et al 2008; weak [+] in Tk locus6 cells at >10 mM#Koyama et al 2006,[+],"[+]
",#at >10nM,"[+] in CHL cells [6-18, 24, 0h or 48-0h treatment without S9 and at 6-18h tretament with S9]",[+],#[+] only above 10 mM,,,[+] only above 10 mM#Moore et al 1987; [+] at 2 mM in V79 cells#Tsuda et al 1993; [+]#Martins et al 2007; [+]#Oliveira et al 2009; [+] at lower concs in CHL cells#JETOC 2008,[+],,[+],,,[+],,,[+]#Krishna and Theiss 1995; #Paulsson et al 2002; #Ghanayem et al 2005; #Manjanatha et al 2006; #Zeiger et al 2009; #OECD SIDS 2001; #EC RAR 2002,[+],,,,,,,[+]#Krishna and Theiss 1995,[+],[+],,,,,,[+] (published and unpublished),"[+] in testis of young but [-] in old male rats and [-] in liver, drinking water; [+] in liver of male and female mice and in lung, brain and testes of male mice, drinking water; [+] in liver, bone marrow and testis of male mice, ip",#Hoorn et al 1993; #Myhr 1991; #Wang et al 2010; #Manjanatha et al 2006; #Manjanatha et al 2015; #Koyama et al 2011; #Krebs and Favor 1997; #Douglas unpublished,[+],[E],,,,,,,[E],[+],,,,,,[+],,[+],,[+]#Rothfuss et al 2010,"[+] in liver, thyroid, testicular mesothelium and adrenal medulla of male rats via drinking water, and in leukocytes, duodenum, testes, thyroid and brain but mixed results in liver, bone marrow and stomach and sperm of male rats via gavage; [+] in liver, leukocytes, duodenum, testes (germ and somatic cells), brain and spleen of male mice via gavage; [+] in stomach, colon, lung, bladder, bone marrow, liver, spleen, kidney and blood but [-] in brain of male mice via ip; [+] in liver and leukocytes but [-] in lung of female mice and [-] in all 3 tissues in CYP2E1-null mice via ip ",#Friend et al 1993;#Dobrovolsky et al 2016;#Ghanayem et al 2005;#Koyama et al 2011;#Maniere et al 2005;#Recio et al 2009;#Sasaki et al 2000;#Tice et al 1990;#Tice et al 1991;#Zamorano-Ponce et al 2006,[+]
11,Aldicarb,116-06-3,QGLZXHRNAYXIBU-WEVVVXLNSA-N,CNC(=O)O\N=C\C(C)(C)SC,"1,130",[-],,,,[-],"[-] in TA97, TA98, TA100, TA1535, TA1537#Zeiger et al 1988;#Dunkel et al 1985",,,,,,"[-] in TA97, TA98, TA100, TA1535, TA1537, E.coli WP2 uvrA #ECVAM Review 2016",[-],,[+],,, [+] at high conc only,[U],,,,[-] in Hprt locus#Wang et al 1998,[I],,,,,,,"weak [+] in CHO cells < 2-fold, but top conc 32 ug/ml not toxic, only treated without S9#Wei et al 1997",weak [+],[-],,,[-] ,#up to 5000 ug/ml,,,"weak [+] in human lymphocytes with S9, but no cytotox measure#Gonzalez Cid and Matos 1987",[E],,,,,,,,"[+] in rats#Hamam and Foda 2004; weak [+] in mouse retics, ip and oral, no clear dose-response, overall [E]#Wei et al 1997; [-] in mice at oral doses close to LD50#Kevekordes et al 1996",[E],,,,,,,"[+] in rats, data questionable#Hamam and Foda 2004; [-]#APVMA Doc 2001",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
12,Aldrin,309-00-2,QBYJBZPUGVGKQQ-SJJAEHHWSA-N,ClC1=C(Cl)[C@@]2(Cl)[C@H]3[C@H]4C[C@H](C=C4)[C@H]3[C@]1(Cl)C2(Cl)Cl,"6,500",[-],,,,,,,,[-],#EFSA Journal 285 2005,,"[-] in TA98, TA100, TA1535, TA1537#Moriya et al 1983; #De Flora et al 1989; [-] in E. coli WP2 Try- (auxotrophic which can reverse to prototrop. By true reverse or induction ochre mut UAA#Ashwood-Smith et al 1972; [-] in E.coli#Fahrig 1974; [-] in E. coli WP2, WP2(HCR)#Shirasu 1975;#ATSDR 2002b",[-],,,,,,,,,,[+] in V79 cells without S9#Ahmed et al 1977,[+],,,,,,,,,[+],#Ishidate et al 1988,,,,,,[+] in human lung cells#Majumdar et al 1976; [+] SCE in CHO cells with dieldrin#Galloway et al 1987,[+],,[-],#Rani et al 1980,,,,,,[-],[+],#Georgian 1975,,,,,"[+] in swiss mice#Rani and Reddy 1986; [+] mice with dieldrin, ip#Majumdar et al 1976",[+],,,,,,,,,,,,,,,,,,,,,,,,,[-],,,,,"[-] in stomach, colon, liver, kidney, bladder, lung, brain and bone marrow of male mice via oral",,[-]
13,Allura Red AC (Food Red 40),25956-17-6,CEZCCHQBSQPRMU-LLIZZRELSA-L,[Na+].[Na+].COc1cc(c(C)cc1N=Nc2c(O)ccc3cc(ccc23)S(=O)(=O)[O-])S(=O)(=O)[O-],"-0,550",,,,,[-],"[-] in TA97, TA98, TA100, TA1535",,,,,,"[-] in TA98, TA100, TA1537, TA1538, weak [+] in TA1535#Brown et al 1978;#Muzzall and Cook 1979;#Chung et al 1981;#Prival et al 1988; [-] in TA97, TA102#Fujita et al 1992; [-] in E. coli#Haveland-Smith and Combes 1980; [-]#Zeiger and Margolin 2000; [+] in TA102, after reduction by faecal bacteria due to oxygen radicals#Sweeney et al 1994",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,[-] in mouse bone marrow after ip injection at 2000 mg/kg#Abramsson-Zetterberg and Ilback 2013,[-],,,,,,,,,,,,,,,,[-] for cII mutations in glandular stomach and liver of MutaMouse at 1000 mg/kg/day for 28 days,#Honma et al 2015,[-],,,,,,,,,,,,,,,,,,,,"[+] in stomach, colon and lung, but [-] in liver, kidney, bladder, brain and bone marrow of mice via oral up to 2000 mg/kg when isolated nuclei processed; [-] in all tissues (including colon) in rats; [-] in glandular stomach and liver of mice via oral 2 daily up to 2000 mg/kg when whole cells processed",#Tsuda et al 2001;#Honma 2015;#Shimada et al 2010,[E]
14,Alosteron ,122852-42-0,JSWZEAMFRNKZNL-UHFFFAOYSA-N,Cc1[nH]cnc1CN2CCc3c(C2=O)c4ccccc4n3C,"2,323",,,,,,,,,,,,"[-] in TA98, TA100, TA1535, TA1537#Brambilla and Martelli 2009; [-] in E. coli#BfArM Doc",[-],,,,,,,,,,[-] in Tk locus#Brambilla and Martelli 2009; [-] up to 500 µg/ml#BfArM Doc,[-],,,,,,,,,,,,,,,,[-]#Brambilla and Martelli 2009; [-] human lymphocytes up to 1000 µg/ml#Bafrm Doc,[-],,,,,,,,"[-] in rat bone marrow, 2 studies: 1) up to 40 mg/kg 1x, po and 2) up to 12.5 mg/kg 1x, iv #Brambilla and Martelli 2009",[-],,,,,,,,,,,,,,,,,,,,,,,,,"[-] in rat liver, up to 100 mg/kg single po#Brambilla and Martelli 2009 ",[-],,,,,,,,,,,,,,
15,11-aminoundecanoic acid,2432-99-7,GUOSQNAUYHMCRU-UHFFFAOYSA-N,NCCCCCCCCCCC(=O)O,"-0,160",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537 up to 10000 ug/plate, w/out S9#Mortelmans et al 1986 ",[-]," [-] in TA98, TA100, TA1535, TA1537, TA1538 and E. coli WP2 uvrA, w/out#Benfenati DB",,,,"[-] in TA98, TA100, TA1535, TA1537, TA1538 and E. coli WP2 uvrA, up to 5000ug/plate, w/out S9#OECD SIDS 2002",[-],,[+],,,[+],[U],,,,,[I],,,,,,,,,[-],,,[-] ,"#in CHO cells up to 1000 ug/ml, w/out S9 ",,,,[-],,[-],#Shelby and Witt 1995,,[-],,,"[-] in male mice up to 500 mg/kg, 3x ip doses#Shelby et al 1993",[-],[-],,,[-],,,[-] in bone marrow of male mice after single ip dose#Shelby and Witt 1995,[-],,,,,,,,,,,[-],#Madle et al 1994,,,,,[-] in male rat liver up to 1000 mg/kg gavage#Mirsalis et al 1989,[-],,,,,,,,,,,,,,
16,"Amitrole (3-amino-1,2,4-triazole)",61-82-5,MPSUGQWRVNRJEE-UHFFFAOYSA-N,Nn1ccnn1,"-0,860",[-],,,,[-],"in TA97, TA98, TA100, TA1535, TA1537",,,[-],"[-] in TA98,  TA100, TA1535, TA1537 and E.coli WP2, w/out S9 (Wallner Study)#EC DRAR 2013; #EFSA Jounal 12 2014a",,[-] in E. coli#Moriya et al 1983,[-],,[-],#Mitchell et al 1997,,,[U],,,,,[I],,,,,,,,,[-],,,[-],,,[-] in human lymphocytes #EC DRAR 2013,,[-],,[-],#Carver et al 1985,,,,, [-]#Tsuchimoto and Matter 1981; weak [+] not confirmed#Salamone et al 1981; [-]#Herbold 1982;#JPMR Doc;#EHC Doc,[-],[-],#Carver et al 1985,,,,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
17,Ampicillin trihydrate,7177-48-2,RXDALBZNGVATNY-UHFFFAOYSA-N,O.O.O.CC1(C)SC2C(NC(=O)C(N)c3ccccc3)C(=O)N2C1C(=O)O,"1,450",[-],#Zeiger 1997,,,,,,,,,,[-] in TA102#Kirkland et al 2016,[-],,[-] ,up to 2000ug/ml#Mitchell et al 1997,,[-],[U],,,,,[I],,,,,,,,,[-],,,[-] ,#up to 1.5 mg/ml,,,[-] up to 10 mg/ml#Stemp et al 1989; [+] at conc higher than plasma conc#Jaju et al 1984,[-],,,,,,,,[-] with 2 different protocols up to 5g/kg#Stemp et al 1989,[-],,,,[-],,,[-]#Anderson et al 1990; [+] in human peripheral lymphocytes#Jaju et al 1984; [-] in human fibroblasts#Byarugaba et al 1975; [-] SCE in human lymphocytes#Jaju et al 1984,[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,[-],,[-] in stomach and liver of male rats via oral,,[-]
18,Anilazine,101-05-3,IMHBYKMAHXWHRP-UHFFFAOYSA-N,Clc1ccccc1Nc2nc(Cl)nc(Cl)n2,"3,880",[-],,,,[-],"in TA97, TA98, TA100, TA1535, TA1537",,,,,,"[-] in TA97, TA98, TA100, TA1535, TA1537, E. coli WP2#ECVAM Review 2016; [-] in E. coli WP2uvrA#Dunkel et al 1985; [-] in TA strains and E. coli, no details#Moriya et al 1983",[-],,[+],,,[+],[+],,,,"[-] in Hprt locus in CHO cells up to 50% toxicity without S9, >90% toxicity  with S9#Oshiro et al 1991; [+] in Tk locus in TK6 cells#Caspary et al 1988",[+],,,,,,,"[+]in CHO cells, 3x without S9, 5x with S9 #Oshiro et al 1991",[+],[-],,,[-] overall,#weak [+] at toxic conc with S9 in 1/2 experiments,,,NTP result concluded [+] by #Shelby and Stasiewicz 1984,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
19,Aniline/Aniline hydrochloride,142-04-1/62-53-3,PAYRUJLWNCNPSJ-UHFFFAOYSA-N / MMCPOSDMTGQNKG-UHFFFAOYSA-N,Nc1ccccc1 / Cl.Nc1ccccc1,,[-],,,,[-],,,,,,,[-]#Bohmard and Herbold 2006,[-],,,,,[+],,,,,"[+] in Tk locus, free base#McGregor et al 1981; [-] in Hprt locus in V79 cells, without S9, free base#Fassina et al 1990; [+] false, free base#Bohmard and Herbold 2006; [+] in Tk studies; [-/+] in Hprt studies, free base#MAK Value Doc 2010b; controvresial findings#EU RAR 2004",[+],,,,,,,[-] in CHO cells without S9#Fritzenschaf et al 1993#EU RAR 2004; [-] in CHL/IU without S9 but [+] with S9#Matsushima et al 1999;#MAK Value Doc 2010b,[+],[+],free base#Ishidate et al 1983,,[+],"weak [+] in CHO cells and [+] SCE, free base#Galloway et al 1987",,,"[-] in CHL cells without S9#Ishidate et al 1983; #Ishidate and Odashima 1977; [-] in CHO cells without S9#Abe and Sasaki et al 1977; [+] in CHO cells without S9, free base#Chung et al 1995; [+] free base#Chung et al 1996",[+],,[+],,,[+] in mice,,,[+] in mice#Witt et al 2000; [+] in mice#Westmoreland and Gatehouse 1991; [+]/[-] in male rats#Bohmard 2003; [+]#George et al 1990; free base: [+] in mice#Ress et al 2002; [+] in mice and rats#EU RAR 2004; several studies#Bohmard and Herbold 2006,[+],[+] ,,,,,,[-] in mice#Jones and Fox 2003; [+] in rats#Bohmard 2003; but at at haematotoxic doses#Bohmard & Herbold 2006; free base: [-] in mouse BM ip two doses with 24hrs interval#EC RAR 2004;,[+] at haematoxic concentrations,,,,,,,,,,,,,,,,,,,[+],,,,,,[+],,,,,,"alkaline elution: [-] in rat spleen# Parodi et al 1982; [+] in rat liver and kidney#Parodi et al 1982; [+] mouse liver, kidney#Cesarone et al 1982; [-] in mouse liver, kidney and BM#Parodi et al 1982; comet: [+] in colon, liver, bladder, lung, stomach, kidney male rats#Sekihashi et al 2002; [-] brain, BM male rats#Sekihashi et al 2002; [+] in mouse liver, bladder, lungs, brain, bone marrow#Sasaki et al 1999; [-] in mouse stomach, colon, kidney# Sasaki et al 1999",[+]
20,o-Anthranilic acid,118-92-3,RWZYAGGXGHYGMB-UHFFFAOYSA-N,Nc1ccccc1C(=O)O,"1,210",[-],,,,[-],[-]#Zeiger 1997; [-] in TA102#Gadupudi and Chung 2011,,,,,,,[-],,[+],#Mitchell et al 1997,,[+],[U],,,,[-] in Hprt locus#Oshiro et al 1991,[I],[+] above 4000 ug/ml,Oshiro et al 1991,,,,,[-] in both p53 competent human and deficient hamster cells#Fowler et al 2012a,[-],"[+]
at >10 mM",,,[+],,,,,[-],,,,,,,,[-]#McFee 1989,[-],,,,,,,[-]#McFee 1989,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,[-],,[-] stomach and liver male rats via oral#Uno et al 2015,,[-]
21,Apicidin,183506-66-3,XWKJTSOFFKCRMH-YVHAWAGASA-N,CC[C@H](C)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]2CCCCN2C1=O)c3cn(OC)c4ccccc34,"4,038",[-],#Yoo and Lee 2005,,,,,,,,,,"[-] in TA98, TA100, TA102, TA100, TA1535, TA1537#ECVAM Review 2016",[-],,,,,,,,,,,,,,,,,,,,[+],#Yoo and Lee 2005,,,,,,[+] CCRIS; [+] in CHO cells w/out S9#Yoo and Lee 2005,[+],,[+],#Yoo and Lee 2005,,,,,"[+] at 1000 uM/kg, ip#Yoo and Lee 2005",[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
22,Aroclor 1254,11097-69-1,,Clc1ccc(cc1Cl)c2ccc(Cl)c(Cl)c2Cl,"6,500",[-],,,,[-],"in TA97, TA98, TA100, TA1535, TA1537",,,,,,"[-] in TA97, TA98, TA100, TA1535, TA1537, E. coli WP2#ECVAM Review 2016; [-] in standard strains and E. coli#Dunkel et al 1984",[-],,,,,,,,,,,,,,,,,,,,,,,"[-] in CHO cells, up to 50 ug/ml, w/out S9",,,,[+] in human lymphocytes at 48 hrs exposure#Sargent et al 1989,[E],,,,,"[-] in male mice up to 2000 mg/kg (single ip), 2 separate studies",,,,[-],,,,"[-] in male mice BM  up to 5000 mg/kg, single ip, 17 and 36 hrs",,,,[-],,,,,,,,,"weak [+] in lacI mice, 7 weeks diet#Davies et al 2000",weak [+],,,,,,,"[-] in SD rat, primary hepatocytes 300 ip single#Kornbrust and Dietz 1985; [-] in rat, primary hepatocytes, 500 ip single#Shaddock et al 1989; [-] in male cynomolgus monkey, primary hepatocytes, 50 ip single#Hamilton et al 1997;#IARC vol 107 2016",[-],,,,,,,,,,,,,[+] in mouse sperm at 4 mg/kg/day for 5 weeks via ip daily; evidence of oxidative damage#Attia et al 2014,[+]
23,"Aspirin, phenacetin, and caffeine",8003-03-0,PITMOJXAHYPVLG-UHFFFAOYSA-N,CCOc1ccc(NC(=O)C)cc1.CN2C(=O)N(C)c3ncn(C)c3C2=O.CC(=O)Oc4ccccc4C(=O)O,"4,588",[-],,,,,,,,,,,"[-] in TA1535, TA1537, TA98, TA100 and E. coli WP2#ECVAM Review 2016; [-] in TA98, TA100, TA1535, TA1537, TA1538 and E. coli WP2uvrA#Dunkel et al 1985",[-],,,,,,,,,,,,[-],,,,,,"[-] in NRK-49F cells up to 2.8 mM, non-toxic, without S9#Dunn et al 1987",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
24,Atrazine,1912-24-9,MXWJVTOOROXGIU-UHFFFAOYSA-N,CCNc1nc(Cl)nc(NC(C)C)n1,"2,610",[-],#Bartsch et al 1980,,,[-],"in TA97, TA98, TA100, TA1535, TA1537",[-],"[-] in TA97, TA98, TA100, TA1535, TA1537",,,"[-] in TA97, TA98, TA100, TA1535, TA1537, TA102, w/out S9","[-] in TA97, TA98, TA100, TA102, TA1535, TA1537#Mersch-Sundermann et al 1988; [-] in TA97, TA98, TA100, TA102, TA1535, TA1537#Ruiz and Marzin 1997",[-],,,,,,,,,,[-] in human lymphocytes#Surralles et al 1995a; [-] up to solubilty limit#Ribas et al 1998; [+] in CHO cells with S9#Roustan et al 2014,[E],,,,,,,,,[+],in human lymphocytes at moderate toxicity#Lioi et al 1998,,,,,,[-] in human lymphocytes up to solubilty limit#Ribas et al 1998; [-] in human lymphocytes up to solubilty limit#Kligerman et al 2000a; weak [+] at low concs#Meisner et al 1992; weak [+] in CHO cells#Rayburn et al 2001,[E],,,,,,,,"[-] at doses causing bone marrow toxicity, ip#Kligerman et al 2000b; [+] in rats after 7, 14 or 21 days, oral#Singh et al 2008; [+] in female mice#Gebel et al 1997; [+]#Campos-Pereira et al 2012; [+]#APVMA Doc 1997",[+],,,,,,,[E] or [-] in mouse BM after 30 days#Meisner et al 1992; [+]#Loprieno et al 1980,[E],,,,,,,,,,,,,,,,,,,,,,,,,[+],,,,,"[+] in male rats liver, blood, kidney, bone marrow and spleen (oral) and mice via ip","[+] in rat liver and blood after 7, 14 or 21 days oral#Singh et al 2008; [+]#McGregor and Anderson 1999",[+]
25,Benzaldehyde,100-52-7,HUMNYLRZRPPJDN-UHFFFAOYSA-N,O=Cc1ccccc1,"1,480",[-],#Zeiger 1997,[-],"[-] in TA98, TA100, TA1535, TA1537 and E. coli WP2 uvrA/pKM101, up to 5 mg/plate, w/out S9",[-],"in TA98, TA100, TA102, TA104, TA1535, TA1537",,,,,,"[-] in standard strains in several publications; [-] in TA97, TA102#Fujita et al 1992; [-] in TA102, TA104#Dillon et al 1998; [-] in E. coli#JETOC 2000",[-],,[+],,,[+],[U],[-],"[-] in Tk locus in L5178Y cells w/out S9, study dossier",,,[I],,,,,"[-] MN in human PBL, w/out S9",,,[-],[+],#Ishidate  et al 1988,"[+] in CHL cells [6-18, 24-0 or 48-0h treatment without S9 and at 6-18h tretament with S9]","[-] up to 500 ug/ml without S9, 1600 ug/ml with S9",,[+] in CH B241 cells with S9,,[+] in CHL cells without S9#Kasamaki et al 1982; [-] with S9#JETOC 2005; [-] with S9#Sofuni et al 1985,[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
26,Benzene,71-43-2,UHOVQNZJYSORNB-UHFFFAOYSA-N,c1ccccc1,"2,130",[-],#Zeiger 1997,,,[-],,[-],"[-] in TA97, TA98, TA100, TA1535, w/out S9; some [+] in TA1535  with S9 but not dose dependent",,,"[-] in standard strains and TA102, w/out S9",[-]#Baker and Bonin 1985;#Rexroat and Probst 1985;#Zeiger and Haworth 1985;#Brams et al 1987;#Jung et al 1992;#Mueller et al 1993; [-] with 2E1 inducers including TA102#Burke et al 1994; [+] in TA1535 using dessicator#Glatt et al 1989,[-],,[+] ,#Mitchell et al 1997,,[-],[U],,,,[+] in Tk locus locus#Oberly et al 1985; [+]#Styles et al 1985; Probable [+]#Sofuni et al 1996; [E]#Oglesby et al 1989; [-]#Amacher and Turner 1985; [-] in Hprt locus#Kuroda et al 1985; [-] in Hprt locus#Fox and Delow 1985; [-] in Hprt locus#Zdzienicka and Simmons 1985; [-] in Hprt locus#Oberly et al 1990; [+] in Hprt locus#Tsutsui et al 1997,[E],[+],#Matsushima et al 1999,,,,,[+]#Piesova and Sivikova 2003; [+]#Crofton-Sleigh et al 1993; [+]#Jiang et al 2014; [-]#Von der Hude et al 2000,[+],[+],#Ishidate et al 1988,,[-],[-] CA and [+] SCE#Gulati et al 1989 ,,,[+]#Sivikova et al 2005; [-] for structural and [+] for numerical#Tsutsui et al 1997,[+],,,,,[+],[+],,[+]#Ciranni et al 1988;#Mavournin et al 1990;#Farris et al 1996;#Ress et al 2002;#Chen et al 1994;#Wetmore et al 2008;#Kitamoto et al 2015;#Shelby and Witt 1995,[+],,,,[+],,,[+]#Ciranni et al 1991;#Fujie et al 1992;#Eastmond et al 2001,[+],,,,,,,[+],"[+] in bone marrow at low doses but [-] at high doses, [+] in spleen at intermediate dose, [-] in lung of male mice, dosing period only 14 days, gavage; [+] in lung and spleen but [-] in liver of male mice, 12 weeks inhalation",#Provost et al 1996;#Mullin et al 1995; [+]#Lambert et al 2005,[+],,,,,,,,,[+],#Tuo et al 1996,,,,,[+],,[+],[-],,"[+] in peripheral blood, bone marrow and liver but [-] in spleen of female mice (inhalation); [+] in stomach, liver, colon, kidney, bladder and brain but [-] in lung and bone marrow of male mice via ip; [+] in stomach, liver and lung, conflicting results in bone marrow and brain in 2 papers from same lab, but [-] in colon, kidney and bladder of male mice (oral); [+] in lymphocytes and bone marrow of male mice (gavage); [+] in stomach, colon, liver, kidney, bladder, lung and brain but [-] in lymphocytes and bone marrow of male rats (oral); however, also reported [-] in liver and stomach but +ve in bone marrow of male rats (gavage); [+] in liver and kidney of female rats (intramuscular); also [+] in lymphocytes of humans",#Andreoli et al 1997;#Plappert et al 1994a;#Plappert et al 1994b;#Sekihashi et al 2001;#Sekihashi et al 2002;#Tuo et al 1996;#Tuo et al 1999;#Verma and Rana 2011;#Kitamoto et al 2015,
27,Benzoate sodium,532-32-1,WXMKPNITSTVMEF-UHFFFAOYSA-M,[Na+].[O-]C(=O)c1ccccc1,"-2,270",[-],,,,,,,,,,"[-] in standard strains and TA102, w/out S9","[-] in TA92, TA94, TA98, TA100, TA1535 and TA1537, up to 3.0 mg/plate, at the max dose#SCCNFP/0532/01; [-] in E. coli#Ishidate et al 1984; [-] in TA 98, TA 100, TA 1535, TA 1537, TA 1538 and  E. coli  WP2#Prival et al 1991;#CICAD 26 WHO 2000; [-]#OECD SIDS 2001b",[-],,,,,,,,,,,,,,,,,,[+] in Human lymphocytes#Zengin et al 2011,[+],[+],#Ishidate et al 1988,,,,,,"[+] in CHL max eff dose 2mg/ml (138.8x10^-4 M)#Ishidate and Odashima 1977; [-] in HPLT cells, 2-20-200 mg/kg#Zengin et al 2011; [+] Bibra working group 1989",[+],,,,,,,,,,,,,,,,"[-] in rats, gastric intubation (50-500-5000 mg/kg) aberrations in bone marrow metaphase chromosomes#Litton Bionetics 1974; [-]#Bibra working group 1989; [-] DL in Rats (50-500-5000 mg/kg) oral intubation#Litton Bionetics 1974",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,[-]#Sasaki et al 2002,"[-] in stomach, colon, liver, kidney, bladder, lung, brain and bone marrow of male mice (oral)",,[-]
28,Benzoic acid,65-85-0,WPYMKLBDIGXBTP-UHFFFAOYSA-N,OC(=O)c1ccccc1,"1,870",,,,,[-],"in TA97, TA98, TA100, TA1535, TA1537",,,,,,"[-] in TA97, TA98, TA100, TA1535, TA1537, TA102#ECVAM Review 2016; [-] in TA97a, TA102#Fujita and Sasaki 1986",[-],,,,,,,,,,,,,,,,[-] in L5178Y cells w/out S9 up to 1000 ug/ml (toxic),,,[-],,,,,,,,[E] 24 hr or 48 hr continuos treatment without S9 mix up to 1.5 mg/mL (12 mM)#Sofuni 1998; [-] in human lymphocytes without S9#Zhurkov et al 1975,[I],,,,,,,,,,,,,,[-] Sodium benzoate for CA in rat bone marrow up to 5000 mg/kg (read across),,,[I],,,,,,,,,,,,,,,,,,,,,,,,,,,,,[-]#Sasaki et al 2002,"[-] in stomach, colon, liver, kidney, bladder, lung, brain and bone marrow of male mice (oral)",,[-]
29,Benzoin,119-53-9,ISAOCJYIOMOJEB-UHFFFAOYSA-N,OC(C(=O)c1ccccc1)c2ccccc2,"1,840",[-],,,,[-],[-]#Zeiger and Haworth 1985; [-]#Mortelmans et al 1986 ,,,,,,[-] in TA102#Mueller et al 1993; [+] in E. coli#Rexroat et al 1995,[-],,[-],,,[+],[U],,,,[E] in Hprt locus#Flowers and Li 1988; #Stankowski et al 1988; [-] in AS52/Xprt locus#Oberly et al 1993; [+] in Hprt locus#Lee and Webber 1985; #Kuroda et al 1985,[E],,,,,,,[-]#Fritzenschaf et al 1993,[-],[+],,,[-]/[E],[-] CA in CHO cells; [E] SCE in CHO cells#Gulati et al 1989,,,"[+] in only 1 study in CHL cells, but [-] in other studies and cell types at higher concs#Ishidate et al 1988",[-],,,,,"[-] mouse bone marrow, 3x ip#Shelby et al 1993",,,"[-] Male ICR/JCL mice single ip (250, 500, and 1000 mg/kg) #Ishidate and Odagiri 1989;  [-]in mice FM#Sheldon 1989b; [-] mouse bone marrow, ip#Shelby and Witt 1995;",[-],,,,"[-] mouse BM, 750-3000 mg/kg, single ip, non-stand method#McFee and Lowe 1989",,,[-]#Shelby and Witt 1995,[-],,,,,,,,,,,"[-] in Fischer 344 rats, hepatocytes isolated 12, 24 or 48 h at 750 mg/kg gavage",#Bermudez et al 1989,,,,,[+] in vitro rat hepatocytes#Glauert et al 1985,[-],[-],#Sasaki et al 2000,,,,,,[-],,,,"[-] in stomach, colon, liver, kidney, bladder, lung, brain and bone marrow of male mice (oral)"," [-] strand breaks in Fischer 344 rats, hepatocytes isolated 12, 24 or 48 h at 750 mg/kg gavage##Bermudez et al 1989; [+] alkaline elution in rat and mouse liver, change in DNA coil without breaks#Parodi et al 1989",[-]
30,Benzyl alcohol,100-51-6,WVDDGKGOMKODPV-UHFFFAOYSA-N,OCc1ccccc1,"1,100",[-c],,,,[-],#Mortelmans et al 1986,,,,,,[-] in TA102#Fujita et al 1992;[-] #Fall at al 2007,[-],,[E],,,weak [+] at high conc [30-40 mM],[U],,,,,[I],,,,,,,[-] in both p53 competent human and deficient hamster cells#Fowler et al 2012a,[-],"[+]
at >10 mM",,,weak [+] only at high conc [30-40 mM],,,,,[-],,,,,,,,[-]#Hayashi et al 1988,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,[+],#Sasaki et al 2000,,,,,,[+],,,,,"[+] in stomach, colon and bladder but [-] in liver, kidney, lung, brain and bone marrow of male mice (oral)",[+]
31,n-Butyl chloride,109-69-3,VFWCMGCRMGJXDK-UHFFFAOYSA-N,CCCCCl,"2,640",[-],,[-],"[-] in 4 TA strains and E. coli WP2 uvrA, w/out S9",[-],[-]#Zeiger et al 1987; #Zeiger 1990,[-],"[-] in TA98, TA100, TA1535, TA1537 and E. coli WP2 uvr A, w/out S9#Benfenati DB",,,,[-] in E. coli#OECD SIDS 1997,[-],,[-],,,,[U],,,,[-] for 6/7 MLA trials#Mitchell et al 1997,[I],,,,,,,[-] for 24 hrs without S9#Sobol et al 2007,[I],[-],,"[-] in CHL cells at 6-18, 24-0 or 48-0h treatment without S9 and at 6-18h treatment with S9",[-],,,,[-] up to 5mg/ml#Anderson et al 1990,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
32,tert-Butyl alcohol,75-65-0,DKGAVHZHDRPRBM-UHFFFAOYSA-N,CC(C)(C)O,"0,350",[-],,,,[-],[-]#Zeiger et al 1987,,,,,,[-] in TA102#McGregor et al 2005,[-],,[-],,,[-],[U],,,,,[I],,,,,,,,,[-],,,[-],,,,,[-],,[-],,,"[-] in mouse PB, drinking water for 13 wks; [-] in rat BM, ip injection ",,,[-] no effect#MAK Value Doc 2003,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
33,Butylated hydroxyanisole,25013-16-5,,COc1ccc(O)c(c1)C(C)(C)C,"3,500",[-],#Zeiger et al 1992,,,[-],"in TA97, TA98, TA100, TA1537, TA104#Zeiger et al 1992",,,,,,"[-] in TA97, TA98, TA100, TA102, TA104, w/out S9#Hageman et al 1988; [-] in TA102, TA2638 and E. coli WP2, with S9 only#ECVAM Review 2016; #Watanabe et al 1998",[-],,,,,,,[-] in Hprt locus in CHO cells w/out S9 up to 2.5 mM which was toxic,,,[-] in Hprt locus in V79 cells w/out activation by rat or hamster hepatocytes#Rogers et al 1985; [-] in Hprt locus in adult rat liver cells#Williams et al 1990,[-],[+] in CHL cells with S9,#Matsushima et al 1999,,,,,,[+],[+] in CHL cells only with S9,#Matsuoka et al 1990,,,,,,"[+] in CHO cells only with S9, due to reactive oxygen#Phillips et al 1989; [-] in Don and CHL cells tested without S9#Ishidate et al 1988; [-]#Williams et al 1999",[+],,,,,"[-] in male rats up to 1250 mg/kg, 3x daily gavage doses ",,,"[-] in male mice, single or 4 daily ip doses#Hayashi et al 1988; also see#Williams et al 1999",[-],,,,,,,,,,,,,,,,,,,,,,,,,"[-] in mouse forestomach, single oral#Benford et al 1994",[-],,,,,,,[+],,,,[+]#Sasaki et al 2002,"[+] in stomach and colon; but [-] in liver, kidney, bladder, lung, brain and bone marrow of male mice via oral",,[+]
34,Butylated hydroxytoluene,128-37-0,NLZUEZXRPGMBCV-UHFFFAOYSA-N,Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C,"5,100",[-],,,,[-],"in TA98, TA100, TA1535, TA1537#Mortelmans et al 1986",,,,,,"[-] in TA97, TA98, TA100, TA102, TA104, w/out S9#Hageman et al 1988; [-] in TA102, TA2638 and E. coli WP2, with S9 only#Watanabe et al 1998; [-] in TA97, TA98, TA100, w/out S9#Brams et al 1987; [-] in TA98, TA100, w/out S9#Yoshida et al 1990;#Yamaguchi et al 1991;#ECVAM Review 2016",[-],,[+],,,[+],[+],[-],"[-] in Hgprt locus in ARL rat cells, w/out S9#William et al 1990; [-] in DT (diphtheria toxin) locus in EUE cells, w/out S9#Ferreri et al 1986; [-] in Tk locus, w/out S9#Kim et al 2007 reported but not found",,[+] in Hprt locus in V79 cells#Paschin and Bahitova 1984,[+],,,,,,,,,[-],,,[-],"#[-] in CHO cells  without S9 and at 1.6 ug/ml with S9, weak increases at 5 and 16 ug/ml with S9, but [-] call overall",,,"[-] in CHO, CHL and V79 cells, but [+] in WI-38 cells#Bomhard et al 1992; [+] in CHO cells#Williams et al 1999; [-] in Don and CHL cells when tested without S9#Ishidate et al 1988; [+] in CHO cells#Grillo and Dulout 1997; [+] structural and numerical CA in CHO cells without S9 but no cytotox data and no dose response#Patterson et al 1987",[E],,[-],[-] in mouse bone marrow#Bomhard et al 1992,,"[-] in male mice, up to 600 mg/kg3x ip","[-] in mouse bone marrow up to 600 mg/kg, 3x ip; [-] in female mice up to 1000 mg/kg, 5 days ip",,"[-] in mouse bone marrow, 75 mg/kg single ip#Paschin et al 1986; [-] in mouse bone marrow#Karamova et al 1997",[-],[-],[-] in rat bone marrow#Bomhard et al 1992,,,"[-] in rat bone marrow up to 100 mg/kg single, or up to 500 mg/kg 5 days, oral",,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,[+]#Sasaki et al 2002,"[+] in stomach, colon, bladder and brain; but [-] in liver, lung, kidney and bone marrow of male mice via oral","[+] alkaline elution in female rat liver, 700 mg/kg oral#Kitchin and Brown 1994",[+]
35,gamma-Butyrolactone,96-48-0,YEJRWHAVMIAJKC-UHFFFAOYSA-N,O=C1CCCO1,"-0,640",[-],#Zeiger 1997,,,[-],"in TA98, TA100, TA1535, TA1537",[-],"[-] in TA98, TA100, TA102, TA104, TA1535, TA1537, E. Coli WP2uvrA, and WP2uvrA\pKM101, up to 5000 ug/plate, w/out S9, no data on neg or pos controls#Benfenati DB",,,,[-] in TA102#Aeschbacher et al 1989; [-] in TA104 and E. coli#JETOC 2000; [-] in Mutascreen test#Falck et al 1985,[-],,,,,,,,,,,,,,,,,,,,,,,clear [+]  with S9,,,,,[+],,,,,,,,[-]#Salamone et al 1981;#Tsuchimoto and Matter 1981; inadequate test#Mavournin et al 1990; [-]#EPA Doc 2006,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
36,Caffeine,58-08-2,RYYVLZVUVIJVGH-UHFFFAOYSA-N,CN1C(=O)N(C)c2ncn(C)c2C1=O,"-0,070",[-],,,,[-],"in TA98, TA100, TA1535, TA1537#Mortelmans et al 1986",[-],"[-] in TA98, TA100, TA1535, TA1537 and E. coli WP2 uvrA, w/out S9#Benfenati DB",,,,[-] in E. coli#Dunkel et al 1985; [-] in E. coli#Prival et al 1991,[-],,TC, [I]#Mitchell et al 1997 ,,,,,,,[-] in Tk locus up to toxic concs but only tested without S9#Amacher et al 1980; [+]#Clive et al 1990; [+]#Ogawa et al 2009,[+],[+],,,,,,[+]#Wakata and Sasaki 1987;#Dunn et al 1987;#Ogawa et al 2009,[+],[+],,,,,,,[-] up to 100 ug/ml#Aeschbacher et al 1985; [+] in various cell types from 80-2000 ug/ml#Ishidate et al 1988; [+]#Wakata and Sasaki 1987,[+],,[E],,,,,,weak [+]#Aeschbacher et al 1986; weak [+]#Haynes et al 1996; [-]#King et al 1979; [-]#Tsuchimoto and Matter 1979,[E],,,,,,,[-] in hamster#Tsuchimoto and Matter 1979,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
37,Calcium 3-hydroxy-4-[(4-methyl-2-sulphonatophenyl)azol]-2-napthoate,5281-04-9,VPWFPZBFBFHIIL-LLIZZRELSA-L,[Na+].[Na+].Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)[O-])c(c1)S(=O)(=O)[O-],,,,[-],"[-] in 4 TA strains and E. coli WP2 uvrA, up to 5 mg/plate, w/out S9",,,[-],"[-] in TA98, TA100, TA1535, TA1537 and E. coli, up to 5000 ug/plate (hamster S9 also used with TA98, TA100)",,,,,[-],,,,,,,[-] in Hprt locus in V79 cells up to 1000 ug/ml (ppt),,,,[-],,,,,,,,,,,"[-] in CHL cells at 6-18, 24-0 or 48-0h treatment without S9 and at 6-18h tretament with S9",,,[-] in V79 cells up to 250 ug/ml (ppt); [-] in CHL cells up to 5000 ug/ml,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
38,Caprolactam,105-60-2,JBKVHLHDHHXQEQ-UHFFFAOYSA-N,O=C1CCCCCN1,"0,660",[-],,,,[-],,[-],"[-] unamed study report 1979; [-] in TA98, TA100, TA1535, TA1537, TA1538#Greene et al 1979; [-] in TA102, up to 5000 ug/mL, with S9#Mueller et al 1993;#Jung et al 1992",,,"[-] in TA98, TA100, TA102, TA1535, TA1537, w/out S9",,[-],,[-],,,[-],[U],[-],"[I] in Hprt locus in CHO k1-BH4 cells w/out S9 but cytotoxic from 7500 ug/mL#Greene et al 1979; [I] in Hprt locus in V79 cells w/out S9 at 300 to 4000 ug/mL but short treat#Fox and Delow 1985; [-] in Tk locus in TK6, AHH-1, and V79 cells from 1000 to 5000 ug/mL#Crespi et al 1985; [I] in Tk locus in LY5178Y cells, 500 to 5000 ug/mL w/out#Myhr et al 1985",,,[-],,,,,[-] in SHE#Fritzenschaf et al 1993; [-] in CHL cells#Li et al 1993,,,[-],[E],#Ishidate et al 1988,,[-],,[+] but tested at 6 to 12 mg/mL#Ishidate et al 1985; [-] in CHO and rat liver RL4 cells at 200 to 2000 ug/mL#Dandord et al 1985; [-]#Priston and Dean 1985; [-]#Natarajan et al 1985;  several [+] results in human lymphocytes but very high dosage with sign of toxicity#Howard et al 1985;#Sheldon 1989a;#Kristiansen and Scott 1989;#Norppa and Jaerventaus 1989,,,[-],,,,,[-],"[-] in BM of B6C3F1 male mice#Shelby et al 1993; [-] in C57BL/6J mice#Sheldon 1989b; [-] in BM ICR/JCL male mice dosed ip, sign of toxicity#Ishidate and Odagiri 1989",,,[-],,,,," [-] in B6C3F1 mice BM, sign of toxicity/death at highest dose 1000 ug/mL#McFee and Lowe 1989; [-] in BM of 1C3F1 mice sampled after 24, 30 and 48 h #Adler and Ingwersen 1989",,,[-],,,,,,,,,,,,,,,[-] in F-344 rat hepatocytes#Bermudez et al 1989; [-] in Fischer 344 rat pachytene spermatocytes#Working 1989 ,,,[-],,,,,[-] in CD-1 mice and rat liver#Parodi et al 1989; [-]#Taningher et al 1987,,,,,,,,,[-]
39,"Chlordane, analytical grade",57-74-9,BIWJNBZANLAXMG-YQELWRJZSA-N,ClC1CC2C(C1Cl)[C@]3(Cl)C(=C(Cl)[C@@]2(Cl)C3(Cl)Cl)Cl,"6,160",[-],#Zeiger 1997,,,[-],"in TA98, TA100, TA1535, TA1537#Mortelmans et al 1986",,,,,,"[-] in TA98, TA100, TA1535, TA1537 and E. coli WP2#ECVAM Review 2016; [-] in E. coli#Probst et al 1981",[-],,,,,,,,,,"[+] in Tk locus without S9, 2 experiments#McGregor et al 1988b; [+] ouabain mutations in V79 cells#Ahmed et al 1977; [-] in Hprt locus in V79 cells but not clear if done w/out S9#Tsushimoto et al 1983",[+],[+],,,,,,[+] in beluga whale skin fibroblast without S9 but; weak [+] or [-] with S9#Gauthier et al 1999,[+],[-],,,[-] in CHO cells up to 20 ug/ml without S9 (not toxic); or up to 33.2 ug/ml with S9 (toxic),,,,,[-],,,,,,,,"[+] in mouse BM, at highest dose topical application#Schop et al 1990",[+],,,,,,,"[+] in mouse BM, 10 mg/kg gavage#Sarkar et al 1993",[+],,,,,,,,,,,,,,,,,,,,,,,,,[-],[-] no effect via po#Sasaki et al 2000,,,,"[-] in stomach, colon, liver, kidney, bladder, lung, brain and bone marrow of male lice via ip",,[-]
40,Chlorobenzilate,510-15-6,RAPBNVDSDCTNRC-UHFFFAOYSA-N,CCOC(=O)C(O)(c1ccc(Cl)cc1)c2ccc(Cl)cc2,"4,740",[-],,,,[-],"in TA97, TA98, TA100, TA1535, TA1537",,,,,,"[-] in TA97, TA1535, TA1537 (only with S9), TA98, TA100  and E. coli WP2 w/out#ECVAM Review 2016; [-] in E. coli#Moriya et al 1983",[-],,[+],,,"[+] and [-], 2 studies",[E],,,,"[-] in Tk locus, Hprt and ouabain loci in L5178Y cells, but only without S9#Back et al 1987; weak [+] without S9, [+] in 2-4 trials with S9#McGregor et al 1988b",[E],,,,,,,,,[-],,,[-] in CHO cells w/out S9 up to toxic concs,,,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
41,(2-Chloroethyl)trimethylammonium chloride,999-81-5,UHZZMRAGKVHANO-UHFFFAOYSA-M,[Cl-].C[N+](C)(C)CCCl,"-3,800",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537#Mortelmans et al 1986",,,,,,[-] in E. coli#California EPA 2002,[-],,[-],,,[-],[U],,,,,[I],,,,,,,,,[-],,,[-] up to 5 mg/ml,,,,,[-],,,,,,,,,,,,,,,,[-] in rat BM at 125-250-500 mg/kg with harvest times at 12-24-48 hrs#California EPA 2002,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
42,"Chlorpheniramine maleate 
[AKA pyridine,2-p-chloro-alpha-(2-
(dimethylamino)ethyl)benzyl)-, maleate (1:1),]",113-92-8,DBAKFASWICGISY-BTJKTKAUSA-N,CN(C)CCC(c1ccc(Cl)cc1)c2ccccn2.OC(=O)\C=C/C(=O)O,"2,822",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537",,,,,,[-] in TA102#Kirkland et al 2016, [-],,[-],[-]#Myhr et al 1990; [-]#McGregor et al 1991,,[-],[+],,,,,[+],,,,,,,,,[+],,,[+] at cytotoxic conc#Anderson et al 1990,,,,,[+],,,,,"[-] in mice and rats, via ip",,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
43,C.I. pigment yellow 12 (Diarylanilide yellow),6358-85-6,,CC(=O)C(N=Nc1ccc(cc1Cl)c2ccc(N=NC(C(=O)C)C(=O)Nc3ccccc3)c(Cl)c2)C(=O)Nc4ccccc4,"6,800",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537",[-],"[-] in TA98, TA100, TA102, TA1535, TA1537 w/out S9 with Prival modification#Benfenati DB; [-] in TA98, TA100, TA1535, TA1537; [+] in E. coli Prival modification ",,,,[-] in TA1538 even with reductive metabolism#Reid et al 1984,[-],,[-],,,[-],[U],[-] in Tk locus up to 1000 ug/ml (pptn),,,,[I],,,,,,,,,[-],,,[-] up to lethal concs,,,,,[-],,,,,,[-] in mice up to 5000 mg/kg ip,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
44,Citrinin,518-75-2,CQIUKKVOEOPUDV-IYSWYEEDSA-N,C[C@@H]1OC=C2C(=C(C(=O)O)C(=O)C(=C2[C@H]1C)C)O,"0,450",[-],,,,,,,,"[-] in TA98, TA100, TA102, TA1535, TA1537",#EFSA Journal 10 2012b,,"[-] in TA97, TA98, TA100 , TA102, TA1535, TA1537#ECVAM Review 2016; [-] in TA100#Takahashi et al 1992; [-] in TA102#Wuergler et al 1991; [-] in TA97, TA98, TA1535, TA1537#Sabater-Vilar et al 1999; [-] in TA98, TA100, TA1535, TA1537, TA1538, at up to 400 ug/plate#IARC vol 40 1986 ",[-],,,,,,,,,,,,,,,,,,"[+] in V79 cells, aneuploidogenic, CREST-positive#Pfeiffer et al 1998;  [+] in Hplt#EFSA Journal 10 2012b",[+],,,,,,,,[+] in V79 cells at only conc. 5 x10-4 M#IARC vol 40 1986; [-] in CHO-K1 cells#Liu et al 2003;  [+] in Hplt numerical aberration and [+] in V79 cells#EFSA Journal 10 2012b; [+] in human peripheral blood mononuclear cells#Chang et al 2011,[+] (numerical),,,,,,,,,,,,,,,,"[-] in mouse BM, ip#Bouslimi et al 2008; [+] in mouse BM 8 weeks, po#EFSA Journal 2012b",,,,,,,,,,,,,,,,,,[-] in Wistar rats primary hepatocytes and human embryonic hepatocytes#IARC vol 40 1986,[-],,,,,,,,,,,,,,
45,Clofibrate,637-07-0,KNHUKKLJHYUCFP-UHFFFAOYSA-N,CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1,"3,620",[-],,,,,,,,,,,"[-] in TA97, TA98, TA100, TA1535, TA1537, TA102#Dayan et al 1985;#Ishidate et al 1988; [-] in E. coli#Watanabe et al 1998",[-],,,,,,,,,,[-]in Hprt locus#Dayan et al 1985,[-],[-],[-] in hepatocytes#Mueller et al 1993,,,,,[-] in human RKO cells#Salazar et al 2009,[-],[+],[+] in CHL cells#Ishidate et al 1988,,,,,,[-] in SHE cells#Tsutsui et al 1993,[E],,,,,,,,[-]#Rothfuss et al 2010,[-],,,,,,,,,,,,,,,[-],[-] in liver of male and female mice (6 ip doses each of 90 mg/kg over 2 weeks) ,#Boerrigter 2004,[I],[-],#Nilsson al 1991,,,,,,[-],,,,,,,,,,,[-]#Rothfuss et al 2010,[-] in liver of male SD rats 300mg/kg/day for 29 days or 600 mg/kg/day for 3 days via gavage,,[-]
46,Curcumin,458-37-7,VFLDPWHFBUODDF-FCXRPNKRSA-N,COc1cc(\C=C\C(=O)CC(=O)\C=C\c2ccc(O)c(OC)c2)ccc1O,"3,290",,,,,[-],"[-] in TA98, TA100, TA1535, TA1537",,,,,,[-] in TA102#Kirkland et al 2016,[-],,,,,,,,,,,,,,,,,,[+] only with apoptosis#Mientieres et al 2003; [+] in both hamster p53 deficient and human p53 competent cells#Fowler et al 2012a,[+],,,,,,,,,,,,,,[-] oral dosing ,,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
47,Colchicine,64-86-8,IAKHMKGGTNLKSZ-UHFFFAOYSA-N,COC1=CC=C2C(=CC1=O)C(CCc3cc(OC)c(OC)c(OC)c23)NC(=O)C,"1,300",TC [-],,,,,,,,,,,"[-] in TA98, TA100, TA1535, TA1537, at 0.10 to 10 mg/plate, w/out rat or hamster liver S9, microsome preincubation, highest ineffective dose 10 mg/plate#Mortelmans et al 1986",[-],,[+] in Tk locus,,,,,,,,,[+],[+],[+] in human lymphocytes#Elhajouji et al 1997; [+]#Clare et al 2006,,,,,,[+],,,,,,,,[+]#Muehlbauer and Schuler 2005,[+],,[+],"[+] in mouse gut, gavage#Vanhauaert et al 2001",,,,,[+] in mouse PB#Cammerer et al 2007;#Asano et al 2006;[+] in mice BM#Mavournin et al 1990;[+] in mouse sRETs#De Boeck et al 2005;[+] in mouse liver#Igarashi et al 2007,[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
48,Coumaphos,56-72-4,BXNANOICGRISHX-UHFFFAOYSA-N,CCOP(=S)(OCC)Oc1ccc2C(=C(Cl)C(=O)Oc2c1)C,"4,130",[-],,,,[-],"[-] in TA97, TA98, TA100, TA1535, TA1537#Zeiger et al 1992",,,,,,"[-] in TA97, TA98, TA100, TA1535, TA1537 and E. coli WP2#ECVAM Review 2016; #Dunkel et al 1985",[-],,TC,,,[-],[U],,,,,[I],,,,,,,,,[-],,,[-] up to 1000 ug/ml,,,,,[-],,,,,,,,"[+] in mice 480 mg/kg48 hr, oral and [-] at 24 and 72 hrs#California EPA 1992 ",[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
49,Cyclohexanone,108-94-1,JHIVVAPYMSGYDF-UHFFFAOYSA-N,O=C1CCCCC1,"0,810",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537",[-],"[-] in TA98, TA100, TA1535, TA1537 and E.coli WP2 uvrA, up to 10 mg/plate, w/out S9#Benfenati DB",,,,"[-] in TA98, TA100, TA1535, TA1537#Florin et al 1980; [+] particularly in TA98 (abstract only)#Massoud et al 1980 ",[-],,[-],,,[-],[U],[-],[-] in Hprt locus up to 980 ug/ml (10 mM),,Re-evaluated as [+]#Seifried et al 2006,[E],,,,,,,[-] only tested without S9#Piesova et al 2003,[I],[-],TSCATS,,,,,,[+]#Collin 1971; [+]#Lederer et al 1971; [+]#Dyshlovoi et al 1981,[+],,,,,,,,,,,,,,[-] in rats (inhalation),,[+] in rats#De Hondt et al 1983,[E],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
50,Cypermethrin (Supercypermethrin),52315-07-8,KAATUXNTWXVJKI-HBFSDRIKSA-N,CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@@H](C#N)c2cccc(Oc3ccccc3)c2,"6,600",[-],TC [-]#Garajova and Miadokova 1991;#Miadokova et al 1992;#Miadokova et al 1993;#Pluijmen et al 1984; [-]#Simmon et al 1985,,,,,,,,,,"[-] in TA97, TA98, TA100, TA1535 and E. coli WP2 uvrA#ECVAM Review 2016",[-],,,,,,,,,,"[-] in Hprt locust in V79 cells, concentrations relatively non-toxic#Pluijmen et al 1984",[I],[+],,,,,,[+]#Surralles et al 1995b; [+]#Muranli et al 2013; weak [+]#Zeljezic et al 2016; [+] for a formulation#Kocaman and Topaktas 2009,[+],[+],,,,,,,[+]#Amer et al 1993; [+]#Suman et al 2006; [+]#Dianovsky and Sivikova 1995; [+] for a formulation#Kocaman and Topaktas 2009; [-]#Puig et al 1989,[+],,[+],,,,,,"weak [+] in mice, oral (7-14 days) and dermal (2-4 applications)#Amer and Aboul-ela 1985; [-] in mice, ip (2-3 injections)#Amer and Aboul-ela 1985;#Dianovsky and Sivikova 1995; weak [+] in mouse bone marrow, ip and sc#Bhunya and Pati 1988; clear [+] in rats after single or repeated admin#Assayed et al 2010",[+],weak [+],"weak [+] in mouse bone marrow, ip and sc#Bhunya and Pati 1988; weak [+]#Dianovsky and Sivikova 1995",,,,,"[+] in rat bone marrow, numerical but not structural CA #Institoris et al 1999; [+] in mouse bone marrow and spleen, structural CA , ip injection#Amer et al 1993;",weak [+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"[+] in brain, kidney, liver, spleen, bone marrow and lymphocytes of male mice via ip#Patel et al 2006; [-] in lymphocytes of rats after 60 days via oral#Gabbianelli et al 2004",[+]
51,"Daidzein (4',7-Dihydroxyisoflavone)",486-66-8,ZQSIJRDFPHDXIC-UHFFFAOYSA-N,Oc1ccc(cc1)C2=COc3cc(O)ccc3C2=O,"2,550",,,,,[-],"in TA97, TA98, TA1535, TA102, TA104",,,,,,[-]#Bartholomew and Ryan 1980,[-],,,,,,,,,,[-] in Hprt locus only without S9#Kulling and Metzler 1997; [+] in Hprt locus#Tsutsui et al 2003,[I],,,,,,,weak [+] only without S9#Kulling and Metzler 1997;#Di Virgilio et al 2004; [-]#Schmitt et al 2003;#Kulling et al 2002,[E],,,,,,,,[-]only without S9#Kulling et al 1999; [-] in SHE cells#Tsutsui et al 2003,[I],,,,,,,,,,,,,,,,,,,,,,,,[-],[-] in mammary gland of ovariectomised female rats (up to 100 mg/kg bw/day for 18 weeks in feed),#Manjanatha et al 2006,[-],,,,,,,,,,,,,,,,,,,,"[-]in male ICR mice, stomach only tested at a single dose of 1 mg/kg via gavage",#Toyoizumi et al 2010,[-]
52,Daminozide,1596-84-5,NOQGZXFMHARMLW-UHFFFAOYSA-N,CN(C)NC(=O)CCC(=O)O,"-1,500",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537#Zeiger et al 1987;[-] in E. coli in WP2 uvrA#Dunkel et al 1985",,,,,,,[-],,[E],,,[E] /questionable,[U],,,, [-]#Seifried et al 2006,[I],,,,,,,,,[-],,,[-],,,,[-] in CHO cells#California EPA 1991;#California EPA 2004,[-],,[E],NTP,,[E] in mouse BM,,,,[E],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
53,Dapsone,80-08-0,MQJKPEGWNLWLTK-UHFFFAOYSA-N,Nc1ccc(cc1)S(=O)(=O)c2ccc(N)cc2,"0,970",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537",[-],"[-] in TA98, TA100, TA1535, TA1537 and E.coli WP2 pKM 101, WP2 uvrA pKM 101#Study report 1999; [-] in E. coli WP2 uvrA#Publication 1985; [-] in TA98, TA100#Publication 1985",,,,"[-] in TA98, TA100, TA1535, TA1537 and E. coli WP2#ECVAM Review 2016; [-] in TA98, TA100#Tanaka et al 1985;  [-] in TA98, TA100#Takashi and Ono 1993; [-] four studies#Brambilla and Martelli 2009",[-],,[-],NTP,,[-],[U],[-],#Study report 2000,,,[I],,,,,,,,,[E],NTP,,weak [+],,[+]#Study report 2012,,[+] cytogenetic#Brambilla and Martelli 2009,[+],,,,,,"[-] in M and F mouse BM, po#Study report 2001",,the data set indicates that the substance is not genotoxic in vitro and in vivo#EFSA Journal 248 2005,[-],,,,,,,[-] cytogenetic#Brambilla and Martelli 2009,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
54,Decabromodiphenyl oxide,1163-19-5,WHHGLZMJPXIBIX-UHFFFAOYSA-N,Brc1c(Br)c(Br)c(Oc2c(Br)c(Br)c(Br)c(Br)c2Br)c(Br)c1Br,"12,110",[-],,[-],"[-] in 4 TA strains and E. coli WP2 uvrA/pKM101, up to 10 mg/plate, w/out S9 (In ISHL DB, the name is decabromodiphenyl ether)",[-],"[-] in TA98, TA100, TA1535, TA1537",[-],"[-] in TA98, 100, 1535, 1537 and E. coli WP2 uvrA, w/out S9#Benfenati DB",,,,"[-] in TA98, TA100, TA1535, TA1537 and E. coli#JETOC 2000",[-],,[-],,,[-],[U],,,,,[I],,,,,,,,,[-],,,[-] up to 500 ug/ml,,,,,[-],,,,,[+] in male rats after 3 ip doses (>4-fold at 1250 and 2500 mg/kg where no sign bone marrow toxicity) ,,,,[+],,,,,,,"[-] in rat bone marrow but part of repro study 90 days dosing, not designed for CA#Norris et al 1975",[I],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
55,Decalin,91-17-8,NNBZCPXTIHJBJL-UHFFFAOYSA-N,C1CCC2CCCCC2C1,"4,200",,,[-],"[-] in 4 TA strains and E. coli WP2 uvrA, w/out S9",[-],"in TA97, TA98, TA100, TA1535",[-],"[-] in TA98, TA100, TA1535, TA1537, up to 5000 ug/plate",,,,,[-],,,,,,,[-],[-] in Tk locus locus up to 450 ug/ml,,,[-],,,,,,,,,,,[-] in CHL cells at 6-18 or 24-0h treatment without S9 and at 6-18h tretament with S9,,,,,,[-],,,,,"weak [+] males, [-] females, 13-week inhlation study",,,,weak [+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
56,p-DDD,72-54-8,AHJKRLASYNVKDZ-UHFFFAOYSA-N,ClC(Cl)C(c1ccc(Cl)cc1)c2ccc(Cl)cc2,"6,020",[-],,,,,,,,,,,"[-] in TA98, TA100, TA1535, TA1537 and E. coli polA and some other strains old data#McCann et al 1975;#ATSDR 2002a",[-],,,,,,,,,,,,,,,,,,,,,,,[-],"[-] in CHO cells, w/out S9",,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
57,Diallyl phthalate,131-17-9,QUDWYFHPNIMBFC-UHFFFAOYSA-N,C=CCOC(=O)c1ccccc1C(=O)OCC=C,"3,230",TC [-],#Zeiger et al 1985; in TA100#Seed 1982,[-],"[-] in 4 TA strains and E. coli WP2 uvrA/pKM101, up to 5 mg/plate, w/out S9",[-],"in TA98, TA100, TA1535, TA1537",[+]/[-],"[+] in TA1535; [-] in TA98, TA100, TA1535, TA1537, up to 10 uL/plate",,,,"[-] in TA98, TA100, TA1535, TA1537 and E. coli (probably same data as ISHL)#JETOC 2000 ",[-],,[+],,,[+],[+],,,,[+]#Mitchell et al 1997; [+]#Myhr and Caspary 1991,[+],,,,,,,,,[+],NTP,,[+],,,,,[+],,[-],#Shelby and Witt 1995,,[-] in male mice (1 or 3 ip injections),,,[-]#Shelby et al 1993,[-],[+],#Shelby and Witt 1995,,[+] (> 2-fold but no clear dose-response) in mouse bone marrow (single ip injection),,,,[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
58,Diazinon,333-41-5,FHIVAFMUCKRCQO-UHFFFAOYSA-N,CCOP(=S)(OCC)Oc1cc(C)nc(n1)C(C)C,"3,810",[-],,,,[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537 and E. coli WP2#EFSA DAR 2004a; [-]#EFSA Scientific Report 85 2006",,,[-],,[+],,,[+],[U],,,[-] in Tk locus locus#EFSA DAR 2004a,,[E],[E],#Bianchi Santamaria et al 1997,,,,,,[E],[+],#Ishidate et al 1988,,[-],,,[-] in human lymphocytes#EFSA DAR 2004a; [E] to high cytotoxicity#EFSA Scientific Report 85 2006,[-] in HPLT w/out S9#JMPR 2016,[-],,,,,,,[-] in mouse BM erythrocytes#EFSA DAR 2004a,,[-],,,,,,"[-] in male mice germ cells, no GLP study#EFSA DAR 2004a",,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
59,"1,2-Dichlorobenzene",95-50-1,RFFLAFLAYFXFSW-UHFFFAOYSA-N,Clc1ccccc1Cl,"3,430",TC [-],#Haworth et al 1983;#Shimizu et al 1983;#Connor et al 1985,[-],"[-] in 4 TA strains and E. coli WP2 uvrA, w/out S9",[-],"in TA98, TA100, TA1535, TA1537",[-],"[-] in standard strains and E coli WP2 uvrA, up to toxic concs#Masumori et al 2001;#Azegami 2001",,,,,[-],,[+],,,[+],[+],[-],[-] in Hprt locus (no details),,[+]#Myhr and Caspary 1991,[+],,,,,,,,,[-],#Loveday et al 1990,,[-],,"[+] at cytotoxic or ppt conditions#Masumori et al 2001, probably same as CSCL data",,,[E],,[+], very weak [+] <2-fold at >50% of LD50#Mohtashamipur et al 1987,,[-] in male mice 3x ip injections or 65 days gavage,,,[-] 3x ip lower doses#Shelby et al 1993,[-],,,,weak [+] <2-fold at >50% of LD50 via ip in 1 study in mice; [-] at higher doses in 2nd study,,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,[-],,,,"[-] in stomach, colon, liver, kidney, bladder, lung, brain and bone marrow of male mice via oral",,[-]
60,Dichlorodifluoromethane,75-71-8,PXBRQCKWGAHEHS-UHFFFAOYSA-N,FC(F)(Cl)Cl,"2,160",[-],,[-],"[-] in 4 TA strains and E. coli WP2uvrA, up to 45 or 46% Gas exposure, w/out S9",,,[-],"[-] in TA98, TA100, TA1535, TA1537 and E. coli WP2, w/out S9",,,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,"[-] in Hprt locus in CHO cells, gas-air mixture for 19hr without S9, 5hr with S9",,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
61,"2,4-dichlorophenoxyacetic acid",94-75-7,OVSKIKFHRZPJSS-UHFFFAOYSA-N,OC(=O)COc1ccc(Cl)cc1Cl,"2,810",[E],,,,[-],"in TA98, TA100, TA1535, TA1537",,,,,"[-] in TA98, TA100, TA102, TA1535, TA1537, with/out S9",weak [+]#Kappas and Markaki 1988; mainly [-] in standard strains#Grover et al 1990;#Charles et al 1999a; [-] in TA102#Mersch-Sundermann et al 1988; [-] in E. coli#Brusick et al 1980;#Probst et al 1981, [-],,[+],,,,,,,,[+] in Hprt locus#Pavlica et al 1991,[+],,,,,,,,,[+],,,[+] with S9 (>2000 ug/ml) at early sampling but not at later sampling time,,,,[-]#Mustonen et al 1986; [+]#Nair et al 2005; [+]#Korte and Jalal 1982; [+]#Pilinskaya 1974,[E],,[-],,,,,,[-] at single ip dose of 100 mg/kg#Jenssen and Renberg 1976; [-] up to MTD (400 mg/kg) oral#Charles et al 1999b,[-],[+],,,,,,"[+] in mice, ip#Venkov et al 2000; [+] in rats, ip#Turkula and Jalal 1987; #Adhikari and Grove 1988; [+] dietary#Pilinskaya 1974; [+] in mice, oral gavage#Amer and Aly 2001",[+],,,,,,,,,,,[-],,,,,,[-] in rats up to 1000 mg/kg via oral#Charles et al 1999a,[-],,,,,,,,,,,,,,
62,Dicyclanil,112636-83-6,PKTIFYGCWCQRSX-UHFFFAOYSA-N,Nc1nc(NC2CC2)nc(N)c1C#N,"0,191",[-],#Lambert et al 2005,,,,,,,,,,"[-] in TA98, TA100, TA1535, TA1537 and E. coli#JECFA 45 2000;#Novartis GLP study 1992",[-],,,,,,,,,,[-] in Hprt locus#JECFA 45 2000,[-],,,,,,,,,[-],,,,,,,[-]#JECFA 45 2000;#Lambert et al 2005,[-],,[-],#Lambert et al 2005,,,,,[-]#JECFA 45 2000; [-] in male and female mice bone marrow#Burlinson et al 2017,[-],,,,,,,,,[+],#Lambert et al 2005,,,,,[+],"+ve in liver of female mice (gpt only), -ve in liver of male mice (diet); considered ""unreliable"" by Japanese FSC.",#Umemura et al 2007,[+],,,,,,,,,[-],#Moto et al 2003,,,,,,,,,[+]#Burlinson et al 2017,"[-] in stomach, colon, liver, kidney, bladder, lung, brain, bone marrow of male mice via oral; [+] in liver, duodenum, bone marrow of female mice, [-] all 3 tissues in male mice via oral",,[+] females
63,Dieldrin,60-57-1,DFBKLUNHFCTMDC-PICURKEMSA-N,ClC1=C(Cl)[C@@]2(Cl)[C@H]3[C@H]4C[C@H]([C@@H]5O[C@H]45)[C@H]3[C@]1(Cl)C2(Cl)Cl,"5,400",[-],,,,[-],"in TA98, TA100, TA1535, TA1537",,,,,,"[-] in TA98, TA100, TA102, TA1535, 1537#ECVAM Review 2016; [-] in E. coli WP2 uvrA#Dunkel et al 1985; [-] in TA1535, TA1536, TA1537, TA1538, 2 strains of E. coli#NIOSH 1978; [+]/ [-] in Sal and E. coli#ATSDR 2002b
",[-],,[+],#McGregor et al 1991,,[+],[U],,,,,[I],,,,,,,,,[+],#Ishidate et al 1988,,[-],,,,"[+] in WI-38 cells without S9#Ishidate et al 1988; [-] in CHO cells w/out S9#Galloway et al 1987; [+] in WI-38 cells without S9#ATSDR 2002b;#Majumdar et al 1976
",[E],,[+],,,,,,,[+],,,,,,,"[+] in mouse BM, ip#NIOSH 1978; [+] in mouse, ip, [-] in hamster, ip#ATSDR 2002b",[+],,,,,,,,,,,,,,,,,,,,,,,,,[-],,,,,"[-] in stomach, colon, liver, kidney, bladder, lung, brain and bone marrow of male mice via oral",,[-]
64,Diethanolamine,111-42-2,ZBCBWPMODOFKDW-UHFFFAOYSA-N,OCCNCCO,"-1,430",[-],,,,[-],"in TA98, TA100, TA1535, TA1537",,,,,,[-] in E. coli#IARC vol 101 2013,[-],,[-],,,[-],[U],,,,,[I],,,,,,,,,[-],#Loveday et al 1989,,[-],,,,,[-],,,,,"[-] in mice PB, dermally treated 13 weeks",,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,[-],,[-] in stomach and liver of male rats via oral,,[-]
65,Diethylene glycol,111-46-6,MTHSVFCYNBDYFN-UHFFFAOYSA-N,OCCOCCO,"-1,470",[-],,[-],"[-] in TA97a, TA98, TA100, TA102#Yoshida et al 1986",[-],"[-] in TA98, TA100, TA1535, TA1537#Zeiger et al 1987",[-],"[ambiguous] in TA98, TA100, TA102, TA104#Krug 1986; [-] in TA98, TA100, TA1535, TA1537 and E. coli WP2 uvrA#Study report 2013; [-] in TA98, TA100, TA1535, TA1537, TA1538#Study report 1984",,,,"[-] in TA98, TA100, TA102, TA1535, TA1537#ECVAM Review 2016; [-] in TA98, TA100, TA1535, TA1537#Pfeiffer and Dunkelberg 1980",[-],,,,,,,,,,,,,,,,,,,,,,,,,[-] in CHO cells#Study report 1984,,[-] in CHO cells#ECB 2000,[-],,,,,,"[ambiguous], ip#Krug 1986; [-] in mouse BM, ip#Study report 2009",,#MAK Value Doc 1998; #Danish EPA 2013,[-],,,,,,,"[+] in hamster, ip and po#ECB 2000",[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
66,Di(2-ethylhexyl)phthalate,117-81-7,BJQHLKABXJIVAM-UHFFFAOYSA-N,CCCCC(CC)COC(=O)c1ccccc1C(=O)OCC(CC)CCCC,"7,600",[-],,,,[-],"in TA98, TA100, TA1535, TA1537",[-],"[-] in E. coli#Study report 2003; [-] in TA102, TA2638 and E. coli WP2/pKM101 and WP2 uvrA/pKM101, w/out S9#Watanabe et al 1998; [-] in E. coli Wp2 uvrA and uvrA-#Yoshikawa et al 1983; [-] in TA97, TA98, TA100, TA102#Baker and Bonin 1985",[-],[-]#ECB RAR,"[-] in TA98, TA100, TA102, TA1535, TA1537 w/out S9",[-]#WHO Report 1992; [-] in TA102#Schmezer et al 1988;  [-] in TA102#Jung et al 1992;  [-] in TA102#Mueller et al 1993; [-] in E. coli#JETOC 1996; [+]#Tomita et al 1982;[-]#Agarwal et al 1985,[-],,[-],,,[-],[U],,,,[-]#Oberly et al 1985; [-]#Styles et al 1985; [-]in Hprt locus#Phillips et al 1982,[-],[-],#Muller-Tegethoff et al 1995,,,,,[-]#Von der Hude et al 2000,[-],[-],#Ishidate et al 1988,,[-],,,,[-]#Phillips et al 1982; [-]#Tsutsui et al 1993,[-],,[-],#Morita et al 1997; [-] in peripheral blood and hepatocytes #Douglas et al 1986;,,[-]; [E],,, [-]#Suzuki et al 2005; [-]#Kitamoto et al 2015,,[-],#IARC vol 77 2000,,[-],,,[-]#Putman et al 1983,[-],[-],#Lambert et al 2005,,,,,[-]; [+],"[-] in liver female mice and rats (diet for at least 11 weeks); [+] in liver, [-] in kidney and spleen male and female mice (route not specified)",#Gunz et al 1993;#Kanki et al 2005;#Boerrigter 2004,[E],[-],#Madle 1994,,,,,,[-],,,,,,,[-],,,[-],,"[-] in stomach, colon, liver, kidney, bladder, lung, brain and bone marrow of male mice via gavage; [-] in stomach, liver and bone marrow of male rats via gavage",#Kitamoto et al 2015; #Sasaki et al 2000,[-]
67,Diethylstilbestrol ,56-53-1,RGLYKWWBQGJZGM-ISLYRVAYSA-N,CC\C(=C(\CC)/c1ccc(O)cc1)\c2ccc(O)cc2,"5,070",[-],,,,[-],"in TA97, TA98, TA100, TA1535",,,,,"[-] in TA98, TA100, TA102, TA1535, TA1537,  w/out S9","[-] in TA97, TA98, TA100, TA1535#Baker and Bonin 1985; [-]#Rexroat and Probst 1985; [-]#Zeiger and Haworth 1985; [-]#Brams et al 1987; [-] even under different metabolic conditions#Glatt et al 1979; [-] in TA102#Jung et al 1992; [-] in TA102#Mueller et al 1993; [-] in E. coli#Dunkel et al 1984",[-],,[+],,,[+],[U],,,,[-]#Oberly et al 1985; [+] with S9#Styles et al 1985; [+] with S9#Sofuni et al 1996,[I],[+],#Matsushima et al 1999,,,,,[+]#Banduhn and Obe 1985; #Fritzenschaf et al 1993; #Von der Hude et al 2000; [+] centromere MN#Farooqi et al 1993; #de Stoppelaar et al 1997; #Quick et al 2008,[+],[+],#Ishidate et al 1988,,[+] most clearly with S9,,,,"[+] in mutiple studies in Chinese hamster cells and human lymphocytes, both w/out S9; [-] studies also reported#Ishidate et al 1988; [+] for numerical#Wheeler et al 1986; [+] for numerical#Tsutsui et al 1997; [+] for numerical#Schuler et al 1998; [-] for structural#Banduhn and Obe 1985",[+] (mainly numerical),,,,,"[-] in TG.AC and FVB/N mice (gavage and dermal, 2x weekly for 26 weeks); [+] in female BRCA1+/+  and +/-;  [-] in C3H mice (26 weeks diet)",,,[+] in mouse splenocytes after ip injection#Farooqi et al 1993; [-] in mouse bone marrow#Henderson and Regan 1985; [+] in mouse bone marrow after via ip#Mavournin et al 1990; [+] in mouse bone marrow after via ip#Fucic et al 2009; [I] after via ip#Morita et al 1997,[E],,,,,,,"[+] in hamster kidney#Bannerjee et al 1994; [-] for ploidy changes in mouse bone marrow#Zijno et al 1989; [+] for structural CA but [-] for ploidy changes, [+] in bone marrow#Ivett and Tice 1981; [+] in bone marrow#Shelby 1988",[+],,,,,,,,,,,,,,,,,,,,,,,,,[-],,,,,"[-] in stomach, colon, liver, kidney, bladder, lung, brain and bone marrow of male mice via ip",#Sasaki et al 2000,[-]
68,"N,N-Dicyclohexylthiourea",1212-29-9,KAJICSGLHKRDLN-UHFFFAOYSA-N,S=C(NC1CCCCC1)NC2CCCCC2,"3,690",[-],,[-],,[-],"[-] in TA97, TA100, TA1535, TA1537#Zeiger et al 1988",,,,,,"[-] in TA97, TA98, TA100, TA1535, TA1537 and E.coli WP2#ECVAM Review 2016;  [-] in E. coli WP2 uvrA#Dunkel et al 1985",[-],,[-],,,[+] 1 study; [-] 2 studies,[U],,,, [+]#McGregor et al 1987; [-]#Mitchell et al 1988; [-]#Myhr et al 1988,[I],,,,,,,,,[-] to 1600 ug/ml,,,[-],,,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
69,Diisopropylcarbodiimide,693-13-0,BDNKZNFMNDZQMI-UHFFFAOYSA-N,CC(C)N=C=NC(C)C,"4,110",,,,,[-]; [Eq],,,,,,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,[+] skin painting; [-] via gavage,,,"[+] mouse peripheral blood, via skin painting, [-] mouse peripheral blood, via skin painting and ip, [+] mouse peripheral blood, via ip, [-]mouse peripheral blood, via ip, [-] mouse peripheral blood, via ip, [-] rat bone marrow PCEs via ip, overall [+]#Witt et al 1999; [-] rat and mouse bone marrow PCEs via ip, [-] mouse bone marrow PCEs via painting, [+] and [-] mouse bone marrow PCEs via ip#NTP 2007",[E],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
70,"N,N-dimethylaniline",121-69-7,JLTDJTHDQAWBAV-UHFFFAOYSA-N,CN(C)c1ccccc1,"2,310",[-],,[-],"[-] in TA98, TA100, TA102, TA104, TA1535, TA1537 and in E. coli strains WP2uvrA and WP2 uvrA/pKM101, w/out hamster S9 ",[+],,,,,,,, [-],,[+],,,[+],[+],,,,"[+] w/out S9, RTG without reduced to <10%#NTP 1989",[+],[+],#Taningher et al 1993,,,,," [+] in Chinese hamster V79 cells, 48 hour treatment , CREST indicates numerical alterations#Taningher et al 1993",[+],[+],#Loveday et al 1989,"[+] in CHL cells, 6-18 w/out S9, 24-0 or 48-0h treatment without S9",[+],,,,"[+] in CHO cell w/out S9, one trial marginally significant#NTP 1989; [+] w/out S9, weak pos with S9#Loveday et al 1989",[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,weak [+] in male BALB/c mice via ip and male SD rat liver via ip and po with Alkaline DNA elution test#Taningher et al 1993,[+]
71,Dimethylformamide,68-12-2,ZMXDDKWLCZADIW-UHFFFAOYSA-N,CN(C)C=O,"-1,010",[-],,[-],"[-] in 4 TA strains and E. coli WP2uvrA/pKM101, up to 5% Gas exposure, w/out S9.",[-],,,,,,,, [-],,[-],,,[+],[U],,,,"[-] in Tk locus w/out S9#Myhr and Caspary 1988; #NTP 1992a; [-] in Tk locus w/out S9#Jotz and Mitchell 1981; [-] in Tk locus with S9, weak [+] without S9#McGregor et al 1988a; #NTP 1992a; [-] in Tk locus w/out S9#Mitchell et al 1988; [+] in Tk locus at dose eliciting Reduced Relative Growth#NTP 1992a; reviewed by#Kennedy et al 200; #IARC vol 71 1999; #CERI",[I],,,,,,,[-] Ishidate et al 1988,[-],[-],#Ishidate et al 1988,,[-],,,,"[-] in human peripheral blood lymphocytes exposed for 24, 48 or 72 hours up to 1.1 M#Antoine et al 1983; [-] in CHO cells w/out S9 during a 1 hour treatment up to 6.67 ul/ml#Natarajan et al 1981; #IARC vol 71 1999; [+] in human peripheral lymphocytes up to 20% at high dose#Koudela and Spazier 1979; #IARC vol 71 1999; [-]#Kennedy et al 2001; [-] in rat liver RL1 cells after being exposed for 22 hours up to 300 ug/ml#Dean et al 1981; #IARC vol 71 1999; [-] in Chinese hamster ovary cells when exposed up to 5000 mg/ml with and without S9 exposed for 2 hours and 10 hours respectively#NTP 1992a",[-],,,,,,,,"[-] mouse bone marrow PCEs via ip#Antoine et al 1983; [-] mouse bone marrow PCEs via ip#Kirkhart 1981; [-] mouse bone marrow PCEs via ip#Salamone et al 1981; [-] mouse bone marrow PCEs via ip#Tsuchimoto and Matter 1981; [+] mouse bone marrow PCEs via ip#Ye 1987; [I] mouse bone marrow PCEs via ip#Mavournin et al 1990; Reviewed by#Kennedy et al 2001;#IPCS 1991, #IARC vol 71 1999;#Ishidate et al 1988;#CERI",[-],,,,,,,[-]#Mortelmans et al 1986; [-]#Kennedy et al 2001; [-]#Sheveleva et al 1979; #CERI,[-],,,,,,,,,[-] dominant lethal assay#CERI,[-],,,,,,,"All data in vitro [-] in rat hepatocytes after exposure to 10^-3 M  for 3 hours (Ito 1982, IARC vol. 71); [-] in HeLa S3 cells with and without S9 up to 100 ug/ml (Martin et al 1981, HA report on DMF); weak [+] in F344 rat primary hepatocytes (Williams 1977, IARC vol. 71); [-] in rat primary hepatocytes exposed up to 1M (Williams et al. 1979, IARC vol. 71);  [-] in hepatocyte primary culture/DNA-repair test using rat, hamster and mouse hepatocytes that were exposed for 18 hours (McQueen et al 1983, IARC vol. 71); [-] in mouse hepatocytes (Klaunig et al. 1984, IARC vol. 71; Kennedy et al. 2001); [-] in DNA repair synthesis in human hepatocytes from donors without known liver disease (McQueen et al. 1988; Kennedy et al. 2001)",,,,,,,,,[+],,,,"[+] in stomach, colon, liver, bladder, lung and bone marrow but [-] in kidney and brain of male mice via ip","[+] rat lymphocytes, drinking water#Xing et al 2014; [+] in mouse stomach, colon, liver, bladder, lung and bone marrow and [-] kidney, via ip#Sasaki et al 2000; Reviewed in #Kennedy et al 2012",[+]
72,Dimethyl terephthalate,120-61-6,WOZVHXUHUFLZGK-UHFFFAOYSA-N,COC(=O)c1ccc(cc1)C(=O)OC,"2,250",[-],TC [-]#Zeiger et al 1985; TC [-]#Lerda 1996; #Lerda 1998; [-]#Monarca et al 1991,[-]/ [+],"[-] in 5 TA strains; [+] in TA1538; [-] E. coli WP2uvrA, up to 5 mg/plate, w/out S9",[-],,,,,,,,[-],,[-],,,[-],[U],,,,[U]#Myhr et al 1991,[I],[-],,,,,,TC [-]#Lerda 1996; [-] in human peripheral blood lymphocytes sampled at 72 hours#Monarca et al 1991,[-],[-],,,[-],,,,TC [-]#Loveday et al 1990; [-] in human peripheral blood lymphocytes exposed up to 500 ug/ml for 4 hours#Monarca et al 1991,[-],,[+],"[+] mouse bone marrow PCEs, ip#Goncharova et al 1988; [-] mouse bone marrow PCEs, ip#Shelby et al 1993",,[-],,,reviewed #Ball et al 2012,[E],,,,[E] ,,,[E]#Ball et al 2012,[E],,,,,,,,,,,,,,,,,[-] in HeLa cells exposed up to 5000 ug/ml for 1 hour with and without S9 (Monacara et al. 1991),,,,,,,,,,,,,,,
73,"1,4-dioxane",123-91-1,RYHBNJHYFVUHQT-UHFFFAOYSA-N,C1COCCO1,"-0,270",[-],#Zeiger 1997,[-],"[-] in 4 TA strains and E. coli WP2uvrA, w/out S9 rat and hamster S9; [-] in 4 TA strains and E. coli WP2uvrA and WP2uvrA/pKM101, up to 50% gas exposure, w/out S9",[-],,,,,,,,[-],,[-],,,[-] in Tk locus#McGregor et al 1991,[U],,,,[-] in Tk locus w/out S9#Morita et al 1998,[-],,,,,,,[-] in CHO K1 cells following 5 and 44 hour exposures up to 5 mg/ml w/out S9#Morita and Hayashi 1998,[-],[-],,,[-],,,,"[-] in CHO K1 cells following a 5, 20 and 44 hour exposures up to 5 mg/ml w/out S9#Morita and Hayashi 1998; [-] in CHO cells w/out S9#Galloway et al 1987; #IARC vol 71 1999",[-],,,,,,,,"[-] in mouse peripheral blood, ip#Morita and Hayashi 1998; [+] and [-] mouse bone marrow PCEs, gavage#Mirkova 1994; [+] mouse bone marrow and hepatocytes, gavage#Roy et al 2005; [-] mouse peripheral blood,  gavage and [+] hepatocytes#Morita et al 1998; [-] mouse bone marrow PCEs, ip#McFee et al 1994; [-] mouse bone marrow PCEs, gavage#Tinwell and Ashby 1994; Reviewed in #IARC vol 71 1999",[E],,,,,,,,,,,,,,,,,,,[-],,,,,,"[-] rat nasal cells, drinking water and gavage; [-] hepatocytes, drinking water or gavage; [+] hepatocytes, drinking water#Goldsworthy et al 1991; [-] and [+] in rat hepatocytes, drinking water#Stott et al 1981; Reviewed in #IARC vol 71 1999",[E],,,,,,,[-],,,,,"[-] in stomach, colon, liver, kidney, bladder, lung, brain and bone marrow of male mice via oral","[+] rat liver via oral#Kitchin and Brown 1990; [-] mouse stomach, colon, liver, kidney, bladder, brain, lung and bone marrow via oral#Sasaki et al 2000; Reviewed in#IARC vol 71 1999",[E]
74,Disulfiram (Tetraethylthiuram disulfide),97-77-8,AUZONCFQVSMFAP-UHFFFAOYSA-N,CCN(CC)C(=S)SSC(=S)N(CC)CC,"3,880",[-],,,,[-],"in TA98, TA100, TA1535, TA1537",,,,,,[-] in TA102#Kirkland et al 2016, [-],,[+],,,[+],[+],,,,[E] at low concentration#Mitchell et al 1997; [+]#McGregor et al 1991,[+],,,,,,,,,[+],,,[+],,,,[+]#Shelby and Stasiewicz 1984,[+],,[-],,,,,,"[-] with limitations, since no positive control, only 3 animals per group and too few cells scored#Donner et al 1983",[I],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
75,Divinylbenzene-55,1321-74-0,MYRTYDVEIRVNKP-UHFFFAOYSA-N,C=Cc1ccccc1C=C,"3,800",TC [-],,[-],[-] in 4 TA strains and E. coli WP2uvrA/pKM101 w/out S9,[-],,,,,,,,[-],,,,,,,,,,,,,,,,,,,,,,"[-] in CHL cells at 6-18, 24-0 or 48-0h without S9 and at 6-18h treatment with S9.",,,,,,[-],,[E],[+]#Kligerman et al 1996; [-]#NTP,,[-],,,"weak [+] mouse peripheral blood, inhalation#Kligerman et al 1996; [-] mouse peripheral blood NCEs, inhalation#NTP 2006",[E],[+],"[+] weak positive in B6C3F1 mice spleen, inhalation 6 hr/day for 3 days#Kligerman et al 1996",,,,,,[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
76,Dursban (Chlorpyrifos),2921-88-2,SBPBAQFWLVIOKP-UHFFFAOYSA-N,CCOP(=S)(OCC)Oc1nc(Cl)c(Cl)cc1Cl,"4,960",TC [-] ,,,,[-],,,,[-],[-] Data on mutagenicity confidential only other genotoxicity test available#EFSA Addendum 2014,,[-] Salmonella strains and E. coli#Shirasu et al 1976,[-],,,,,,,,,,,,[-],,,,,,#Gollapudi et al 1995,[-],[E],,,,,,,[-] in rat lymphocytes#California EPA 2001,[E],,[+],#Amer and Fahmy 1982,,,,,[-] in 4 mouse BM GLP studies#APVMA Doc 2000; [+]#Ezzi et al 2016; [+]#Yaduvanshi et al 2012; [+]#Gollapudi et al 1995,[+],[+],[+] in spleen#Amer and Fahmy 1996,,,,"[+] in somatic (BM) and germ cells (spermatocytes) of swiss albino mice, gavage#EFSA Addendum 2014",,[+],,,,,,,,,,,,,,,,,,,[+],#Rahman et al 2002;#Mehta et al 2008,,,,[+]  in liver and brain after i.m. injections in M rats#Mehta et al 2008; #EFSA Addendum 2014,,,,,,,,[+]
77,Endrin,72-20-8,DFBKLUNHFCTMDC-SPJPLABQSA-N,ClC1=C(Cl)[C@]2(Cl)[C@H]3[C@@H]4C[C@H]([C@@H]5O[C@H]45)[C@@H]3[C@]1(Cl)C2(Cl)Cl,"5,200",[-],#Zeiger et al 1987,,,[-],,,,[-],"[-] at 8 conc, 0.5 up to 1000 nmol/ml in S. typh and E. coli#Probst et al 1981; #EFSA Journal 286 2005
",,, [-],,[-],,,[I],[U],,,,,[I],,,,,,,,,[-],,,[-],,,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
78,17-Beta-Estradiol,50-28-2,VOXZDWNPVJITMN-ZBRFXRBCSA-N,C[C@@]12CC[C@@H]3[C@H](CCc4cc(O)ccc34)[C@H]1CC[C@H]2O,"4,010",[-],,,,[-],"in TA97, TA98, TA100, TA1535",,,,,,[-]#Lang and Reimann 1993,[-],,[-],,,,,,,,[-]in Hprt#Rajah and Pento 1995;[I] Hprt in SHE cells#Tsutsui et al 2000; [+] in Hprt in V79 cells#Kong et al 2000,[I],[+],,,,,,[+]#Banduhn and Obe 1985; #Yared et al 2002;#Djelic et al 2005,[+],[-],,,,,,,[-] for structural CA#Banduhn and Obe 1985;#Ishidate et al 1988; [+] for structural#Kochhar 1985;#Ahmad et al 2000# and numerical CA#Wheeler et al 1986;#Schuler et al 1998;#Tsutsui et al 2000,[+] (structural and numerical),,[-],,,,,,[-]#Ashby et al 1997;#Shelby et al 1997,[-],,,,,,,,,,,,,,,[-],[-] in heart and mammary gland of female rats (16-20 weeks in diet),#Manjanatha et al 2005; #Manjanatha et al 2006,[-],,,,,,,,,,,,,,,[-],,,,,"[-] in stomach, colon, bladder, lung, kidney, bone marrow, liver and brain of male mice via ip",#Sasaki et al 2000,[-]
79,Estragole,140-67-0,ZFMSMUAANRJZFM-UHFFFAOYSA-N,COc1ccc(CC=C)cc1,"3,470",[-],"[-] in TA98, TA100, TA1537, TA1538#To et al 1982",,,[-],"in TA100, TA1535, TA1537, TA1538#Zeiger et al 1987",,,,,,"[-] in TA98, TA100, TA1535, TA1537 and E.coli WP2#ECVAM Review 2016; [-] in TA strains and E. coli WP2 uvrA#Sekizawa and Shibamoto 1982; [-]#EC SCF 2001
", [-],,,,,,,,,,,,,,,,,,,,,,,,,,,[-] in V79 cells#EC SCF 2001,[-],,,,," [-] in mouse male and female, 3M oral study, PB",,,"[-] male rats, po x3, up to 1000 mg/kg#Ding et al 2014",[E],,,,,,,,,,,,,,,,,,,,,,,,,[+] in rat liver at 2000 mg/kg#EC SCF 2001; [+] in rat liver#Mueller et al 1994,[+],,,,,,,,,,,,,,
80,Ethyl acrylate,140-88-5,JIGUQPWFLRLWPJ-UHFFFAOYSA-N,CCOC(=O)C=C,"1,320",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537#Zeiger 1997; [-]#Waegemaekers and Bensink 1984",,,,,,[-] in TA102#Kirkland et al 2016, [-],,[+],[I]#Mitchell et al 1997;[I] w/out S9#McGregor et al 1988b; [+]#Moore et al 1988;[+]#Dearfield et al 1991,,,[U],,,,[+] in Tk locus in L5178Y cells w/out S9#Moore et al 1989; [-] in Hprt locus in CHO cells#Moore et al 1991,[+],,,,,,,[+] in p53 deficient and competent cells#Fowler et al 2012a,[+],[+],#Ishidate et al 1988,,[+] or weak [+],,,,"[+] with S9, probably asssociated with high level of cytotoxicity#Loveday et al 1990",[+],,[E],[-]#Morita et al 1997; [-]#Ashby et al 1989; [-] dermal#Tice et al 1997; #Przybojewska et al 1984; [+] in splenocytes#Kligerman et al 1991; [+]#IARC vol 39 1986,,,,,[-]#Health Canada 2011; no mutagenic hazard#OECD SIDS 2004c,[-] based on WoE,[E],#Kligerman et al 1991,,[-] in bone marrow ,,,weak [+] in splenocytes at near-toxic doses using via ip ,[E],,,,,,,,"[-] in forestomach and liver of gpt-delta mice, 28-days gavage",#Ellis-Hutchings et al 2018,[-],,,,,,,,,,,,,,,[+],,,,,"[+] in stomach, colon, liver, bladder and lung but [-] in kidney, brain and bone marrow of male mice via oral",#Sasaki et al 2000,[+]
81,Ethylene glycol anhydrous,107-21-1,LYCAIKOWRPUZTN-UHFFFAOYSA-N,OCCO,"-1,360",,,[-],"[-] in 4 TA strains and E. coli WP2uvrA, up to 5 mg/plate, w/out S9.",[-],,,,,,,, [-],,,,,"[-] in Tk locus, 3 trials: 2 negatives one positive w/out S9#McGregor et al 1991; [-] w/out S9#NTP 1993",[U],,,,,[I],,,,,,,,,,,,"[-] in CHO cells, CA and SCE w/out S9#NTP 1993",,,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
82,Ethylene-glycol-monomethyl ether,109-86-4,XNWFRZJHXBZDAG-UHFFFAOYSA-N,COCCO,"-0,770",[-c],TC [-]#McGregor et al 1983; #Hoflack et al 1995,,,,,[-],"in TA98, TA100, TA1535, TA1537, TA1538, TA102, w/out S9#Benfenati DB",,,,, [-],,,,,,,,,,"[-] in Tk locus with S9 up to 10 mg/ml 4 hours, inhalation#McGregor 1984",[-],,,,,,,,,[-],,,,,,,[+] in HL only at 150 and 300 mM without S9#Chiewchanwit and Au 1994; [-] in CHO w/out S9 reported in#McGregor 1984,[-],,,,,,,,,,[-],,,,,,"[-] in young male B6C3F1 mice bone marrow, oral and IV, varying exposure times up to 1000 mg/kg#Au et al 1993; [-] in rat bone marrow, repeated or single dosing, inhalation 7 hours at 5 liters/min per dosage#McGregor et al 1983;#McGregor 1984",[-],,,,,,,,,,,,,,,,,all in vitro [-] in cultured human embryo fibroblasts up to 10 mg/ml but there was evidence of inhibition of repair at 9.66 mg/mL with S9#McGregor et al 1981; #McGregor et al 1984; [-] in human embryonic intestinal fibroblasts with and without S9 exposed for 3 hours up to 10 mg/ml#McGregor et al 1983,,[+],#Anderson et al 1986,,,,,,,,,,," [+] in bone marrow and testicular cells from male rats administered via gavage and examined 2 weeks after treatment using alkaline comet assay#Anderson et al 1996; [-] when examined 5 or 6 weeks after treatment#Anderson et al 1996; [+] in qFISH analysis to determine telomere length in peripheral blood lymphocytes of offspring exposed while in utero, female workers were exposed through inhalation due to poor ventilation and through direct contact to an 85% solution#El-Zein et al 2007",[+]
83,EDTA trisodium salt trihydrate,150-38-9,OABSPZRQQUFHRY-UHFFFAOYSA-K,O.O.[Na+].[Na+].[Na+].OC(=O)CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-],"-13,150",[-],,,,[-],"in TA97, TA98, TA100, TA1535#Zeiger et al 1988;#Zeiger et al 1985",,,,,,[-] in E. coli#Dunkel et al 1985, [-],,[-],,,[-] up to 5mg/ml,[U],,,,,[I],,,,,,,,,[-],,,[-] tested only at 100 ug/ml,,,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,[-],,[-],,"[-] in stomach and liver of male rats via oral; [-] in stomach, colon, liver, kidney, bladder, lung, brain and bone marrow of male mice via oral",,[-]
84,Ephedrine sulphate/Ephedrine hydrochloride,134-72-5/ 134-71-4,CAVQBDOACNULDN-KHFUBBAMSA-N,CN[C@H](C)[C@@H](O)c1ccccc1.CN[C@H](C)[C@@H](O)c2ccccc2.OS(=O)(=O)O,,[-],,,,[-],"in TA97, TA98, TA100, TA1535#Zeiger et al 1988;#Zeiger 1997",,,,,,[-] in TA102#Kirkland et al 2016, [-],,[-],,,[-],[U],,,,,[I],,,,,,,,,[-],,,[-] up to 30% toxicity,,,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
85,Erythromycin/Erythromycin stearate,114-07-8/ 643-22-1,ULGZDMOVFRHVEP-RWJQBGPGSA-N,CC[C@@H]1OC(=O)[C@@H](C)[C@H](O[C@@H]2C[C@](C)(OC)[C@H](O)[C@@H](C)O2)[C@@H](C)[C@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@@](C)(O)C[C@H](C)C(=O)[C@@H](C)[C@H](O)[C@@]1(C)O,,[-],,,,[-],"in TA98, TA100, TA1535, TA1537, stearate salt#Mortelmans et al 1986",,,,,,[-] in TA102#Kirkland et al 2016, [-],,[-],,,[E],[U],,,,[-] in Tk locus locus up to 90% toxicity#Mitchell et al 1997; but [+] at >90% toxicity#Mitchell et al 1997,[I],,,,,,,,,[-],,,[-] up to 500 µg/ml ,,,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
86,Ethionamide,536-33-4,AEOCXXJPGCBFJA-UHFFFAOYSA-N,CCc1cc(ccn1)C(=S)N,"9,849",[-],,,,[-],"in TA97, TA98, TA100, TA1535#Zeiger et al 1988",,,,,,[-] in TA102#Kirkland et al 2016, [-],,weak [+],,,weak [+] at 70-90% toxicity,[U],,,,,[I],[+],,,,,,[-] in p53 deficient and competent cells#Fowler et al 2012a,[+],weak [+],in CHO cells at 5-8 mM#Hilliard et al 1998; in CHL cells at 2.4 mM#Ishidate et al 1988,,,,,,,[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,[-],,[-] in stomach and liver of male rats via oral,#Uno et al 2015,[-]
87,"2-ethyl-1,3-hexanediol",94-96-2,RWLALWYNXFYRGW-UHFFFAOYSA-N,CCCC(O)C(CC)CO,"1,520",,,,,[-],"in TA97, TA98, TA100, TA1535#Slesinski et al 1988",,,,,,[-] in TA102#Kirkland et al 2016, [-],,,,,,,,,,[-] in Tk and Hprt loci loci#Slesinski et al 1988,[-],,,,,,, [-] in p53 deficient and competent cells#Fowler et al 2012a,[-],,,,,,,,[+] with S9 at high conc and no data at lower conc#Slesinski et al 1988,[I],,,,,,,,[-]#Slesinski et al 1988,[-],,,,,,,[-]#Slesinski et al 1988,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
88,Ethinyl estradiol,57-63-6,BFPYWIDHMRZLRN-SLHNCBLASA-N,C[C@@]12CC[C@@H]3[C@H](CCc4cc(O)ccc34)[C@H]1CC[C@]2(O)C#C,"1,600",[-],,,,[-]," in TA97, TA98, TA100, TA1535#Zeiger et al 1988",,,,,,"[-] in TA97, TA98, TA100, TA1535 and E. coli WP2 uvrA#ECVAM Review 2016; [-] in TA98, TA100, TA1535, TA1537 and E. coli WP2 uvrA#Itoh et al 1991; [-] in E. coli WP2 uvrA#Dunkel et al 1984; [-] in TA98, TA100, TA1535, TA1537, TA1538#Lang and Reimann 1993; [-] in 3 studies#Brambilla and Martelli 2009",[-],,,,,,,,,,[-] in Hprt and [-] in Ouabaine loci#Brambilla and Martelli 2009,[-],,,,,,,,,[-],Reimann et al 1996,,,,,,"[+] in HPLT cells w/out S9 and [+]with NADP addition 48 hr continuous treat#Siddique et al 2005; [+] in CHO cells without S9#Kochhar 1985; [+] in DON cells without S9, anuploidy#Wheeler et al 1986; [+] 1 study and 2 [-] studies without S9#Brambilla and Martelli 2009",[+],,[-],[-]#Shyama and Rahiman 1996; #Reimann 1996; #Hundal 1997,,"#[-] in M and F mouse PB, gavage;#[-] in F mouse PB, dermal;#[-] in M and F TGAC (FVB/N) homozygous mouse PB, gavage;#[-] in  M and F TGAC (FVB/N) homozygous mouse PB, dermal",,,"[-] mouse BM for 15 days, oral#Shyama and Rahiman 1996; [-] in mouse BM, po#Reimann et al 1996; [-] in human HPLT#Loncar et al 2004",[-],[-],#Shyama and Rahiman 1996,,,,,"[-] in mouse BM for 15 days, oral#Shyama and Rahiman 1996",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
89,Etodolac,41340-25-4,NNYBQONXHNTVIJ-UHFFFAOYSA-N,CCc1cccc2c3CCOC(CC)(CC(=O)O)c3[nH]c12,"3,670",[-],,,,,,,,,,,"[-] in TA97, TA98, TA100, TA1535 and E. coli WP2#ECVAM Review 2016; [-] in TA98, TA100, TA1535, TA1537 and E. coli WP2 uvrA#Iwakura et al 1990",[-],,[-],#Snyder et al 2001,,,,,,,[-]#Brambilla and Martelli 2009,[-],,,,,,,,,[-],#Snyder et al 2001,,,,,,weak [+] response due to inclusion of gaps only#Brambilla and Martelli 2009,[-],,,,,,,,,,,,,,,,[-]#Brambilla and Martelli 2009,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
90,Eugenol,97-53-0,RRAFCDWBNXTKKO-UHFFFAOYSA-N,COc1cc(CC=C)ccc1O,"3,930",[-],,,,[-],"in TA98, TA100, TA1535, TA1537#Haworth et al 1983",,,[-],"[-] in TA92, TA94, TA97, TA98, TA100, TA102, TA1530, TA1531, TA1532, TA1535, TA1537, TA1538 and TA1964 at  ≤ 107 mg/plate w/out S9#EFSA Journal 965 2009;  [-] in E. coli WP2 uvrA (trp-), up to 600 ug/plate#Sekizawa and Shibamoto 1982",,[-]#Zeiger 1997; [-]#Ishidate et al 1984;[I]#To et al 1982,[-],,[+],#Mitchell et al 1997,,,,,,,[+]#Sofuni et al 1996; [+]#Myhr and Caspary 1991,[+],[+]  in p53-deficient ,,,,,,[+] in p53 deficient hamster but [-] in p53 competent human cells#Fowler et al 2012a,[+],[+],#under condition of high cytotoxicity,,,,,,[+]#Galloway et al 1987;#Ishidate et al 1984;#Stich et al 1981;#Maralhas et al 2006; #Someya et al 2008,[+],,[E],,,"#[-] in male mice, ip",,,"weak [+] at LD50 dosed ip#Woolverton et al 1986; [+] in mice, ip#Ellahuene et al 1994; [-] in mice, after 3 ip doses#Shelby et al 1993; [-] after 1 or 4 daily ip doses#Hayashi et al 1988; [-] dosed orally#Allavena et al 1992; [-] dosed orally#Maura et al 1989; [-] in mouse, 75, 150, 300 mg/kg orally#Tiku et al 2004; [-] in mouse, 40, 400 mg/kg orally#Abraham 2001",[-],,,,,,,,, [-] liver,#Lambert et al 2005,[-],,,,[-],#[-] in liver of male mice (diet),,[-],[-],#Rompelberg 1996,,,,,,[-],,,,,,,,,,,,,,
91,"FD and C red no. 3 (fluorescein, 2', 4', 5', 7'-tetraiodo, disodium salt)",16423-68-0,RAGZEDHHTPQLAI-UHFFFAOYSA-L,[Na+].[Na+].[O-]c1c(I)cc2c(Oc3c(I)c([O-])c(I)cc3C24OC(=O)c5ccccc45)c1I,"2,270",[-],,,,,,,,[-],"[-] in TA97a, TA98, TA100, TA1535, TA1537, TA1538, TA102, TA104 and E. coli WP2 uvrA, Erythrosine is not of concern with respect to genotoxicity#EFSA Journal 9 2011a ",,"[-] in TA97, TA98, TA100, TA1535, TA1537, TA102#ECVAM Review 2016; [-] in TA97a, TA98, TA100, TA102, TA104#Lakdawalla et al 1988; [-] in TA98, TA100, TA1535, TA1538#Salas et al 1987; [-] in TA98, TA100, TA1535, TA1537, TA1538#Lin and Brusick 1986; [-] in TA98, TA100#Ozaki et al 1998",[-],,[-],#Lin and Brusick 1986,,,,,,"[+] in Tk locus, hight toxicity and [-]#EFSA Journal 9 2011a;[I]Hprt in V79 cells#Rogers et al 1988;#EFSA Journal 9 2011",[+]#NCI Y85; [+] Tk w/out S9#Seifried et al 2006,[+]Tk and [I] Hprt,,,,,,[+] in V79 cells#EFSA Journal 9 2011a,,[+],[+],#Ishidate et al 1988,,,,,[+] (polyploidy) in SHE cells and [-] other study#EFSA Journal 9 2011a,,[+],,,,,,,,"[-] in mouse BM and PB, ip#Zijno et al 1994; [-] in mouse, 4 studies#EFSA Journal 9 2011a; [-]#Lin and Brusick 1986",[-],,,,,,"[+] in rat BM, 0, 0.08 or 0.4 g/kg diet for 30 days, CA induced but no conclusions can be drawn#Mekkawy et al 2000; Erythrosine is not of concern with respect to genotoxicity#EFSA Journal 9 2001",,[I],,,,,,,,,,,,,,,,,,,,,,,,"[+]  in stomach, colon, urinary bladder, lung; [-] in bone marrow data from mouse via po#EFSA Journal 9 2011a",,,,,,,,[+]
92,Fenvalerate (cyano-3-phenoxyphenylmethyl-4-chloro-alpha-1-methylethylbenzene acetate),51630-58-1,NYPJDWWKZLNGGM-UHFFFAOYSA-N,CC(C)C(C(=O)OC(C#N)c1cccc(Oc2ccccc2)c1)c3ccc(Cl)cc3,"-0,290",TC [-],[-]#Herrera and Laborda 1988;#Plujimen 1984,,,,,,,,,,"[-] in TA97, TA98, TA100, TA1535, TA1537 and E. coli WP2#ECVAM Review 2016; [-] in TA98, TA100, TA1535, TA1538 and TA98, TA100 Ames fluctuation#EHC 95 1990; [-] in TA97, TA98, TA100, TA104, TA1535, TA1537, TA1538#UK PID monograph; [-] in TA97, TA98, TA100, TA104, TA1535, TA1537, TA1538#Herrera and Laborda 1988",[-],,,,,,,,,,,,[-],,,,,,"[+] in Hplt, cytB#Surralles et al 1990; [-] in Hplt, cytB#Surralles 1995b",[-],[+],#Caballo et al 1992;#Puig et al 1989,,,,,,"[+] in workers spermatozoa, numerical#Xia et al 2004; [+] in workers Hplt#Rupa et al 1991",[+],,[+],#Pati and Bhunya 1989,,,,,[+] in mouse#UK PID monograph; weak[+]#Giri et al 2011; [-]#Tyrkiel et al 2011,[E],[+],[+] in mice#Ghosh et al 1992;#Pati and Bhunya 1989,,,,,"[+] in rats#Chatterjee et al 1982; [+] in BM mice#Giri et al 2002a; [-] in hamster BM, po and rat, po, 3 weeks, no raw data#EHC 95 1990",[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, [+] in workers spermatozoa#Bian et al 2004,
93,"Fluometuron (urea, 1,1-dimethyl 3-(alpha, alpha, alpha-trifluoro-m-tolyl)-)",2164-17-2,RZILCCPWPBTYDO-UHFFFAOYSA-N,CN(C)C(=O)Nc1cccc(c1)C(F)(F)F,"6,200",[-],,,,[-],"in TA98, TA100, TA1535, TA1537#Dunkel et al 1985;#Zeiger et al 1988",,,[-],"[-] in TA98, TA100 TA1535, TA1537, up to 5000 ug/plate; [-] in TA98, TA100 TA1535, TA1537 and E. coli WP2. in vitro clastogen but in vivo non-genotoxic#EFSA conclusion 2011",,,[-],,[-],,,[-],[U],,,,,[I],,,,,,,,,[-],#Loveday et al 1990,,[-],,,[+] in HPLT cells w/out S9#EFSA Addendum 2010;#EFSA DAR 2007,,[E],,,,,,,"[-] in CD1 mouse BM cells, up to 2000 mg/kg bw#EFSA Addendum 2010",,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
94,5-fluorouracil,51-21-8,GHASVSINZRGABV-UHFFFAOYSA-N,FC1=CNC(=O)NC1=O,"2,420",[-],,,,[-],"in TA98, TA100, TA1535, TA1537#Zeiger et al 1987",,,,,,; [-] in TA102 and E. coli#Watanabe et al 1998,[-],,[+],#Honma et al 1999,,,,,,,[-]#Oka et al 2012,[-],[+],#Matsushima et al 1999,,,,,[+]#Kirkland 2010;#Lorge et al 2006;#Oka et al 2012 ,[+],[+],#Ishidate et al 1988,,,,,,,[+],,[+],,,,,,[+]#Ohuchida et al 1992;#Higashikuni and Sutou 1995;#Wakata et al 1998;#Suzuki et al 2009,[+],,,,,,,,,,,,,,,,,,,,,,,,,,,[-],#McGregor and Anderson 1999,,,,,[-],,,[-],,"[-] in stomach, colon, liver, kidney, bladder, lung, brain, bone marrow and spleen of male mice via ip; [-] in stomach and liver of male rats via oral",,[-]
95,Fluoxymesterone,76-43-7,YLRFCQOZQXIBAB-RBZZARIASA-N,C[C@@]1(O)CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@]3(F)[C@H](O)C[C@@]12C,"-0,890",[-],#Dhillon et al 1995,,,,,,,,,,"[-] in TA97, TA98, TA100, TA1535, TA102#ECVAM Review 2016; [-] two studies#Brambilla and Martelli 2009",[-],,,,,,,,,,,,[+],,,,,,#Dhillon et al 1995,[+],[+],,,,,,,"[+] in Hplt, 48-72h#Dhillon et al 1995; [+]#CCRIS; [+] 2 studies#Brambilla and Martelli 2009",[+],,[+],#Dhillon et al 1995,,,,," [+] in mouse BM, ip#Dhillon et al 1995; [+]#CCRIS",[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
96,Fluvastatin/Fluvastatin sodium salt,93957-54-1/93957-55-2,FJLGEFLZQAZZCD-MCBHFWOFSA-N,CC(C)n1c(\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)c(c2ccc(F)cc2)c3ccccc13,"2,380",[-],,,,,,,,,,,"[-] in TA98, TA100, TA1535, TA1537 and E. coli WP2#ECVAM Review 2016; [-] in TA98, TA100, TA1535, TA1537, TA1538 and E. coli WP2 uvrA and WP2 uvrA(pKM101)#Robinson et al 1994",[-],,,,,,,,,,[-] in Hgprt in V79 cells#Robinson et al 1994,[-],,,,,,,,,[-],,,,,,,[-] in V79 cells#Robinson et al 1994,[-],,[-],#Ciaravino et al 1995,,,,,"[-] in mouse BM once at 1700 mg/kg, gavage#Robinson et al 1994",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
97,Fluphenazine/Fluphenazine hydrochloride,146-56-5/69-23-8,MBHNWCYEGXQEIT-UHFFFAOYSA-N,Cl.Cl.OCCN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1,,[-],#Suzuki et al 1990,,,,,,,,,,"[-] in TA98, TA100, TA1535, TA1537 and E. coli WP2#ECVAM Review 2016; [-]#Snyder 2009; [-] in TA98, TA100, TA1535, TA1537 and E. coli WP2 uvrA#Suzuki et al 1990",[-],,,,,,,,,,,,,,,,,,,,[+],,,,,,,"[+]#Shafer et al 1987; [-] in CHL cells, hydrochloride#Suzuki et al 1990",[+],,[+],#Rao and Rao 1981,,,,,"[+]#Snyder 2009; [-] in mice BM, single dose#Suzuzki et al 1990",[E],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
98,Fluphenazine decanoate,5002-47-1,VIQCGTZFEYDQMR-UHFFFAOYSA-N,CCCCCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1,"9,136",[-],,,,,,,,,,,#Suzuki et al 1990,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,[-] in CHL cells#Suzuki et al 1990,[-],,,,,,,,"[-] in mice BM, single dose#Suzuzki et al 1990",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
99,Fosetyl AI,39148-24-8,ZKZMJOFIHHZSRW-UHFFFAOYSA-K,CCOP(=O)O[Al](OP(=O)OCC)OP(=O)OCC,"-2,514",[-],,,,,,,,[-],"[-] in TA98, TA100, TA1535, TA1537 and E. coli WP2, w/out S9#EFSA DAR 2005",,,[-],,,,,,,,,[+] in Tk locus#EFSA DAR 2005,,[+],,,,,,,,,,,,,,,[-] in CHO cells#EFSA DAR 2005,,[-],,,,,,,[-] in mouse BM 2 studies reported#EFSA DAR 2005,[-]#Bayer MSDS 2015,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
100,Fumonisin B1,116355-83-0,GPIYLYZFGAXYSU-UHFFFAOYSA-N,CCCC(C)CC(OC(=O)CC(CC(=O)O)C(=O)O)C(CC(C)CC(O)CCCCC(O)CC(O)C(C)N)OC(=O)CC(CC(=O)O)C(=O)O,"1,731",[-],,,,,,,,,,,"[-] in TA97, TA98, TA100, TA1535, TA102#Ehrlich et al 2002; [-] in TA1535#ECVAM Review 2016",[-],,,,,,,,,,,,[+],,,,,,[+] in bovine blood lymphocytes exposed up to 100 uM for 72 hours#De lorenzi et al 2005; [+] in human HepG2 cells when exposed up to 200 ug/ml for 24 hours#Ehrlich et al 2002; [+] in primary rat hepatocytes exposed up to 10 mg/kg for 3 hours#Knasmuller et al 1997; [+] in human blood lymphocytes exposed up to 10 ug/g for 44 hours#Lerda et al 2005; [+] in RK13 cells exposed up to 500 M for 24 or 48 hours#Rumora et al 2002,[+],[+],,,,,,,[+] in primary rat hepatocytes exposed up to 10 mg/kg for 3 hours#Knasmuller et al 1997; [+] in human blood lymphocytes exposed up to 10 ug/g for 44 or 51 hours#Lerda et al. 2005,[+],,[+],#Aranda et al 2000,,,,,"weak [+] mouse bone marrow PCEs, ip#Aranda et al 2000; [-] mouse bone marrow, ip#Karuna and Rao 2013; [+] rat spleen, diet#Theumer et al 2010; [+] rat bone marrow PCEs, diet#Hassan et al 2010",[+],,,,,,,,,,,,,,,,,,,,,,,,,[-] in DNA repair assay in hepatocytes of rats fed up to 1% for 26 days or administered up to 200 mg/kg by oral gavage either single or repeated dosages#Gelderblom et al 1992 ,[-],,,,,,,,,,,,, [+] in alkaline comet assay in rat kidney when exposed to 0.5 mg/kg ip injection for 2 and 7 days and sacrificed 24 hours after last treatment#Domijan et al 2007; [-] in liver under same conditions when exposed for 2 days and [+] when exposed for 7 days#Domijan et al 2007; [+] in DNA fragmentation assay in liver and kidneys of rats sub chronically dosed with 100 ug/kg for 12 weeks#Hassan et al 2015; [+] in alkaline comet assay in spleens of rats sub chronically administered 100 ppm in diet for 90 days#Theumer et al 2010;  [+] in the liver and spleen of rats administered 1.55 mg/kg through via iv Dosage after 4 hours#Atroshi et al 1999; ,[+]
101,Furfuryl Alcohol,98-00-0,XPFVYQJUAUNWIW-UHFFFAOYSA-N,OCc1occc1,"0,280",[-],,,,[-],"in TA98, TA100, TA1535, TA1537, w/out S9",[-],"in TA98, TA100, TA102, w/out S9 (company study)",,,,"[-] in TA97, TA98, TA100, TA1535, TA1537, TA102#ECVAM Review 2016",[-],,,,,,,,,,,,,,,,,,,,[E],,,[-] without S9; [E] with S9 in CHO cells,,,,"[-] in human lymphocytes exposed up to 960 ppm for 24, 48, and 72 hours#Sujatha 2008b; [+] in CHO cells exposed up to 2.5 mM for 3 hours with/out S9 with sampling completed 20 hours after treatment#Stich et al 1981",[E],,,,,"[-] in mouse BM erythrocytes, inhalation",,,"[-] in mouse bone marrow PCEs, inhalation#NTP 1999a",[-],,,,"[+] and [-] mouse bone marrow PCEs, ip#NTP 1999a",,,"[+] in mouse bone marrow PCEs, oral#Sujatha and Subramanyan 1994",[E],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,in vitro: weak[+] in single cell COMET assay in Chinese hamster V79 cells exposed up to 15 mM for 3 hours#Huffman et al 2016,
102,Gallium arsenide,1303-00-0,JBRZTFJDHDCESZ-UHFFFAOYSA-N,[Ga]#[As],"0,000",[-],,,,[-],"in TA97, TA98, TA100, 1535, TA102",,,,,,"[-] in TA97, TA98, TA100, 1535, TA102#ECVAM Review 2016",[-],,,,,,,[-],in Hprt in L5178Y cells up to 2000 ug/ml ,,,[-],,,,,,,[-] in SHE cells up to toxic concs#Gibson et al 1997,[-],,,,,,,,[-] in CHO cells at concs above TC50#Husgafvel-Pursiainen et al 1990,[-],,,,,[-] in mice (90-day inhalation at doses much higher than induced tumours),,,NTP study cited in#Witt et al 2000,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,[+],,[+]#Flora et al 2004,"[+] in liver and kidney but [-] in spleen of male rats by DNA fragementation assay, [+] in blood by comet assay  via oral 5 days/week for 12 weeks",,[+]
103,Gum arabic,9000-01-5,,,,[-],,,,[-],"in TA98, TA100, TA1535, TA1537#Zeiger et al 1992",,,[-],"[-] in TA1535, TA1537, TA1538#EFSA Journal 8 2010; #JEFCA 526 [-] in TA97a, TA98, TA100, TA1535 and E. coli WP2 uvrA#JEFCA 526",,"[-] in TA97, TA98, TA100, TA1535, TA1537 and E. coli WP2#ECVAM Review 2016; [-] in TA98, TA100, TA1535, TA1537, TA1538 and E. coli WP2#Prival et al 1991; [-] in TA98, TA100#De Veer et al 1994",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,[+] in WI-38 cells#JEFCA 526,[+],,,,,,,,,,,,,,,,"[+] in BM cultured metaphase cells from dosed rats, not a standard test#JEFCA 526",[I],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
104,Hexachlorocyclopentadiene,77-47-4,VUNCWTMEJYMOOR-UHFFFAOYSA-N,ClC1=C(Cl)C(Cl)(Cl)C(=C1Cl)Cl,"5,040",[-],,,,[-],"in TA98, TA100, TA1535, TA1537#Haworth et al 1983",,,,,,"[-] in TA97, TA98, TA100, TA1535, TA1537 and E. coli WP2#ECVAM Review 2016; [-] in TA strains and E. coli, with S9#Greim et al 1977; [-] in TA98, TA100, TA1535, TA1537#EU RAR 2007; [-] in TA98, TA100, TA1535, TA1537, TA1538 and E. coli WP2, WP2uvrA#EPA/OTS Doc no. 878214192",[-],,,,,,,,,,[-]#EU RAR 2007,[-],,,,,,,,,[+],,,[+] CA and [+] in SCE,,,,weak [+]#EU RAR 2007,[+],,,,,"[-] in F and M mouse, inhalation for 13-wks",,, [-]#EU RAR 2007,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
105,Hexachloroethane,67-72-1,VHHHONWQHHHLTI-UHFFFAOYSA-N,ClC(Cl)(Cl)C(Cl)(Cl)Cl,"4,140",[-],,,,[-],"in TA98, TA100, TA1535, TA1537#Zeiger 1997",,,,,,[-] in TA102#Kirkland et al 2016,[-],,,,,,,,,,,,[-],#Parry et al 1996;#Doherty et al 1996,,,,,,[-],[-],,,[-],,,,,[-],,[-],#Crebelli et al 1999,,,,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"[-] in stomach, colon, liver, kidney, bladder, lung, brain and bone marrow of male mice (oral)",,[-]
106,"Hinosan (o-ethyl-S,S-diphenyldithiophosphate)",17109-49-8,AWZOLILCOUMRDG-UHFFFAOYSA-N,CCOP(=O)(Sc1ccccc1)Sc2ccccc2,"3,480",[-],,,,,,,,,,,"[-] in TA1535, TA1537 and E. coli WP2, no info on metabolic activation#IPCS doc 2003; [-] all strains#Moriya et al 1983; [-] in E. coli hcr#ECVAM Review 2016",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,[-],#Vijayaraghavan and Nagarajan 1994,,,,,"[+] in swiss albino mice, polychromatic erythrocytes #Jayashree et al 1994",[+],[+],#Vijayaraghavan and Nagarajan 1994,,,,,[+] in BM swiss albino mice#Jayashree et al 1994,[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
107,Isobutene,115-11-7,VQTUBCCKSQIDNK-UHFFFAOYSA-N,CC(=C)C,"2,340",,,[-],"[-] in 4 TA strains and E. coli WP2uvrA, up to 48% gas exposure, w/out S9.",[-],,[-]," in TA98, TA100, TA1535, TA1537, TA1538 and E. coli WP2uvrA, w/out S9#Benfenati DB",,,,,[-],,,,,,,,,,,,,,,,,,[-] in cytokinesis blocked lymphocytes derived from human blood samples when exposed for 72 hours up to 50000 ppm#Jorritsma et al 1995,[-],,,,,,,,,,,,,,[-],,,[-] in bone marrow polychromatic erythrocytes (PCEs) in male B6C3F1 mice#OECD SIDS 2003a,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
108,Isobutyraldehyde,78-84-2,AMIMRNSIRUDHCM-UHFFFAOYSA-N,CC(C)C=O,"0,740",,,,,[-],"[-] in TA98, TA100, TA1535, TA1537, TA102, TA104",[-],"in TA98, TA100, TA1535, TA1537 and E. coli w/out S9#Benefenati DB",,,,[-]#Aeschbacher et al 1989;[-]#Dillon et al 1998,[-],,,,,[+] without S9 not tested with S9,,,,,may be oxidative metabolism,[+],,,,,,,[-] in p53 deficient hamster and p53 competent human cells#Fowler et al 2012a; [-] in Tk locus6 cells with and without S9 up to 1  mM exposed for 3 and 24 hours respectively#Thougaard et al 2014; [-] in Tk locus6 and CHL cells up to 10 mM for a 3 hour exposure#Fowler et al 2012a,[-],,,,[+] CHO without S9 at elevated concentrations; inconsistent with S9 in 2 trials#NTP 1999b,,,,[+] oxidative damage#Fowler et al 2012a,[+],,,,,[-],,,"[-] in rat bone marrow PCEs, gavage#Kraynak et al 2015; [-] in rat and mouse bone marrow PCEs, ip#NTP 1999b; Reviewed in#Morita et al 2015",[-],,,,[+] at intermediate dose only by via ip,,,"[+] mouse bone marrow PCEs, ip#NTP 1999b",[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,[-],,stomach and liver#Uno et al 2015, [-] up to 2000mg/kg/day through oral gavage in male SD rats glandular stomach and  liver through alkaline COMET assay#Kraynak et al 2015,[-]
109,Isoeugenol,97-54-1,BJIOGJUNALELMI-ONEGZZNKSA-N,COc1cc(\C=C\C)ccc1O,"3,040",,,,,[-],,,,,,"[-] in TA98, TA100, TA1535, TA1537, TA102, w/out S9",,[-],,,,,,,,,,,,,,,,,,,,[-],,,[-] w/out S9#NTP 2010,,,,,[-],,,,,[+] only at the highest dose in female rats,,,[+] female mouse via gavage#NTP 2010; [-] mouse via gavage#EPMAR 2010; Reviewed in# Api et al 2015,[-],,,,,,,,,,,,,,,,,,,,,,,,,in vitro: [-] in hepatocytes up to approx 800 uM in rats and mice#Burkey et al 2000,,,,,,,,,,,,,,,
110,Isoprene,78-79-5,RRHGJUQNOFWUDK-UHFFFAOYSA-N,CC(=C)C=C,"2,420",[-],,,,[-],,[-],"in TA98, TA100, TA1535, TA1537 and E.coli WP2 uvrA pKM 101, w/out S9#Benfenati DB",,,,,[-],,,,,,,,,,,,,,,,,,,,[-],,,[-],,,,[-] in CHO cells expose up to 5000 ug/ml w/out S9#NTP 1995;#NTP 2000;#Anderson 2001,[-],,[+],,,[+],,,[+] in bone marrow PCEs and NCEs of mice exposed 6 hours a day through ambient air up to 7000 ppm for 12 days#Tice et al 1988;#Tice 1988;#Shelby 1990;#IARC vol 60 1994;#Anderson 2001; [+] in peripheral blood PCEs of mice following 14 day inhalation exposure up to 7000 ppm#Shelby and Witt 1995,[+],,,,,,,[-] in bone marrow of mice exposed 6 hours a day through ambient air up to 7000 ppm for 12 days#Tice et al 1988;#Tice 1988;#Shelby 1990;#NTP 2000;#IARC vol 60 1994;#Anderson 2001; [-] in bone marrow cells of mice following 14 day inhalation exposure up to 7000 ppm#Shelby and Witt 1995,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,," [+] in alkaline comet assay with human peripheral blood mononuclear cells and human leukemia cells with S9 up to 100mM for 24 hours, with 2 hour exposure#Fabiani et al 2007;#NTP 2000",
111,"4,4'-isopropylidenediphenol",80-05-7,IISBACLAFKSPIT-UHFFFAOYSA-N,CC(C)(c1ccc(O)cc1)c2ccc(O)cc2,"3,320",[-],,[-],"[-] in TA98, TA100, TA1535, TA1537 and E. coli WP2 uvrA#JAPAN ISHL 1996",[-],"in TA97, TA98, TA100, TA1535",[-],"in TA98, TA100, TA1535, TA1537 and E. coli WP2 uvrA#Study report 1996",,,,"[-] in TA98, TA100, TA1535, TA1537, TA102#ECVAM Review 2016; [-] in TA97a, TA98, TA100, TA102#Schweikl et al 1998; [-] in TA98, TA100#Schrader et al 2002; [-] in TA98, TA100#Masuda et al 2005",[-],,[-],,,[-],[U],[-],#publication unnamed 1991,,"[-] in Hprt locus in V79, w/o S9#Schweikl et al 1998",[I],,,,,,,[-] in AHH-1 cells w/out S9#Johnson and Parry 2008,[-],[+],[+] in CHO cells without S9#Galloway et al 1998,,[-],,[-]#publication unnamed 1989,,[+] in CHO cells without S9#Hilliard et al 1998; [-] in CHO cells w/out#Ivett et al 1989,[+],,,,,"[-] in BM rat, male","[-] in mouse BM, po, male, female#Study report 1999",,"[-] in mouse BM, oral#Naik et al 2009",[-],,,,[+] in mouse,,,"[+] in mouse BM, oral#Naik et al 2009",[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
112,Kepone (Chlordecone),143-50-0,LHHGDZSESBACKH-WIMKAVSNSA-N,ClC1(Cl)[C@@]2(Cl)[C@]3(Cl)[C@@]4(Cl)C(=O)[C@]5(Cl)[C@@](Cl)([C@@]1(Cl)[C@@]35Cl)[C@]24Cl,"5,410",[-],,,,[-],"in TA98, TA100, TA1535, TA1537, w/out rat and hamster liver S9; [-] in TA97, TA98, TA100, TA1535, with mouse S9 only",,,,,,[-] in E. coli WP2#ECVAM Review 2016,[-],,[+],,,[+],[U],,,,,[I],,,,,,,,,[-],,,[-] up to toxic concs,,,,[+] in Chinese hamster M3-1 cells#Bale 1983,[E],,,,,,,,,,,,,,,,,,,,,,,,,,,,weak [+] (using scintillation counting),#Ikegwuonu and Mehendale 1991,,,,,,weak [+],,,,,,,,,,,,,,
113,Lead Acetate,301-04-2,GUWSLQUAAYEZAF-UHFFFAOYSA-L,CC(=O)O[Pb]OC(=O)C,"-0,080",[-],,,,[-],"in TA97, TA98, TA100, TA1535",,,,,,"[-] in TA97, TA98, TA100, TA1535 and E. coli WP2#ECVAM Review 2016; [-] in E. coli#Dunkel et al 1985",[-],,[TC],,,E/[-] ,[U],,,,"[+] in Hprt locus in CHO cells without S9, 0.5-1.5 mM#Yang et al 1996; [+] CD59 mutations in CHO cells#French et al 2011",[+],,,,,,,[+] in human melanoma cells#Poma et al 2003; [+] human coronary artery endothelial cells#Carmignani et al 2004; [+] in V79 cells#Bonacker et al 2005,[+],[+],[+] in human lymphocytes without S9#Beek and Obe 1974,,,,,,[-] in CHO cells without S9#Bauchinger and Schmid 1972,[E],,[E],"[-] in mice, ip#Morita et al 1997; weak [+] in rats, ip#Tachi et al 1985",,"[-] in mice, 3x ip injections, some evidence of bone marrow toxicity",,,"[+] in rat blood (3-fold at doses toxic to bone marrow) 1x gavage/week for 10 weeks#Celik et al 2005; [+] in male rats, weak [+] in female rats, 125 days drinking water#Alghazal et al 2008; [+] mouse bone marrow, 1 month diet#El-Ashmawy et al 2005; [+] in rat kidney, oral#Robbiano et al 1999",[E],[+],[+] gavage#Aboul-Ela 2002,,,,,"[+] mouse bone marrow, diet#El-Ashmawy et al 2005;#El-Ashmawy et al 2006); [+] ip#Tachi et al 1985; [+] rat bone marrow, ip#Chakraborty et al 1987",[+],,,,,,,,,,,,,,,,,,,[+],#Robbiano et al 1999,,,,,[+],"[-] in stomach, colon, bladder, lung, kidney, bone marrow, liver and brain of male mice via ip#Sasaki et al 2000)",,,,[+] in various tissues but route-dependent,"[+] in lymphocytes, 6 weeks dosing#Martinez-Alfaro et al 2012; [+] kidney male rats, 1 or 3 doses, by gavage#Robbiano et al 1999; [+]spermatocytes, drinking water; [+] in lung, kidney, liver, brain, bone marrow and nasal epithelium of male mice by inhalation 2x weekly for 1-4 weeks#Valverde et al 2002 ",[+]
114,Leucomalachite green,129-73-7,WZKXBGJNNCGHIC-UHFFFAOYSA-N,CN(C)c1ccc(cc1)C(c2ccccc2)c3ccc(cc3)N(C)C,"6,073",[-],#Lambert et al 2005,,,,,,,,,,"[-] in TA97a, TA98, TA100, TA102#Fessard et al 1999",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,[+],#Lambert et al 2005,,,,,,,,,,,,,,,[+],#Lambert et al 2005,,,,,[-],"[-] in liver of female BigBlue rats, diet; [+] in liver of female mice (diet)","[-] neg results, if any positive results due to expansion of spontaneous mutations#Nohmi et al 2017;[+] cII mutations liver female mouse but [-] Hprt mutations in splenic lymphocytes#Mittelstaedt et al 2004",[+],,,,,,,,,,,,,,,,,,,,,,
115,Lithocholic acid,434-13-9,SMEROWZSTRWXGI-HVATVPOCSA-N,C[C@@H](CCC(=O)O)[C@@H]1CC[C@@H]2[C@H]3CC[C@H]4C[C@@H](O)CC[C@@]4(C)[C@@H]3CC[C@@]12C,"6,190",[-],,,,[-],"in TA97, TA98, TA100, TA1535#Zeiger et al 1988",,,,,,"[-] in TA97, TA98, TA100, TA1535 and E. coli WP2#ECVAM Review 2016; [-] in TA98#Namba et al 1988; [-] in TA100#Watabe and Bernstein 1985; [-] in E. coli WP2 uvrA#Dunkel et al 1985",[-],,[E],,,"[+] in Tk locus, without S9, positive in 3/4; [+] in Tk locus , without S9, positive in 2/2; [-] with S9, negative in 2/2; [-] in Tk locus w/out S9",[U],,,,[-] one non-reproducible and [+]#Mitchell et al 1988; [-]#Myhr and Caspary 1988; [-]#McGregor et al 1991,[I],,,,,,,,,[+],[+] questionable results in CHO cell w/out S9 from another study#Barnes and Powrie 1982; #Ishidate et al 1988,,[-],,,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,[-],,,,"[-] in stomach, colon, liver, kidney, bladder, lung, brain and bone marrow of male mice via oral",,[-]
116,d-Mannitol,69-65-8,FBPFZTCFMRRESA-KVTDHHQDSA-N,OC[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)CO,"-3,100",[-],,,,[-],"in TA98, TA100, TA1535, TA1537#Haworth et al 1983",,,,,"[-] in TA98, TA100, TA1535, TA1537, TA102, w/out S9",[-] in TA102#Fujita et al 1988; [-] in E. coli WP2#Prival et al 1991,[-],,[-],,,[-],[U],,,[-] up to 5mg/ml#Mitchell et al 1997,,[I],,,,,,,,,[-],#Gulati et al 1989,,[-] up to 5mg/ml,,,,,[-],,,,,[-],,,[-]#Shelby and Witt 1995,[-],[-],[-]#Shelby and Witt 1995,,,,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
117,d-l menthol/ also racemic form,15356-70-4/89-78-1,NOOLISFMXDJSKH-UHFFFAOYSA-N,CC(C)C1CCC(C)CC1O,"3,400",,,,,[-],"in TA97, TA98, TA100, TA1535#Zeiger et al 1988",,,,,,[-] in TA102#Kirkland et al 2016,[-],,[-]/ [I],#Mitchell et al 1997,,,,,,,,[-],,,,,,,[-] in p53 deficient hamster and p53 competent human cells#Fowler et al 2012a,[-],,,,,,,,"[+] 3 hr treatment (with 17 hr recovery) without S9,  1.6-1.9 mM with toxicity#Hilliard et al 1998; [-]#Ivett et al 1989; [-]#Murthy et al 1991",[+],,,,,,,,[-]#OECD SIDS 2004a,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,[-],,[-],,"[-] in stomach and liver of male rats via oral; [-] in stomach, colon, liver, kidney, bladder, lung, brain and bone marrow of male mice via oral",#Uno et al 2015,[-]
118,D-limonene,5989-27-5,XMGQYMWWDOXHJM-JTQLQIEISA-N,CC(=C)[C@H]1CCC(=CC1)C,"4,570",[-],,,,[-],"in TA98, TA100, TA1535, 1537#Zeiger 1997",,,[-],"[-] in TA98, TA100, TA1535, TA1537, TA1538, TA102, up to 5000 ug/plate#EFSA Journal 9 2011b",,[-] in TA102#Jung et al 1992; [-] in TA102#Mueller et al 1993,[-],,[TC],#Mitchell et al 1997,,[TC],[U],,,[+]/[-]#Myhr et al 1990; [+]/[-]#WHO Report 1998;  [+] at toxic conc#Heck et al 1989,,[I],,,,,,,,,[-],,,[-],,,[-] in CHO cells#Anderson et al 1990; #WHO Report 1998 in #EFSA Journal 9 2011b,,[-],,,,,,,,,,,,,,,,,,[-],#Lambert et al 2005,,,,"[-] in liver and kidney, BigBlue mouse#Turner et al 2001",[-],[-] in liver and kidney of male rats (diet) but only 10 days dosing,,[I],,,,,,,,,,,,,,[-] in kideny cells#Nesslany et al 2007,[-],,,,,"[-] in stomach, colon, liver, kidney, bladder, lung, brain and bone marrow of male rats and mice via oral; [-] in kidney of male rats via oral",#Sekihashi et al 2002,[-]
119,Malathion,121-75-5,JXSJBGJIGXNWCI-UHFFFAOYSA-N,CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC,"2,360",[-],,,,[-],,,,[-],"[-] in TA98, TA100, TA1537, TA1538 and E. coli WP2#EFSA DAR 2004b",,,[-],,[E],,,[E],[U],,,"[+] but with marked cytotoxicity, Edwards et al study in#EFSA DAR 2004b",,[E],[+],#Titenko-Holland 1997,,,,,,[+],[+],,,[+],,,[+] in human lymphocytes#EFSA DAR 2004b,#Galloway et al 1987; #Garry et al 1990; #Herath et al 1989;#Ishidate et al 1981;#Gupta et al 1988;#Huang 1973,[+],,[+],#Dulout et al 1982,,,,,"[+] in BM mouse cells, ip and ora pol#Giri et al 2011",[+],[+],"[+] in mice, ip#Dulout et al 1982; [+] in mice, gavage#Kumar et al 1995;[+] in mice, ip#Amer et al 1996; [+] in mice, ip#Giri et al 2002b",,,,"[-] in rat bone marrow,Gudi et al study in#EFSA DAR 2004b",,[+],,,,,,,,,,,,,,,,[-] in male rat hepatocytes up to 2000 mg/kg bw#EFSA DAR 2004b,,[-],,,,,,,,,,,,,,
120,Melamine,108-78-1,JDSHMPZPIAZGSV-UHFFFAOYSA-N,Nc1nc(N)nc(N)n1,"-1,370",[-],,,,[-],"in TA98, TA100, TA1535, TA1537#Haworth et al 1983",[-],"[-] in TA98, TA100, TA1535, TA1537, TA1538 and E. coli WP2uvrA, W3110/pol A+, p3478/pol A-, w/out S9#Benfenati DB",,,,[-] in TA102#IUCLID v.5,[-],,[-],#Mitchell et al 1997,,,[U],,,,,[I],,,,,,,,,[-],,,[-],,,,,[-],,[-],#Mast et al 1982,,,,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
121,2-Mercaptobenzothiazole,149-30-4,YXIWHUQXZSMYRE-UHFFFAOYSA-N,Sc1nc2ccccc2s1,"2,420",[-],,,,[-],"in TA98, TA100, TA1535, 1537 ",[-],[-] in TA102,,,,"[-] in TA98, TA1535, TA1537, with S9 -/E, TA100; [-] in TA98, TA100, TA1535, TA1537 and E. coli WP2#Hinderer et al 1983",[-],,[+],,,[+],[U],,,,,[I],,,,,,,,,[+],,,[+],,,,,[+],,[-],#Toxikologishe Bewertung 2000,,[-] in male rats and mice (3x ip),[-],,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
122,Mercuric chloride,7487-94-7,LWJROJCJINYWOX-UHFFFAOYSA-L,Cl[Hg]Cl,"1,161",[-],,,,[-],"in TA98, TA100, TA1535, 1537 ",,,,,,"[-] in TA98, TA100, TA1535, TA1537, TA102 and E. coli WP2#ECVAM Review 2016; [-] in TA102#Marzin and Phi 1985; [-] in E. coli#Codina et al 1995",[-],,[+],,,[+],[U],,,,"[+] in Hprt locus in lymphocytes#Xue et al 2001; [+] in lacZ locus in NIH 3T3 cells, possibly oxidative#Schurz et al 2000; [-] in Hgpt mutations in Chinese hamster G12 cells#Klein et al 1994; [-] in Hprt locus in FM3A mouse cells#Nishimura and Umeda 1978",[E],[+],#Ogura et al 1996,,,,,"[+] in human lymphocytes, oxidative#Ogura et al 1996; [+]#Turkez and Dirican 2012; [+] in HepG2#Kaivalya et al 2011; [+] in V79 cells#Bonacker et al 2004",[+],[+],#Ogura et al 1996,,[+],,,,"[+] in human leukocytes#Verschaeve et al 1985; [+] in human lymphocytes, oxidative#Ogura et al 1996;  [+] in human lymphocytes#Halder et al 2005; [+] in CHO cells#Howard et al 1991; [-] for structural and numerical CA, [+] for C-anaphases in human blood cultures, but only 4 hr treatment and no recovery#Rao et al 2001; [+] for C-mitoses#Verschaeve et al 1984",[+],,[+],"[+] in rat blood, 5 days oral#Rozgaj et al 2005",,,,,[-] in mice but only single dose level used (2x 3 mg/kg)#Grisolia and Takahashi 1994,[+],[+],"[+] in mice, gavage#Ghosh et al 1991",,,,,"[+] in rats acute and 15-day treat#Bhowmik and Patra 2015; [+] 90 days drinking water, possibly oxidative#Boujbiha et al 2012; [+] rats and mice, acute and chronic#Das et al 1985; [-] in rats, only single dose level (2x 3mg/kg)#Grisolia and Takahashi 1994; [+] chronic treat, drinking water#Yoon et al 2005",[+],,,,,,,,,,,,,,,,,,,[+],#Grover et al 2001; #Rozgaj et al 2005,,,,,,,,,"[+] in rats, acute and 15-day treat#Bhowmik and Patra 2015; [+] in rats, 5 days via oral#Rozgaj et al 2005 and acute#Grover et al 2001",,,[+]
123,Methidathion,950-37-8,MEBQXILRKZHVCX-UHFFFAOYSA-N,COC1=NN(CSP(=S)(OC)OC)C(=O)S1,"2,200",[-],,,,,,,,,,,"[-] in TA98, TA100, TA1535, TA1537, E. coli#INCHEM Doc Methidathion; [-] in TA102 and all other necessary strains#US EPA 1999; [-]#California EPA 2007",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,[-],,,,,,"[-] in mouse bone marrow, oral#Kevekordes et al 1996",[-],,,,,,,[-] in Chinese hamster bone marrow#Quest et al 1990,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
124,Methoxychlor,72-43-5,IAKOZHOLGAGEJT-UHFFFAOYSA-N,COc1ccc(cc1)C(c2ccc(OC)cc2)C(Cl)(Cl)Cl,"5,080",[-],,,,[-],,,Potential PBT/vPvB but further assessment is postponed; no document available as from 2-3-2016,,,,"[-] in TA98, TA100, TA1535, TA1537, TA1538, G46, C3076, D3052, w/out S9#Grant et al 1976;#Mortelmans et al 1986;#Probst et al 1981;#Waters et al 1980; [-] in E. coli WP2#Brusick et al 1980",[-],,[E],,,[+],[+],,,,,[+],,,,,,,,,[-],NTP,,[-],,,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
125,4-methoxyphenol (Hydroquinone monomethyl ether),150-76-5,NWVVVBRKAWDGAB-UHFFFAOYSA-N,COc1ccc(O)cc1,"1,580",[-],,,,,,[-],"[-] in TA98, TA100, TA1535, TA1537, TA102, w/out S9#Benfenati DB",,,,,[-],,,,,,,[-],"[-] in Hgprt locus in V79 CHL cells, w/out S9",,,[-],,,,,,,,,[+],#Kaul 1979,,,,"[-] in primary human lymphocyte cultures, w/out S9",,[+] Allium root tip assay,[I],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
126,Methyl acrylate,96-33-3,BAPJBEWLBFYGME-UHFFFAOYSA-N,COC(=O)C=C,"0,800",TC [-],#Zeiger et al 1987;#Waegemaekers and Bensink 1984,,,[-],"[-] in TA97, TA98, TA100, TA1535, TA1537",[-]," [-] in TA98, TA100, TA1535, TA1537, TA1538, C3076, G46, D3052 and E. coli WP2 and WP2uvrA-, w/out S9#Benfenati DB",,,,"[-] in TA97, TA98, TA100, TA1535, TA1537 and E. coli WP2#ECVAM Review 2016; [-] in TA98, TA100, TA1535, TA1537, TA1538#Waegemaekers and Bensink 1984; [-] in TA98, TA100, TA1535, TA1537, TA1538, G46, C3076, D3052 and E. coli WP2,and WP2 uvrA#IUCLID 2000; [-] in TA98, TA100, TA1535, TA1537, TA1538#Oesch 1977;#Hachiya et al 1981; [-] in TA98, TA100, TA1535, TA1537, TA1538, G46, C3076, D3052 and E. coli WP2 and WP2uvrA#McMahon et al 1979",[-],,[+],,,,,,,,[+]#Moore et al 1988; #Dearfield et al 1991; #Amtower et al 1986; #Millis et al 1988; #Doerr et al 1988; #Moore et al 1989; [+] in Hgprt in CHO#Seifried et al 2006; [+] in Hgprt in CHO#Moore et al 1991; [-] in Xprt in CHO#Oberly et al 1993,[+],,,,,,,,,[+],[+]#Doerr et al 1988; TC [-]#Ishidate et al 1988,,,,,,[+] in CHO and CHL cells#Zenz et al 1994; [+] in CHL cells#Ishidate et al 1981; [+] in CHL cells#Sofuni et al 1984a; [+] in CHO cells#Moore et al 1989,[+],,[+] ,"[+] at high conc, ip#Przybojewska et al 1984",,,,,"[-] in mouse BM#IUCLID 2000; [-] in mouse BM, oral#Hachiya et al 1981; [-] inhalation#Sofuni et al 1984b",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
127,Methyl carbamate,598-55-0,GTCAXTIRRLKXRU-UHFFFAOYSA-N,COC(=O)N,"-0,660",[-],,,,[-],"[-] in TA97, TA98, TA100, TA1535, TA1537#Zeiger et al 1988; #Zeiger 1997; #Brams et al 1987",,,,,,[-] in E. coli#Dunkel et al 1985; [-] in TA102#Watanabe et al 1998,[-],,[-],#Mitchell et al 1997,,[-],[U],,,,,[I],,,,,,,,,[-],,,[-] in CHO cells,,,,[-]#Anderson et al 1990,[-],,[-],#Shelby and Tice 1991,,[-],,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,[-],,[-] in stomach and liver of male rats via oral,,[-]
128,Methyleugenol,93-15-2,ZYEMGPIYFIJGTP-UHFFFAOYSA-N,COc1ccc(CC=C)cc1OC,"3,030",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537",,,,,,"[-] in TA98, TA100, TA1535, TA1537 and E. coli WP2#IARC vol 101 2013; #ECVAM Review 2016; [-] in TA strains and E. coli#Sekizawa and Shibamoto 1982",[-],,,,,,,,,,[-] in Hprt locus in V79 cells#Groh et al 2012,[-],,,,,,,[-] in V79 cells#Groh et al 2012,[-],[-],,,[-] in CHO cells up to toxic concs,,,,,[-],,,,,"[-] in male and female mouse blood, 13 weeks gavage",,,,[-],,,,,,,,,,,,,,,,[+] for gpt and Spi mutations in liver of gpt-delta male and female rats (13 weeks oral),#Jin et al 2013,[+],,,,,,,,,,,,,,,,,,,,"[+] in male rat bone marrow, 8 hrs only; [-] in liver, lung, kidney and bladder, but [+] with endo III in liver, 6-8 hrs, oxidative damage via gavage",#Ding et al 2011,[+] oxidative
129,Methyl isocyanate,624-83-9,HAMGRBXTJNITHG-UHFFFAOYSA-N,CN=C=O,"0,790",[-],,,,[-],"[-] in TA97, TA98, TA100, TA1535, TA1537",,,,,,"[-] in TA97, TA98, TA100, TA1535, TA1537, TA102#ECVAM Review 2016; [-] in TA97a, TA98, TA100, TA102, TA104#Meshram and Rao 1988a;#Meshram and Rao 1988b [-] in TA97, TA98, TA100, TA1535, TA1537#Mason et al 1987; [-]#Shelby et al 1987",[-],,[E],,,[+],,,,,[+]#Seifried et al 2006; #Seifried et al 2008; #Caspary and Myhr 1986;#ACGIH 2005,[+],,,,,,,,,[+],,,[+],,,, [+] in CHO#Mason etal 1987; [+] in CHO#ACGIH 2005,[+],,[E],"weak [+]#Tice et al 1987; [-] in mouse BM and PB, ip#Meshram and Rao 1988b; [-] in mouse BM, inhalation#Kar et al 1989",,"[-] in M and F mouse BM, by inhalation",,,,[E],[E],"weak [+]#Tice et al 1987; [-][-] in mouse BM, inhalation#Kar et al 1989",,,,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
130,Methyl tert-butyl ether,1634-04-4,BZLVMXJERCGZMT-UHFFFAOYSA-N,COC(C)(C)C,"0,940",[-],,,,,,[-],"[-] in TA98, TA100, TA1535, TA1537, TA102, w/out S9#Benfenati DB",,,,"[-] in TA98, TA100, TA1535, TA1537, TA1538, up to 5000 ug/plate#IUCLID 2010; [-] in TA98, TA100, YG1041, YG1042#Vosahlikova et al 2006",[-],,[+],,,,,,,,[+] in Tk locus L5178Y#Mackerer et al 1996; [-] in Hprt locus in V79#Cruzan et al 2007,[+],,,,,,,[-] in NIH/3T3 cells exposed up to 20uL/mL#Zhou et al 2000,[-],[-],,,,,,,[U]#Cruzan et al 2007,[I],,[-],#Kado et al 1998; #McKee et al 1997,,,,,[-]#Cruzan et al 2007; #Mennear et al 1997,[-],[-],#McKee et al 1997,,,,,[-] in F344 rat bone marrow cells when exposed up to 8000 ppm through inhalation 6 hours a day for 5 days and sacrificed 6 or 24 hours after final dosage#McKee et al 1997;#Cruzan et al 2007;#Mennear et al 1997,[-],,,,,,,,,,,[-],[-] in mouse hepatocytes#McKee et al 1997,,,,,[-] in CD-1 mouse bone marrow cells when exposed up to 8000 ppm through inhalation 6 hours a day for 25 days and sacrificed 16  hours after final dosage#McKee et al 1997;#Cruzan et al 2007;#Mennear et al 1997,[-],,,,,,,,,,,,,"[+] in vivo mouse hepatocytes, renal cells and phenumocytes when exposed up to 4968 mg/m3 by inhalation for 20 days#Yang et al 2005; [+] in rat type II phenumocytes and rat hepatocytes in vitro#Yand et al 2005",[+]
131,N-methylolacrylamide,924-42-5,CNCOEDDPFOAUMB-UHFFFAOYSA-N,OCNC(=O)C=C,"-1,810",[-],,[-],"[-] in TA98, TA100, TA1535, TA1537, TA102, TA104 and E. coli WP2uvrA and WP2 uvrA/pKM101, w/out S9.",,,,,,,,,[-],,,,,[+],,,,,"[+]  in Tk locus in L5178Y cells w/out S9, without RTG dropped below 10% at effective doses#NTP",[+],,,,,,,,,[+],,,[+],,,, [+] in CHO cells w/out S9 dosed up to 250 ug/ml#IARC vol 60 1994,[+],,[E],"[-] rat bone marrow PCEs, via ip; weak [+] mouse bone marrow PCEs, via ip#Paulsson et al 2002",,"weak [+], not dose-dependent manner",,,[-] Witt et al 2003,[E],,,,,,,biomonitoing data: ([+] chromatid gaps only) in male workers exposed daily to a solution containing an average of 26-31% of the compound exposed for an average of 586 days#Kjuus et al 2005,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
132,Methylphenidate HCl,298-59-9,JUMYIBMBTDDLNG-UHFFFAOYSA-N,Cl.COC(=O)C(C1CCCCN1)c2ccccc2,"3,017",[-],,,,[-],"[-] in TA97, TA98, TA100, TA1535, TA1537",,,,,,"[-] in TA97, TA98, TA100, TA1535, TA1537 and E. coli WP2#Teo et al 2003; d-Methylphenidate free base [-] in E. coli, no HCl#ECVAM Review 2016",[-],,,,,,,,,,[-] in Tk locus#Teo et al 2003,[-],,,,,,,,,[+],,,[+] in CHO cells with S9 but control CA frequency zero and no dose response,,,,[-] in human lymphocytes up to 10 mM#Suter et al 2006,[-],,[-],,,"[-] in male rats, 28 day gavage; [-] in male and female Tg:AC mice, 6 months dosed feed",,,"[-] in monkey retics sampled every 3 months for 20 months, oral#Morris et al 2009; [-] in mice, after acute oral#Teo et al 2003;#Suter et al 2006;#Zamora-Perez et al 2011; [-] 28 days gavage#Manjanatha et al 2008; [-] 24 weeks dosed feed#Manjanatha et al 2009; [-] in rats 28 days gavage#Witt et al 2010; [-] acute ip#Andreazza et al 2007",[-],,,,,,,"[-] in monkey lymphocytes sampled every 3 months for 20 months, oral dosing#Morris et al 2009",[-],,,,,,,,[-] in livers of male Big Blue mice (24 weeks dosed feed),#Manjanatha et al 2009,[-],,,,,,,,,[+],"[+] in blood and brain of rats, via ip#Andreazza et al 2007",,,,,,,,,,"[+] in blood of male rats, 28 days via ip, but confusing paper and results considered not reliable; [-] in blood, liver and brain of rats, 28 days via oral",#Andreazza et al 2007; #Witt et al 2010,[-]
133,Mirex,2385-85-5,GVYLCNUFSHDAAW-LDQOBNSHSA-N,ClC1(Cl)[C@@]2(Cl)[C@@]3(Cl)[C@@]4(Cl)C(Cl)(Cl)[C@]5(Cl)[C@](Cl)([C@@]1(Cl)[C@]35Cl)[C@@]24Cl,"6,890",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537",,,,,,"[-] in TA98, TA100, TA1535, TA1537 and E. coli WP2#ATSDR 1995; #ECVAM Review 2016; [-] in E. coli#Probst et al 1981",[-],,,,,,,,,,[-] in Hprt locus in human fibroblasts using hepatocytes for metabolic activation#Tong et al 1981,[-],,,,,,,,,[-],,,"[-]  in CHO cells up to 260 µg/mL, probably not toxic",,,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
134,Monochloroacetic acid,79-11-8,FOCAUTSVDIKZOP-UHFFFAOYSA-N,OC(=O)CCl,"0,220",[-],,,,[-],,[-],"[-] in TA98, TA100, TA1535, TA1537, TA1538, TA102, TA104 and E. coli  WP2 uvrA and WP2 uvr A pKM 101, w/out S9#Benfenati DB",,,,,[-],,TC,,,[+],[U],,,,"[+] in Tk locus without S9#McGregor et al 1987; [-] oauabain resistance assay in V79#Huberman et al 1975; reviewed by ECETOC 1999, noted pH issue",[I],,,,,,,,,[-],,,[-],,,,weak [+] in CHO w/out S9#NTP 1992b; [-] in CHL cells w/out S9#Sawada et al 1987,[E],,,,,,,,,,,,,,,,"[-] in newt MN test#Giller et al 1997; [+] in mouse, via ip#Bhunya and Das 1987, as cited in ECETOC 1999 and NRC 2009, newt not a mammailan species not control no possibility to check the original paper",[I],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"[-] stomach, duodenum, liver, spleen in mouse and/or rat, alkaline unwinding#Chang et al 1992; [-] in vitro in primary hepatocytes and human cells#Chang et al 1992; [+] in vitro in CHO cells comet#Plewa et al 2010;#Plewa et al 2002",[-]
135,Naphthalene,91-20-3,UFWIBTONFRDIAS-UHFFFAOYSA-N,c1ccc2ccccc2c1,"3,300",[-],,[-],"[-] in 4 TA strains and E. coli WP2uvrA, w/out S9.",[-],"[-] in TA97, TA98, TA100, TA1535, TA1537, TA1538#Mortelmans et al 1986",,,[-],"[-] in TA97, TA98, TA100, TA1535, TA1537 and E. coli WP2uvrA, various studies#EFSA Journal 931 2009",,,[-],,[-] ,[-] in TK and HPRT loci in MCL-5 cells#Sasaki et al 1997,,,,,,,[+] in Tk locus with S9#Seifried et al 2006,[E],,,,,,,"[+] in MCL-5 cells#Sasaki et al 1997; [+] in Tk locus6, non-linear#Recio et al 2012",[+],[+],,"[+] in CHL cells (6-18, 24-0 or 48-0h treatment without S9 and at 6-18h tretament with S9)",[+],,,,[+] in CHO and HPLT#Schreiner 2003,[+],,[-],#Harper et al 1984; #Schreiner 2003; #Natarajan and Obe 1986,,,,,[-] in mouse#Schreiner 2003; [-] in mouse#EU RAR 2003a,[-],,,,,,,,,,,,,,,,,,,[-],#Schreiner 2003,,,,, [-] in rat liver#EU RAR 2003a,[-],,,,,,,,,,,,,"TC [-] in liver, alkaline elution#Kitchin et al 1992",[I]
136,Nickel (II) sulfate hexahydrate,10101-97-0,RRIWRJBSCGCBID-UHFFFAOYSA-L,O.O.O.O.O.O.[Ni+2].[O-]S(=O)(=O)[O-],"-1,764",[-],,[-],"[-] in 4 TA strains and E. coli WP2uvrA, up to 10 mg/plate, w/out S9.",[-],,,,,,,,[-],,[+],,,[+] without S9,[E],,,, [+] in Tk locus without S9#McGregor et al 1988b;#NTP 1996,[E],,,,,,, [+] in V79 Chinese hamster cells exposed for 24 hours to up to 800 uM between 0 and 72 hours after incubation#Ohshima 2001; [+] in human diploid fibroblasts derived from male fetal lung tissue exposed up to 800 uM for 24-26 hours#Seoane et al 2001; [+] in human whole blood derived cytokinesis blocked lymphocytes when exposed up to 0.01 ug/mL for 48 hours#Botta et al 1994,[+],[+],,,,,,,[+] in V79 Chinese hamster cells exposed for 24 hours to up to 800 uM between 0 and 72 hours after incubation#Ohshima 2001; [+] in V79 hamster cells exposed to 320 uM for 24 hours#Ohshima 2003; [+] in Syrian hamster cells as well as in human whole blood lymphocytes exposed for 24 hours#Larramendy et al 1981; [+] in human whole blood derived lymphocytes when exposed up to 0.01 ug/mL for 48 hours#Botta et al 1994,[+],,,,,,,,"[-] in bone marrow PCEs of rats, treated with up to 500 mg/kg/day for 5 days, oral gavage#Oller et al 2007",[-],,,,,,,,,,,,,,,,," [+] F1 of WR mice single locus and dominant lethal, via ip#Domshlak et al 2005",[+],,,,,,,,,,,,,,,,,,,,,"[-] in normal human fibroblasts exposed up to 10^-3 M for 24 hours in the alkaline elution DNA assay#Osipova et al 1998a; [-] in nuclear chromatin and [+] in chromosomal chromatin strand break in situ end labelling/ electron microscopy assays in human blood lymphocytes exposed up to 15 uM for 2 hours#M'Bemba-Meka et al 2005; [+] in mouse spermatocytes exposed up to 5.0 mg/kg, ip, but damaged cells, apoptotic#Domshlak et al 2005; [+] in comet assay using rat and human gastric mucosa cells#Pool-Zobel et al 1994; [-] in alkaline comet assay using human salivary gland cells and lymphocytes exposed up 2 umol/ml for 1 hour#Harreus et al 2007",[-]
137,"Nitrilotriacetic acid/Nitrilotriacetic acid, trisodium salt, monohydrate",139-13-9/18662-53-8,HERBOKBJKVUALN-UHFFFAOYSA-K,O.[Na+].[Na+].[Na+].[O-]C(=O)CN(CC(=O)[O-])CC(=O)[O-],,[-],,,,[-],"[-] in TA97, TA98, TA100, TA1535, TA1537#Zeiger et al 1992; [-] in TA97, TA98, TA100, TA1535, TA1538 and E. coli WP2, salt form#Dunkel et al 1985",,,,,"[-] in TA97, TA98, TA100, TA1535, TA1537, TA102, w/out S9","[-] in TA1538#Loprieno et al 1985; [-] in TA98, TA100, TA1537, TA102#Nesslany et al 2008; [-] in E. coli WP2#Zetterberg 1970; #IARC vol 73 1999; [-] in TA97, TA98, TA100, TA1535 and E. coli WP2, salt form#ECVAM Review 2016",[-],,[-],#Toyokuni et al 1995,,[E] salt form tested,[U] salt form tested,,,,[-] in Tk locus#Mitchell et al 1988; [-]#Myhr and Caspary 1988; [+] in Tk locus#Nesslany et al 2008,[E],[+],#Modesti et al 1995,,,,, [+]#Nesslany et al 2008,[+],[-],NTP,,[-] in CA and SCE,#Loveday et al 1989,,,[+] in HPLT#Nesslany et al 2008; [-] in HPLT#Montaldi et al 1988,[E],,,,,,,,[-] in mouse#Montaldi et al 1988,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,[+],#Robbiano et al 1999,,,,,[+],,,,[+]#Robbiano et al 1999,[+] in kidney and bladder but [-] in liver of male rats via gavage,[+] comet in kidney#Nesslany et al 2008,[+]
138,Nitrobenzene,98-95-3,LQNUZADURLCDLV-UHFFFAOYSA-N,[O-][N+](=O)c1ccccc1,"1,850",[-],,[-],"[-] in TA98, TA100, TA1535, TA1537, TA102, TA104 and E. coli WP2uvrA and WP2 uvrA/pKM101, w/out S9.",[-],"[-] in TA98, TA100, TA1535, TA1537#Haworth et al 1983",,,,,,,[-],,,,,,,,,,[+] and; [-] in Hprt locus in V79 cells#Kuroda 1986,[E],,,,,,,[+] in V79 cells#Bonacker et al 2004; [+] in HPLT cells#Huang et al 1996,[+],[+],[+] at 50 mM#Huang et al 1996,,[-],,,,[-] in CHL cells#Ishidate 1988 ;#EU RAR 2008a,[-],,,,,,,,[-] in mouse#EU RAR 2008a,[-],,,,,,,"[-] in rat spleen and blood lymphocytes, inhalation#Kligerman et al 1983",[-],,,,,,,,,,,[-],#Madle et al 1994,,,,, [-]#Mirsalis et al 1982,[-],,,,,,,[+],,,,,[+] in kidney of male rats via oral,[+] comet#Mattioli et al 2006 in#EU RAR 2008a,[+]
139,Nitromethane,75-52-5,LYGJENNIWJXYER-UHFFFAOYSA-N,C[N+](=O)[O-],"-0,350",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537",,,,,,"[-] in TA98, TA100, TA1535, TA1537 and E. coli WP2#ECVAM Review 2016; [-] in E. coli#Kawai et al 1987; [-] in TA102#Dayal et al 1989",[-],,,,,,,,,,[E] in Tk locus after re-evaluation#Seifried et al 2006,[E],,,,,,,[-] in SHE cells#Gibson et al 1997,[-],[-],,,[-] in CHO cells up to 4980 µg/mL,,,,,[-],,,,,[-] in mouse blood erythrocytes after 13 weeks inhalation,,,"[-] in mouse BM doses up to 3660 mg/kg, ip#Gocke et al 1981",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
140,p-Nitrophenol,100-02-7,BTJIUGUIPKRLHP-UHFFFAOYSA-N,Oc1ccc(cc1)[N+](=O)[O-],"1,910",,,,,[-],"[-] in TA98, TA100, TA1535, TA1537",,,,,,[-] in E. Coli#CICAD20 WHO 2000,[-],,[I],#Mitchell et al 1997,,,,,,,[I] in Hprt locus in CHO cells w/out S9#Oberly et al 1990; [I] in Tk locus with uninduced S9#Amacher and Turner 1982; [I] in Tk locus w/out S9#Oberly et al 1984,[I],,,,,,,[+] in p53 deficient but [-] in p53 competent cells#Fowler et al 2012a,[E],,,,[+] at 1500 ug/ml  with S9,,,,,[+],,,,,,,,[-]#Eichennbaum et al 2009,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
141,o-Nitrotoluene,88-72-2,PLAZTCDQAHEYBI-UHFFFAOYSA-N,Cc1ccccc1[N+](=O)[O-],"2,300",[-b],weak [+]#Chiu et al 1978; TC [-]#Miyata et al 1981;#Tokiwa 1981;#Spanggord et al 1982;#Shimizu and Yano 1986;#Kawai et al 1987;#Nohmi et al 1984; [+] with norharman#Suzuki et al 1983,[-],"[-] in TA98, TA100, TA1535, TA1537, TA102, TA104 and E. coli WP2uvrA and WP2 uvrA/pKM101, w/out S9.",[-],"[-] in TA98, TA100, TA1535, TA1537#Haworth et al 1983",,,,,,,[-],,,,,,,,,,,,[+],,,,,,#Matsushima et al 1999,[+],[+],,,[-],,,,"TC [-]#Galloway et al 1987; TC [-], positive in polyploidy#Ishidate et al 1988; [+] in HPLT#Huang et al 1995",[E],,,,,"#[-] in mouse PB, feed for 13-wks (Male Equivocal, Female Negative); #[-] in mouse BM, ip x1; #[-] in rat BM, ip x3;  ",,,,[-],,,,,,,,,,,,,,,,,,,[E],#Madle et al 1994,,[+] in M and F rats; #[-] in M and F mice#EU RAR 2008b,,,"[+] and [-] in rat, depending on gastrointestinal flora#Butterworth et al 1982;#Doolittle et al 1983; [+] in both sexes of rats and mice after single oral dose#Dunnick 1993;#EU RAR 2008b
",[+],,,,,,,,,,,,,,
142,p-Nitrotoluene,99-99-0,ZPTVNYMJQHSSEA-UHFFFAOYSA-N,Cc1ccc(cc1)[N+](=O)[O-],"2,370",,,[-],"[-] in TA98, TA100, TA1535, TA1537, TA102, TA104 and E. coli WP2uvrA and WP2 uvrA/pKM101, w/out S9.",[-],"[-] in TA98, TA100, TA1535, TA1537#Haworth et al 1983",[-],#NTP,,,,,[-],,,,,[+],,,,,,[+],,,,,,,[-] without S9#Matsushima et al 1999,[I],,,,"[+] with S9, not dose related, precipitation occurred at all doses#Galloway et al 1987",,,,"[+] in HPLT without S9#Huang et al 1996
",[+],,,,, [-] rat; [-] mouse;,,,[-] in mice#Furukawa al 1989;#Furukawa et al 1991,[-],,,,,,,,,,,,,,,,,,,,,,,,,"[-] in rat liver#Doolittle et al 1983; [-]#NTP 1992c
",[-],,,,,,,,,,,,,,
143,Ochratoxin A,303-47-9,RWQKHEORZBHNRI-BMIGLBTASA-N,C[C@@H]1Cc2c(Cl)cc(C(=O)N[C@@H](Cc3ccccc3)C(=O)O)c(O)c2C(=O)O1,"4,740",[-],,,,,,,,[-],studies reported are the ones listed within#WHO Report 2001,"[-] in [-] in TA98, TA100, TA1535, TA1537, TA102, w/out S9","[-] [-] in TA98, TA100, TA1535, TA1537 and 1 study DNA repair with E.coli WP2#WHO Report 2001
",[-],,[TC],[I]#Mitchell et al 1997,,,,,,,"[I] in Tk locus w/out S9#Bendele et al 1985; [-] in HPRT locus in CH3 cells, reported cytotoxicity#Umeda et al 1977; but [+] in LacZ locus in NIH 3T3 cells transfected with human cytochrome P450#De Groene et al 1996;#WHO Report 2001",[+],,,,,,,[+] in Ovine seminal vesicle cell cultures and CH embryo fibroblasts#WHO Report 2001,[+],[-],,,[-],,,,"[-] in CHO cells, 2 NTP studies in#WHO Report 2001",[-],,,,,,,,,,,,,,,,"[+] in mouse, 2 studies#WHO Report 2001",[+],,,,,,,,,,,,,,,,,,,,,,,,,[+],,,,,[+] in kidney of male rats via oral,"[+] single-strand-breaks BALB/c mouse in spleen, kidney, liver via ip#WHO Report 2001",[+]
144,gamma-Oryzanol,11042-64-1,FODTZLFLDFKIQH-XUNXSEOASA-N,COc1cc(\C=C\C(=O)O[C@@H]2CC[C@@]34CC35CC[C@@]6(C)[C@@H](CC[C@]6(C)C5CCC4C2(C)C)C(C)CCC=C(C)C)ccc1O,"13,891",[-],,,,,,,,,,,"[-] in TA98, TA100, TA1535, TA1537 and E.coli WP2#ECVAM Review 2016; [-] in TA98, TA100, TA1535, TA1537 and E. coli WP2 uvrA#Tsushimoto et al 1991",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,[-] rat bone marrow up to 4000 mg/kg#Tsushimoto et al 1991,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
145,Oxamyl,23135-22-0,KZAUOCCYDRDERY-UITAMQMPSA-N,CNC(=O)O\N=C(/SC)\C(=O)N(C)C,"-0,480",[-],,,,,,,,[-],"[-] in TA98, TA100, TA1535, TA1537 and E.coli WP2#EFSA DAR 2004c; #EFSA Report 26 2005",,"[-] in TA98, TA100, TA1535, TA1537 and E. coli#FAO Report 2008; #Moriya et al 1983
",[-],,,,,,,,,[-] in Hgprt locus in CHO cells w/out S9#EFSA DAR 2004c,"[-] in Hprt locus in CHO cells#FAO Report 2008
",[-],,,,,,,,,,,,,,,[-] in human peripherl blood lymphocytes w/out S9#EFSA DAR 2004c,"[-] in HPLT cells#FAO Report 2008
",[-],,,,,,,[-] in mouse BM#EFSA DAR 2004c,"[-] in mouse BM#FAO Report 2008
",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
146,Oxazepam,604-75-1,ADIMAYPTOBDMTL-UHFFFAOYSA-N,OC1N=C(c2ccccc2)c3cc(Cl)ccc3NC1=O,"2,240",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537, TA102",,,,,,#ECVAM Review 2016,[-],,[-],#Stopper et al 1993,,,,,,,,[-],[+],#Stopper et al 1993,,,,,,[+],[-],NTP,,[-] in CA and SCE,,,,,[-],,[-],NTP,,[-]#Witt et al 2000,,,,[-],[-],#IARC vol 66 1996,,,,,,[-],[+],#Lambert et al 2005,,,,,[+]/[-],[+] in liver of male mice; [-] in liver and lung of female mice (diet),,[E],,,,,,,,,,,,,,,,,,,,,,
147,Oxymetholone,434-07-1,ICMWWNHDUZJFDW-CCTJMHFWSA-N,C[C@@]1(O)CC[C@@H]2[C@H]3CC[C@@H]4CC(=O)\C(=C\O)\C[C@@]4(C)[C@@H]3CC[C@@]12C,"3,610",[-],,,,[-],"[-] in TA97, TA98, TA100, TA1535#Zeiger et al 1992",,,,,,"[-] in TA98, TA100, TA1535, TA1537 and E.coli WP2#Holden et al 1999; #ECVAM Review 2016",[-],,,,,,,,,,[-] inTk locus#Holden et al 1999,[-],,,,,,,[+] in SHE cells#Gibson et al 1997,[+],[-],,,[-] in CHO cells up to toxic concs,,,,[-] in human lymphocytes#Holden et al 1999,[-],,[-],,,"[-] in mouse blood, 14 weeks gavage up to 2500 mg/kg/day",,,[-] in mouse blood after 20 weeks dermal or 26 weeks oral dosing#Holden et al 1999,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
148,Patulin,149-29-1,ZRWPUFFVAOMMNM-UHFFFAOYSA-N,OC1OCC=C2OC(=O)C=C12,"-2,400",[-c],TC[-]#Wehner et al 1978; TC[-]#Kuczuk 1978; TC[-]#Takahashi et al 1992; TC[-]#Wurgler et al 1991; TC[-]#Lafont et al1983; #Lindroth 1980 ; TC[-]#von Wright and Lindroth 1978; weak [+]#Canas 1996; TC[-]#Bartsch 1980,,,,,,,,,,"[-] in TA98, TA100, TA1535, TA1537, TA102#ECVAM Review 2016",[-],,[+],[+] in Hprt locus#Shumacher et al 2005,,,,,,,[+] in Ttk locus without S9#Schumacher et al 2005b; [+] 8-azaguanine resistance without S9#Umeda et al 1972,[+],[+],,,,,,[+] in human peripheral blood lymphocytes exposed up to 7.5 uM for 48 hours#Alves et al 2000; [+] in human peripheral blood lymphocytes exposed up to 7.5 uM for 48 hours#Donmez-Altuntas et al 2013; [+] in Chinese hamster V79 cells when exposed to 0.5 uM for 4 hours#Glaser and Stopper 2012; [+] in HepG2 cells exposed up to 0.8 M for 1 hour#Yang et al 2011; [+] in HepG2 cells exposed up to 0.75 uM for 24 hours#Zhou et al 2009; [+] in CHO v79 exposed for 6 hours up to 0.5uM#Pfeiffer et al 1998; [+] in chinese hamster primary cultures exposed up to 2 ug/ml for 1 hour#Kubiak and Kosz-Vnenchak 1983; #Fuchs et al 2008,[+],[+],,,,,,,[+] in v79 Chinese hamster cells exposed up to 0.95 uM for 17 hours#Alves et al 2000; [+] in HepG2 cells exposed up to 15 uM for 24 hours#Ayed-Boussema et al 2013; [+] in human perioheral lymphocytes up to 3.5x10-6M#Withers 1966; #Preston et al 1981; #Korte 1980; in C3H cells#Umeda et al 1977; #Thust et al 1982; in CHO primary cells#Kubiak and Kosz-Vnenchak 1983,[+],,,,,,,,[+] in mouse bone marrow PCEs and NCEs dosed with 1mg/kg i.p. Injections for 7 days and sacrificed 24 hours after last injection#Song et al 2014,[+],[+],#Roll et al 1990,,,,,[+] in bone marrow of mice dosed with 1mg/kg i.p. Injections for 7 days and sacrificed 24 hours after last injection#Song et al 2014;  [+] in Chinese hamsters administered up to 20 mg/kg and sampled at 6 or 24 hours#Korte 1980; [+] bone marrow of chinese hamsters exposed up to 20mg/kg for 48 hours#Korte and Ruckert 1980; [+] in bone marrow of chinese hamsters exposed up to 20 mg/kg exposed for over 48 hours#Korte et al 1979,[+],,,,,,,,,,,,,,,,,in vitro: [-] in human and rat liver cells exposed up to 1.6x10^3 M for 3-5 hours#Belitsky et al 1985; [-] in rat liver cultures#Belitsky et al 1983,,,,,,,,,,,,,,"[+] in alkaline comet assay in skin of mice dosed with 160 ug topically and euthanized 6-72 hours after exposure#Saxena et al 2009; [+] in cortex, bulb, cerebellum, kidney and liver of mice exposed through single i.p. Injection and sacrificed 3 hours after treatment; [-] in same experiment in kidneys exposed up to 3.75 mg/kg#de Melo et al 2012; [+] In alkaline comet assay in Hep G2 cells exposed up to 15 uM for 24 hours#Ayed-Boussema et al 2013; [+] in alkaline comet assay in Chinese hamster V79 cells when exposed to 0.5 uM for 4 hours#Glaser and Stopper 2012; [+] in DNA break analysis in CHO-K1 cells exposed up to 0.3 uM for 42 hours; and [-] in DNA break analysis in human peripheral blood lymphocytes under the same conditions; and [+] in SCGE assay in HEK293 cells exposed up to 20 uM for 2 hours#Liu et al 2003; [+] in alkaline comet assay in HepG2 cells exposed up to 60 uM for 1 hour#Yang et al 2011; [+] in alkaline filter elution assay in CHO V79 lung fibroblasts exposed up to 50 um for 1 hour#Shumacher et al 2006; [+] in alkaline SCGE assay of HepG2 cells exposed up to 40um for 1 hour#Zhou et al 2010; [+] in HeLa cells#Umeda et al 1972        ",[+]
149,Phenazone,60-80-0,VEQOALNAAJBPNY-UHFFFAOYSA-N,CN1N(C(=O)C=C1C)c2ccccc2,"0,380",[-],,,,,,,,,,,"[-] in TA97, TA98, TA100, TA102, TA104#Parisis and Rao 1988; [-] in TA98, TA100#Kubojama and Fujii 1992; [-] in TA97A, TA98, TA100, TA102#Giri et al 1998; [-] in TA97, TA98, TA100, TA1535, TA1538#Kier et al 1986#ECVAM Review 2016",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"[-] in polychromatic erythrocytes NMRI mice, gavage",,,[-],,,,,,,"[-] in blood lymphocytes of rats, 117 weeks diet but only small numbers of cells scored#Granberg-Ohman et al 1980",[I],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
150,Phenformin.HCl,834-28-6,YSUCWSWKRIOILX-UHFFFAOYSA-N,Cl.NC(=N)NC(=N)NCCc1ccccc1,"2,375",[-],,,,[-],"[-] in TA97, TA98, TA100, TA1535, TA1537#Zeiger et al 1988; #Zeiger 1997",,,,,,[-] in TA102#Kirkland et al 2016,[-],,[-],,,[E],[U],,,,,[I],,,,,,,,,[-],NTP,,[-] ,[-] at 50% toxicity#Hilliard et al 1998,,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
151,Phenol,108-95-2,ISWSIDIOOBJBQZ-UHFFFAOYSA-N,Oc1ccccc1,"1,460",[-],,[-],"[-] in 4 TA strains and E. coli WP2uvrA, up to 5 mg/plate, w/out S9.",[-],,[-],"[-] in TA98, TA100, TA1535, TA102, TA104, up to 5 mg/plate, w/out S9#Benfenati DB",[-],"[-] in TA1535, TA1537, at 10-100 ug/plate, wihout S9#Gilbert et al 1980; [-] in TA98, TA100, TA1535, TA1537, at 33, 3333 ug/plate, with S9 and 33-2500 ug/plate with S9#Haworth et al 1983; [-] in TA97, TA98, TA100, TA102, TA104, TA1535, at 20-5000 ug/plate, w/out S9#Glatt et al 1989; #EU RAR 64 2006",,,[-],,[+],,,[+],[E],,,"weak [+] in Hprt locus in V79 cells 25-500 ug/ml 2hrs treatment, withoutS9#Paschin and Bahitova 1982; [-] in Hprt locus in V79 cells up to 376.4 ug/ml 24 hrs treatment#Glatt et al 1989: [+] in Hprt locus in SHE cells 0.28-2.82 ug/ml 48 hrs treatment#Tsutsui et al 1997; weak [+] in Tk locus#Wangenheim and Bolcsfoldi 1988; #McGregor et al 1988b; #EU RAR 64 2006",,[+],[+],[+]#Garriott et al 2002; #Miller et al 1995,,,,[+] in CHO cells w/out S9#Miller et al 1995; [+] in V79 cells without S9#Glatt et al 1989; weak [+] in human lymphocytes without S9#Yager et al 1990; #EU RAR 64 2006,,[+],"[+]
at >10 mM",,,[+],,,"[+] in CHO cells  w/out S9 (Ivett et al, 1989); [-] in SHE cells without S9 (Tsutsui et al, 1997)  [EU-RAR vol 64]",,,,,,,[+],,"weak[+] in CD-1 mice BM, oral#Ciranni et al 1988a; #Ciranni et al 1988b; [-] in CD-1 male mice BM, oral#Gad-El-Karim et al 1985; #Gad-El-Karim et al 1986; [+] in B6C3F1 mice bone marrow erythrocytes, ip#McFee et al 1991;  [+] in CD-1 mice BM, ip#Ciranni et al 1988b; [-] in CD-1 mice BM, ip#Barale et al 1990; weak[+] in CD-1 mice BM, ip#Marrazzini et al 1994a; multiple administrations:  weak[+] in B6C3F1 mice bone marrow erythrocytes, ip#Shelby et al 1993;  weak[+] in  NMRI mice bone marrow erythrocytes#Wild et al 1980; #Gocke et al 1981;  weak[+] in CD-1 mice BM#Chen and Eastmond 1995; #EU RAR 64 2006; [+] in mouse BM by induced hypothermia#Spencer et al 2007",,[+] (hypothermia),,,,,,[-] in SD rats bone marrow cells at 20hrs sampling time up to 510 mg/kg bw in males and 410 in females#Thompson and Gibson 1984; #EU RAR 64 2006,,[-],,,,,,,,,,,,,,,,,,,,,,,,[-] DNA strandbreaks  in SD rats testis alkaline elution-fluorimetric assay#Skare and Schrotel 1984; #EU RAR 64 2006,,[+],,,,"[+] in stomach, colon, liver, bladder and lung but [-] in kidney, brain and bone marrow of male mice via oral",,[+]
152,Phenylbutazone,50-33-9,VYMDGNCVAMGZFE-UHFFFAOYSA-N,CCCCC1C(=O)N(N(C1=O)c2ccccc2)c3ccccc3,"3,160",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537",,,,,,"[-] in TA98, TA100, TA1535, TA1537, TA102#ECVAM Review 2016; [-] in TA102#Giri and Mukhopadhyay 1998",[-],,[+],[+] more clearly  with S9#Honma et al 1999;#Schisler et al 2018,,[+] more clear and reproducible with S9,[+],,,,,[+],,,,,,,,,[+],#Galloway et al 1987,,Clear [+] in CHO cells  with S9,,,,[+] in human lymphocytes and CHL cells without S9#Ishidate et al 1988,[+],,[-],#Seiler 1975; I have not been able to check this reference,,"[-] in male mice 3x via ip, causing bone marrow toxicity",,,,[-],,,,,,,"[-] in Chinese hamster bone marrow, 2x oral#Muller and Strasser 1971; [-] in rats, 2x via ip#Gebhart and Wissmuller 1973",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
153,1-Phenyl-3-methyl-5-pyrazolone,89-25-8,QELUYTUMUWHWMC-UHFFFAOYSA-N,CC1=NN(C(=O)C1)c2ccccc2,"2,560",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537, up to 10 mg/plate#Dunkel et al 1985; #Zeiger et al 1987",,,,,,"[-] in TA98, TA100, TA1535, TA1537, TA1538 and E.coli WP2#ECVAM Review 2016; [-] in TA98, TA100, TA1535, TA1537, TA102, up to 5 mg/plate#SCCP/1033/06",[-],,[E],,,[+] in Tk locus with S9 and [I] without S9#McGregor et al 1991,[E],,,,[+] in Tk locus in L5178Y cells with S9#SCCP/1033/06; [-] in Hprt locus in L5178Y cells w/out S9#SCCP/1033/06,[E],,,,,,,[-] in human peripheral blood lymphocytes w/out S9#SCCP/1033/06,[-],[-],,,[-] in CHO cells  w/out S9;,,,,,[-],,,,,,,,"[-] in rat bone marrow upt to 2000 mg/kg bw, clinical signs of toxicity indicate systemic exposure#SCCP/1033/06",[-],,,,,,,,,,,,,,,,,,,,,,,,,[-] no DNA damage leading to UDS in hepatocytes  of rats treated orally with PMP up to the MTD of 1000 mg/kg. Indication of cytotoxic effect in the liver#SCCP/1033/06,[-],,,,,,,,,,,,,,
154,Phorate (Thimet),298-02-2,BULVZWIRKLYCBC-UHFFFAOYSA-N,CCOP(=S)(OCC)SCSCC,"3,560",[-],#various studies,,,,,,,,,,"[-] in TA97, TA98, TA100, TA1535 and E.coli WP2#ECVAM Review 2016; [-] in standard strains and E. coli#Sharma et al 1988, abstract; and [-]#Simmon et al 1979, abstract",[-],,,,,,,,,,[-] in Hprt locus in CHO cells w/out S9#Sharma et al 1988,[-],,,,,,,,,[E],,,,,,,"[+] in CHO cells, without S9, although authors call 13% aberrant cells as questionable; [-] with S9#Lin et al 1987; [+] in human lymphocytes#Timoroglu et al 2014",[+],,[+],,,,,,"[-] in mouse bone marrow, via ip, but only sampled 6 hr after 2nd dose although some bone marrow toxicity#Pandita 1986; [+] in rat bone marrow, 30 hrs after single ip dose#Grover and Malhi 1985",[+],,,,,,,"[-] in rat bone marrow, single ip dose, 3 sampling times#Sharma et al 1988; [+] in rat bone marrow, 5 daily ip doses#Mahli and Grover 1987",[E],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,[+] in rat bone marrow via oral #Saquib et al 2012a,[+]
155,Phthalic anhydride,85-44-9,LGRFSURHDFAFJT-UHFFFAOYSA-N,O=C1OC(=O)c2ccccc12,"1,600",[-],,[-],"[-] in 4 TA strains and E. coli WP2uvrA, up to 5 mg/plate, w/out S9.",[-],,[-],"[-] in TA98, TA100, TA1535, TA1537, TA 102 and E. coli WP2uvrA, w/out S9#Benfenati DB",,,,"[-]#Zeiger et al 1985
",[-],,[+],,,[+],[U],,,,,[I],,,,,,,,,[+],,,[-],,,,"[-]#Galloway et al 1987; [+] in CHO at precipitation conc and high toxicity only, without S9#Hilliard et al 1998",[-],,,,,,,,"[-] in Chinese hamster and rat, cytological effec#Heddle et al 1991; #MAK Value Doc 2012; no studies available, compound rapidly hydrolyzed to non genotoxic phthalic acid#OECD SIDS 2005",[I],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
156,Piperonyl butoxide,51-03-6,FIPWRIJSWJWJAI-UHFFFAOYSA-N,CCCCOCCOCCOCc1cc2OCOc2cc1CCC,"4,750",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537#Haworth et al 1983",,,,,"[-] in TA98, TA100, TA1535, TA1537, TA102, w/out S9","[-] in TA97, TA102#Fujita et al 1994; [-] in TA98, TA100, TA1535, TA1537, TA1538#Butler et al 1996; [-] in E. coli#FAO Report 2011; [-] in E. coli WP2 hcr#Moriya et al 1983
",[-],,[+],,,[+]#McGregor et al 1988b,[+],,,, [-] in Hprt in CHO cells#Butler et al 1996,[+],,,,,,,,,[-],,,[-] ,#Galloway et al 1987,,,[-] in CHO cells#Butler et al 1996; [-] in CHO cells#FAO Report 2011,[-],,,,,,,,[-] in M and F mice#FAO Report 2011,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
157,Polysorbate 80,9005-65-6,,CCCCCCCC\C=C\CCCCCCCC(=O)OCCOCC(OCCO)C1OC(CC1OCCO)OCCO,,[-],,,,[-],"[-] in TA97, TA98, TA100, TA1535",,,[-] ,"[-] in TA97, TA98, TA100, TA1535, no cross-linking or oxidising activity expected#EFSA Journal 13 2015",,"[-] in TA102#Lin and Chen 2011; tween 80 (synonim) studied as alternative solvent for ames test, no info on m.a.; [-] in TA98, TA100, TA1535, TA1537#ECVAM Review 2016;#Yamada and Homna 2018",[-],,,,,,,,,,,,,,,,,,,,TC [+],,,[+] CA and [-] SCE,,,"[-] in CH fibroblasts, without S9#EFSA Journal 13 2015",,[+],,,,,,,[-] in CBA mouse BM #EFSA Journal 13 2015,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
158,Progesterone,57-83-0,RJKFOVLPORLFTN-LEKSSAKUSA-N,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@@]12C,"3,870",[-],,,,[-],"[-] in TA97, TA98, TA100, TA1535",,,,,,"[-] in TA97, TA98, TA100, TA1535 and E.coli WP2#ECVAM Review 2016; [-] in E. coli#Dunkel et al 1984",[-],,[-],,,[-],[U],,,,,[I],,,,,,,[-] in human lymphocytes up to 10 ug/m but may not be high enoughl#Baeyens et al 2005; [+] in MCL-5 cells#Kayani and Parry 2008,[+],[-],[- ]in CHL cells and human lymphocytes up to 1.5 mM#Ishidate et al 1988 ,,,,,,[-] in human lymphocytes up to 35 uM#Ricoul et al 1998; [-] in SHE cells#Tsutsui et al 1995,[-],,[+],,,,,,[+] in liver of female rats dosed orally#Martelli et al 1998,[+],,,,,,,[-] in female mouse bone marrow after single ip dose of 39.5 mg/kg#Ouanes et al 2005,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
159,Pyridine,110-86-1,JUJWROOIHBZHMG-UHFFFAOYSA-N,c1ccncc1,"0,650",[-],,[-],"[-] in 4 TA strains and E. coli WP2uvrA, w/out S9.",[-],"[-] in TA97, TA98, TA100, TA1535#Zeiger 1997",,,,,,[-] in TA102#Aeschbacher et al 1989, [-],,[-],#Mitchel et al 1997,,[E],[U],,,,,[I],,,,,,,,,[-],NTP,,[-],,,,,[-],,[-],#IARC vol 77 2000,,,,,,[-],,,,,,,,,,,,,,,,,,,[-],#MacGregor 2000,,,,,[-]#IARC vol 77 2000,[-],,,,,,,,,,,,,,
160,Pyrimethamine,58-14-0,WKSAUQYGYAYLPV-UHFFFAOYSA-N,CCc1nc(N)nc(N)c1c2ccc(Cl)cc2,"2,690",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537",,,,,,"[-] in TA98, TA100, TA1535, TA1537 and E. coli WP2#ECVAM Review 2016; [-] in E. coli#Ono-Ogata et al 2002",[-],,,,,,,,,,[+]#Moore et al 1985,[+],[+],[+] for aneuploidy#Parry et al 2002,,,,,[-] in V79 cells#Seelbach et al 1993; [-] in human lymphocytes with S9#Migliore and Nieri 1991; [-] in human lymphocytes w/out S9#Van Hummelen and Kirsch-Volders 1992; [-] in Chinese hamster embryo cells#Natarajan et al 1993; [-] for kinetochore [+] MN in human fibroblasts#Bonatti et al 1992; [+] in CHL cells#Ono and Yoshimura 1996; [+] for kinetochore [-] MN in LUC2 cells#Lynch and Parry 1993; [+] for both C+ and C- MN in CL-1 cells#Antoccia et al 1991,[E],[+],,,[+] ,[+] in CHO cells with S9,,,[+] in human lymphocytes#Egeli and Erdogan 1991;#Egeli and Tunca 1997;#Egel et al 2002); [+] in CHL cells without S9#Ono et al 1994; [-] for numerical CA in human lymphocytes#Sbrana et al 1993; [+] for aneuploidy/polyploidy in LUC2 cells#Warr et al 1993,[+],,,,,,,,[+] in mouse bone marrow#Leopardi et al 1993; #Marrazzini et al 1994b; #Vijayalaxmi and Vishalakshi 2000; prolonged dosing#Tunca et al 2002; [+] for kinetochore [+] MN but not for overall MN in mice#Gudi et al 1992; [-] in mouse#Ono and Yoshimura 1996; [+] in rat bone marrow#Ono et al 1997; [+] after acute but not 28-day dosing#Rothfuss et al 2010,[+],,,,,,,"[+] in mouse bone marrow, spermatogonia#Celikler et al 2007; [+] spermatocytes#Aydemir and Bilaloglu 1996; [+] in mouse bone marrow after prolonged dosing #Tunca et al 2002; [-] in mouse bone marrow#Marrazzini et al 1994b",[E],,,,,,,,,,,,,,,,,,,[+],#McGregor and Anderson 1999,,,,,[+],,,,weak [+]#Rothfuss et al 2010,"[+] in liver, kidney, lung and brain; but [-] in spleen and bone marrow of female mice#Tsuda et al 1998; [-] male mice and rats#Sasaki et al 1997; weak [+] in liver of male rats after 28-day but not after acute oral dosing#Rothfuss et al 2010",,[+]
161,Pyriofenone,688046-61-9,NMVCBWZLCXANER-UHFFFAOYSA-N,COc1cc(C)c(C(=O)c2c(C)c(Cl)cnc2OC)c(OC)c1OC,"3,729",,,,,,,,,[-],"[-] in TA98, TA100, TA1535, TA1537 and E. coli#EFSA DAR 2012; #EFSA Journal 11 2013",,, [-],,,,,,,,,[-]#EFSA DAR 2012,,[-],,,,,,,,,,,,,,,[-] in CHL cells#EFSA DAR 2012,,[-],,,,,,,[-] in CD1 mice PCE#EFSA DAR 2012,,[-],,,,,,,,,,,,,,,,,,,,,,,,[-] in rat hepatocytes#EFSA DAR 2012,,[-],,,,,,[-] in mouse liver#DAR report 2012,,,,,,,,
162,Reserpine,50-55-5,QEVHRUUCFGRFIF-MDEJGZGSSA-N,CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c6cc(OC)c(OC)c(OC)c6,"3,320",[-],,,,[-],"[-] in TA97, TA98, TA100, TA1535",,,,,,"[-] in TA97, TA98, TA100, TA1535 and E. coli WP2#ECVAM Review 2016; [-] in E. coli#Dunkel et al 1985",[-],,[-],,,[-],[U],,,,[-] in SHE cells at 2 loci#Tsutsui et al 1994,[I],,,,,,,[-] in human lymphocytes and HepG2 cells#Kevekordes et al 2001,[-],[-],NTP,,[-],[-] in CHO cells up to 50 ug/ml without S9 and 200 ug/ml with S9,,,[-] in SHE cells#Tsutsui et al 1994; [-] in CHL cells#Ishidate et al 1988; [-] in mouse FM3A cells but only tested without S9#Kodama et al 1980,[-],,[+] due to hypothermia,#Tsutsui et al 1994,,"[-] in bone marrow and blood of male mice, 3x ip injections#Shelby et al 1993",,,[+] in mice due to hypothermia#Asanami and Shimono 1997; [-] in rat bone marrow unless body temp lowered artificially#Asanami and Shimono 2000,[+] (hypothermia),[+],#Shelby and Witt 1995,,[+] in mouse bone marrow 36 hrs after single ip injection; [-] at 17 hr,,,,[+],,,,,,,,,,,[-],#Madle et al 1994,,,,,[-] in rat and mouse liver#Mirsalis et al 1989,[-],,,,,,,,,,,,,,
163,"Resorcinol  (1,3-dihydroxybenezene)",108-46-3,GHMLBKRAJCXXBS-UHFFFAOYSA-N,Oc1cccc(O)c1,"0,800",[-],,[-],"[-] in TA98, TA100, TA1535, TA1537, TA102, TA104 and E. coli WP2uvrA and WP2 uvrA/pKM101, w/out S9. ",,,,,,,,[-]#Hakura et al 1996; #JETOC 1997, [-],,[+],,,[+],[+],,,,,[+],[+],[+] in human lymphocytes#Guadano et al 1998 ,,,,,[+] in p53-deficient hamster cells#Darroudi and Natarajan 1983; [-] in p53-competent human cells#Fowler et al 2012a,[+],[+],[+] at >10 mM,"[+] in CHL cells (6-18, 24-0 or 48-0h treatment without S9 and at 6-18h tretament with S9)",[+],,,,,[+],,,,,,,,[-]#Natarajan and Obe 1986; #Darroudi and Natarajan 1983,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
164,Ropinorole,91374-21-9,UHSKFQJFRQCDBE-MADFRBAASA-N,CCCN(CCC)CCc1cccc2NC(=O)Cc12,"2,700",,,,,,,,,,,,"[-] in TA98, TA100, TA1535, TA1537#Bramibilla and Martelli 2009; [-] in E. coli#BfArM Doc", [-],,,,,,,,,,[-] up to 2160 ug/ml and 5000#Brambilla and Martelli 2009,[-],,,,,,,,,,,,,,,,[-] in human lymphocytes up to 506 ug/ml#Brambilla and Martelli 2009; [-] up to 5000 ug/ml#Brambilla andMartelli 2008,[-],,,,,,,,"[-] in mouse BM cells  up to 400 mg/kg 1x oral, 24-48-72 hrs sampling#Brambilla and Martelli 2009",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
165,Rosuvastatin,287714-41-4,RGEBGDYYHAFODH-SYRJKFITSA-M,[Na+].[2H]C([2H])([2H])N(c1nc(C(C)C)c(\C=C\[C@@H](O)C[C@@H](O)CC(=O)[O-])c(n1)c2ccc(F)cc2)S(=O)(=O)C,"2,431",,,,,,,,,,,,"[-] in TA98, TA100, TA1535, TA1537#Bramibilla and Martelli 2009; [-] in E. coli#BfArM Doc", [-],,,,,,,,,,[-] up to 4000 ug/ml#Brambilla and Martelli 2009,[-],,,,,,,,,,,,,,,,[-] in human lymphocytes up to 1000 ug/ml#Brambilla and Martelli 2009,[-],,,,,,,,"[-] in mouse BM cells: up to 1000 mg/kg 1x po and  up to 500 mg/kg 2x oral, pa#Brambilla and Martelli 2009",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
166,Rotenone,83-79-4,JUVIOZPCNVVQFO-HBGVWJBISA-N,COc1cc2OC[C@@H]3Oc4c5C[C@H](Oc5ccc4C(=O)[C@@H]3c2cc1OC)C(=C)C,"4,100",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537",,,,,,"[-] in TA98, TA100, TA1535, TA1537, TA102#Guadano et al 2000#ECVAM Review 2016",[-],,[+],,,[+],[+],,,,,[+],[+],[+] in human lymphocytes#Guadano et al 1998,,,,,[+] in human lymphocytes without S9 but [-] with S9#Guadano et al 1998; [+] in V79 cells but [-] in MCL-5 cells#Johnson and Parry 2008,[+],[-],#Anderson et al 1990,,"[E] in CHO cells without S9, increase only at mid-dose",,,,"[-] in human ymphocytes#Guadano et al 1998; [+] in human lymphocytes when treaed during G1/S or S phases#de Lima et al 2005; [+] for aneuploidy, polyploidy and endoredulpication in CHL cells#Matsumoto and Ohta 1991",[+],,,,,,,,"[-] in mouse bone marrow by ip, oral and dermal routes, single and mulitple treatments #Amer and Aboul-ela 1985",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
167,Saccharin/Sodium Saccharin,128-44-9/81-07-2,WINXNKPZLFISPD-UHFFFAOYSA-M,[Na+].[O-]C1=NS(=O)(=O)c2ccccc12,,[-],"[-] in TA98, TA100, TA1535, TA1537#Zeiger 1997",,,,,,,,,,[-]#Rao et al 1979; [-]#Bandyopadhyay et al 2008; [-] including TA102#Fujita and Sasaki 1986;#Kirkland et al 2016,[-],,[-],,,,,,,,[I]#Mitchell et al 1997 based upon#Clive et al 1979,[-],,,,,,,[-] in p53 deficient and competent cells#Fowler et al 2012a,[-],[+] ,[+] at 8000ug/ml#Ishidate et al 1988,,,,,,[+] only above 10 mM#Ishidate and Odashima 1977#Ashby and Ishidate 1986,[-],,,,,,,,[-]#Eckhardt et al 1980;#Leonard and Leonard 1979,[-],[-],,,,,,[-]#Ashby et al 1985;#Van Went-de Vries and Kragten 1975,[-],[-],#Lambert et al 2005,,,,,[-],"[-] in liver and bladder of male Big Blue rats, but only 10 days dosing, diet",#Turner et al 2001,[I],,,,,,,,,,,,,,,[+],,,[-] with saccharin (81-07-2),[+]#Sasaki et al 2002,"[+] in colon; [+] and [-] in stomach and bone marrow; [-] in liver, kidney, bladder, lung and brain of male mice, gavage; [-] in liver and stomach of male rats viagavage",#Sasaki et al 2002;#Uno and Omori 2015,[E]
168,Salicylazosulfapyridine (Sulfasalazine),599-79-1,NCEXYHBECQHGNR-QZQOTICOSA-N,OC(=O)c1cc(ccc1O)N=Nc2ccc(cc2)S(=O)(=O)Nc3ccccn3,"3,810",TC [-],[-]#Snyder 2009; TC [-]#Zeiger et al 1987; TC [-]#Iatropoulos et al 1997; TC [-]#Zeiger et al 1988 ,,,[-],"[-] in TA97, TA98, TA100, TA1535",,,,,,"[-] in TA97, TA98, TA100, TA1535 and E. coli WP2#ECVAM Review 2016",[-],,,,,,,,,,"[-] in Hprt locus, no details#Snyder and Green 2001",[I],[+],,,,,,[+] in human lymphocytes without S9#Mackay et al 1989;#Iatropoulos et al 1997,[+],TC[-]; [E],,,,,,,"[E] but no detail#Snyder and Green 2001;#Snyder 2009; [-] in CHO cells, w/out S9, up to 1000 ug/ml#Bishop et al 1990",[-],,[+]; [E],,,,,,"[+] in blood of male and female mice after 90 days gavage#Bishop et al 1990; weak [+] in male mouse bone marrow after 2 days gavage#Bishop et al 1990; [+] in bone marrow and blood of mice but [-] in rats, folate deficiency involved?#Iatropoulos et al 1997; [+] for kinetochore +ve MN in mouse bone marrow, 3 daily gavage doses#Witt et al 1992; [+] for MN in male and female mouse bone marrow, single ip dose#Mantena et al 2008; [E] but no details#Snyder 2009",[+],[-],,,,,,"[-] in male mouse bone marrow, single gavage dose#Bishop et al 1990; [+]  in male and female mouse bone marrow, single ip dose#Mantena et al 2008",[E],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
169,SD-0203,N/A,,,,[-],#Yoo and Lee 2005 ,,,,,,,,,,"[-] in TA98, TA100, TA1535, TA1537, TA102#ECVAM Review 2016; [-] in TA98, TA100, TA1535, TA1537, TA102, up to 10 uM (>5000 ug)/plate#Yoo and Lee 2005",[-],,,,,,,,,,,,,,,,,,,,TC [-],,,,,,,"[-] in CHO cells up to 10 mM, 5 hr treatments w/out S9, but only 100 cells scored#Yoo and Lee 2005",[I],,[+],#Yoo and Lee 2005,,,,,"[+] in bone marrow from 40-1000 umol/kg, single ip injection, sampled at 24 hrs, >8x increase over vehicle control#Yoo and Lee 2005",[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
170,SD-2007,N/A,,,,[-],#Yoo and Lee 2005 ,,,,,,,,,,"[-] in TA98, TA100, TA1535, TA1537, TA102#ECVAM Review 2016; [-] in TA98, TA100, TA1535, TA1537, TA102, up to 10 uM (>5000 ug)/plate#Yoo and Lee 2005",[-],,,,,,,,,,,,,,,,,,,,TC [-],,,,,,,"[-] in CHO cells up to 10 mM, 5 hr treatments w/out S9, but only 100 cells scored#Yoo and Lee 2005",[I],,[+],#Yoo and Lee 2005,,,,,"[+] in bone marrow from 40-1000 umol/kg, single ip injection, sampled at 24 hrs,  >20x increase over vehicle control#Yoo and Lee 2005",[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
171,Sodium dehydroacetate,4418-26-2,ZPNRBQVNNIDJHX-UHFFFAOYSA-M,[Na+].CC(=O)C1=C([O-])C=C(C)OC1=O,"-2,570",TC [-],#Ishidate et al 1984;#Zeiger et al 1987,,,[-],"[-] in TA98, TA100, TA1535, TA1537",,,,,,"[-] in TA98, TA100, TA1535, TA1537, TA102#ECVAM Review 2016; [-] in TA102#Fujita and Sasaki 1986; [-] in E. coli#Ohta et al 1980",[-],,,,,,,,,,,,,,,,,,,,[+],,,,,,,[+] in CHL cells#Ishidate et al 1988; [-] in DON cells tested without S9#Ishidate et al 1988; [+] in human lymphocytes without S9 at >50% toxicity#Kirkland et al 1990,[E],,[+],#Hayashi et al 1988 ,,,,,"weak [+] in mouse bone marrow, 1 or 4 days ip or single oral dose#Hayashi et al 1988",weak [+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,[-]#Sasaki et al 2002,"[-] in stomach, colon, liver, kidney, bladder, lung, brain and bone marrow of male mice via oral",,[-]
172,Sodium diclofenac,15307-79-6,KPHWPUGNDIVLNH-UHFFFAOYSA-M,[Na+].[O-]C(=O)Cc1ccccc1Nc2c(Cl)cccc2Cl,,,,,,,,,,,,,"[-] in TA98, TA100, TA1535, TA1537 and E. coli#Stoyanov et al 1987;#Kuboyama and Fujii 1992;#Kadotani et al 1984", [-],,,,,,,,,,[-] in Tk and Hprt loci in CHO cells w/out S9 but 75-80% toxicity#Snyder and Green 2001; #FDA,[-],,,,,,,,,,,,,,,,"[-]#Snyder and Green 2001; [-] in rat lymphocytes 2hrs with S9, 17 hrs without S9 relative survival reduced at 25 and 56% and MI reduced at 38 and 64%, not clear how many cells scored#FDA",[-],,,,,,,,[-]#Snyder and Green 2001; #FDA,[-],,,,,,,"[-]#Snyder and Green 2001; According to FDA, mice were dosed 2x orally, 24h apart, and bone marrow sampled for MN 24h after 2nd dose, top dose was MTD (3/12 died), 1000 PCE/animal scored, no bone marrow toxicity but other tox and TK studies indicate good systemic exposure in rodents after oral dosing#FDA",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
173,Sodium arsenite,7784-46-5,PTLRDCMBXHILCL-UHFFFAOYSA-M,[Na+].[O-][As]=O,,[-],,,,,,,,,,,"[-] in TA97, TA98, TA100, TA1535, TA1537, TA102#De Flora et al 1984; [-] in TA102#Marzin and Phi 1985", [-],,,,,,,,,,[+] in Tk locus #Moore et al 1997; [+] in Tk locus#Soriano et al 2007; [+] for large deletion mutations in AL cells#Hei et al 1998; weak [+] for gpt mutations in AS52 cells#Meng and Hsie 1996,[+],,,,,,,"[+]#Sciandrello et al 2002;#Yih and Lee 1999;#Sinha et al 2005;#Colognato et al 2007, at low concentrations; [+]#Ramirez et al 2003;#Chen et al 2013; weak [+]#Moore et al 1997",[+],[+],[+] at only 13 ug/ml,,,,,,[+] structural and numerical CA#Jha et al 1992; [+] including endoredulpication#Huang et al 1995; [+]#Kochhar et al 1996; numerical changes#Ramirez et al 1997;#Rupa et al 1997; #Chakraborty and De 2009; [+]#Moore et al 1997; #Radha and Natarajan 1998; #Mahata et al 2004; #Hagiwara et al 2006; #Chakraborty and De 2009,[+],,,,,,,,[+]#Tinwell et al 1991; [+]#Lewinska et al 2007; [+]#Tice et al 1997; #Odunola 2003; #Alarifi et al 2009; #Samuel et al 2011; #Sankar et al 2014,[+],,,,,,,[+] #Choudhury et al 1997;#Choudhury et al 1997b; #Alarifi et al 2009; #Sankar et al 2014,[+],,,,,,,[-],"[-] in lung, bladder and bone marrow of male MutaMouse but only 5 daily doses via ip;  [+] in liver of male gpt delta mice (3 weeks drinking water) [-] see also dimethylarsenic acid",#Noda et al 2002; #Takumi 2014,[+],,,,,,,,,,,,,,,,[+],,[E],,"[+] in blood, liver, kidney and bone marrow of male rats (water); both [+] and [-] results in liver; [+] in whole blood, but [-] in stomach  of male rats (gavage);  [+] in bone marrow and spermatogonial cells (males) and in liver (females) of mice (water); [-] in bladder, lung, skin, blood and liver of male mice (gavage); [+] in stomach and colon but [-]in liver, kidney, bladder, lung, brain and bone marrow of male mice via ip",Balakumar 2010; #Muthumani 2013; #Sankar 2014; #Tice et al 1997; #Mishra and Flora 2008; #Uno and Omori 2015; #Hobbs et al 2015; #Beevers et al 2015; #Saha and Ghosh 2010; #Kadirvel et al 2007; #Biswas 2007; #Acharyya et al 2014; #Tsuda et al 2000,[+]
174,Safrole,94-59-7,ZMQAAUBTXCXRIC-UHFFFAOYSA-N,C=CCc1ccc2OCOc2c1,"3,450",[-],,,,[-],"[-] in TA97, TA98, TA100, TA1535, TA1537#Zeiger et al 1985",,,,,"[-] in TA98, TA100, TA1535, TA1537, TA102, w/out S9","[-] in TA102#Jung et al 1992; [-] in TA102#Mueller et al 1993; [-] in TA102 and E. coli  WP2pKM101 and WP2 uvrApKM101#Watanabe et al 1998; [-] in E. coli WP2 uvrA#Sekizawa and Shibamoto 1982; [-] in TA98, TA100, TA1535, TA1537, TA1538#To et al 1982", [-],,[+],,,[+]#Mitchell et al 1988;#Myhr et al 1985,[E],,,,[+]#Amacher and Turner 1985; [+]#Styles et al 1985; [-]#Oberly et al 1985,[+],[+],#Nesslany and Marzin 1999,,,,,,[+],[+],#Ishidate et al 1988,,"[-] 
",#Gulati et al 1985,,,[+]#Tayama 1996,[+],,,,,,,,,,,,,,,,[+] in rat#Daimon et al 1998; [+]#Sharma et al 1982,[+],,,,,,,,,,,[-],#Madle et al  1994,,,,,,[-],,,,,,,,,,,,,,
175,Sodium fluoride,7681-49-4,PUZPDOWCWNUUKD-UHFFFAOYSA-M,[F-].[Na+],"2,530",TC [-],#Haworth et al 1983;#Martin et al 1979;#Tong et al 1988,,,[-],"[-] in TA98, TA100, TA1535, TA1537#Haworth et al 1983",,,,,,"[-] in TA97a, TA98, TA100, TA1535, TA102#Li et al 1987; [-] in E. coli WP2 uvrA, fluctuation test#Li et al 1990; #Ribeiro et al 2004", [-],,[E],,,[+]#Caspary et al 1987,[U],,,,[-] in Hprt locus without S9 in V79#Slamenova et al 1992; [-] in Hprt locus in CHO-K1-BH4#Oberly et al 1990; [-] in Hgprt locus in rat liver epithelial cells#Tong et al 1988; [+] in Tk locus MLA#Cole et al 1986,[E],,,,,,,,,[+],,,[+] and [-] CA in CHO cells; [+] and [-] SCE in CHO cells,,,,"[+]#Aardema et al 1989; [+]#Scott and Roberts 1987; [+] in human diploid fibroblasts#Hayashi et al 1993; [-] in human diploid fibroblasts, treated for 1-3 weeks#Tsutsui et al 1995; [+]ve in HPLT#Albanese 1987; [+] in numan cells#Kishi and Ishida 1993
",[+],,[+],#Pati and Bhunya 1987 ,,[-] in mouse,,,[-] in mouse#Hayashi et al 1988; [+] in mouse#Manivannan et al 2013,[E],,,,"[-] in mouse, non-standard Protocol",,,[+] in mouse#Podder et al 2011a;#Podder et al 2011b); [+] in mouse#Manivannan et al 2013; [-] in metaphase#Zeiger et al 1994,[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"[+] in BM, kidney, liver#Manivannan et al 2013",[+]
176,Sulfisoxazole,127-69-5,NHUHCSRWZMLRLA-UHFFFAOYSA-N,Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C,"1,010",[-],,,,,,,,,,,"[-] in TA98, TA100, TA1535, TA1537#Zeiger 1997; #Zeiger et al 1988; [-] in E. coli#Dunkel et al 1984", [-],,[+],,,[+],[U],,,,[I]#Mitchell et al 1997; weak [+] at <205 RTG#Myhr and Caspary 1991,[I],,,,,,,[-] in p53 deficient hamster and in human competent cells#Fowler et al 2012a,[-],[-],#Ishidate et al 1988; #Ivett et al 1989,,[-],,,,,[-],,,,,"[-] male mouse BM, ip single, 17-36 hrs",,,,[-],,,,"[-] in male mouse BM, ip single, 17-36 hrs",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
177,Tafethion,563-12-2,RIZMRRKBZQXFOY-UHFFFAOYSA-N,CCOP(=S)(OCC)SCSP(=S)(OCC)OCC,"5,070",[-],[I]#Simmon et al 1979; [-] in E. coli#Moriya et al 1983,,,,,,,,,,"[-] in TA98, TA100, TA1535, TA1537 and E. coli WP2#ECVAM Review 2016",[-],,,,,,,,,,,,[+],,,,,,[+] in CHL cells#Ni et al 1993,[+],,,,,,,,,,,,,,,,,"[+] in mouse bone marrow, mulitple ip doses#Ni et al 1993",[+],[+],"[+] in chicks, oral or ip, single or 5 days dosing#Bhunya and Jena 1994",,,,,,[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
178,"Tertbuthylazine (N-tert-butyl-6-chloro-N'-ethyl-1,3,5-triazine-2,4-diamine)",5915-41-3,FZXISNSWEXTPMF-UHFFFAOYSA-N,CCNc1nc(Cl)nc(NC(C)(C)C)n1,"3,210",,,,,,,[-],"[-] in TA98, TA100, TA1535, TA1835, TA102,  and E. coli WP2uvrA (study 1); [-] in TA98, TA100, TA1535, TA1537, TA1538  (study 2); [-] in TA98, TA100, TA1535, TA1537 and E. coli WP2uvrA (study 3)#ECHA RAC 2015",,,,,[-],,,,,,,[-] in Hgprt locus in V79 cells#Hertner GLP study; [-] in Hgprt locus in V79 cells with S9#Seeberg GLP study; [+] without S9#Seeberg GLP study in#ECHA RAC 2015,,,,[I],,,,,,,,,,,,,,[-] in CHO cells#Hertner 1995c;#Seeberg 1988a;#ECHA RAC 2015,,,[-],,,,,,"[-] in Tif:Magf mouse BM#Hertner 1989; [-] in CD-1 mice BM#Mosesso, 1988b;see#ECHA RAC 2015",,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
179,"2,3,5,6-Tetrachloro-4-nitroanisole",2438-88-2,BGPPUXMKKQMWLV-UHFFFAOYSA-N,COc1c(Cl)c(Cl)c(c(Cl)c1Cl)[N+](=O)[O-],"4,470",[-],,,,[-],"[-] in TA97, TA98, TA100, TA1535, TA1537",,,,,,[-] in E. coli WP2#Dunkel et al 1985; #ECVAM Review 2016,[-],,[+],,,[+],[U],,,,,[I],,,,,,,,,[E],,,[E],[E] in CHO cells (details not accessible),,,,[E],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
180,Tetrachlorvinphos,961-11-5,,COP(=O)(OC)O\C(=C/Cl)\c1cc(Cl)c(Cl)cc1Cl,"3,530",[-],,,,[-],"[-] in TA97, TA98, TA100, TA1535",,,,,,[-] in TA1535-97-98-100 and E.coli WP2 and WP2uvrA#Brooks et al 1982;#ECVAM Review 2016; [-] in TA102#Ruiz and Marzin 1997; [-] in E. coli WP2#Moriya et al 1983,[-],,,,,,,,,,,,,,,,,,,,[-],,,[-],[-] in CHO cells up to toxic concs w/out S9,,,"Clearly [+] in cultured mouse spleen cells at low concs, 4 hr treat with 20 hr recovery#Amer and Aly 1992; weak [+] in human lymphocytes#Kurinnyi and Pilinskaia 1977",[+],,,,,,,,[+] in mouse bone marrow by ip and oral#Amer and Fahmy 1983; [-] by dermal route#Amer and Fahmy 1983,[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
181,Tertiary-butylhydroquinone,1948-33-0,BGNXCDMCOKJUMV-UHFFFAOYSA-N,CC(C)(C)c1cc(O)ccc1O,"2,816",,,,,[E]; [-],"[-] in TA97, TA98, TA100, TA1535, TA1537",,,[-],#EFSA Journal 84 2004,,[-] in TA102 and TA104#Hageman et al 1988; #Matsuoka et al 1990,[-],,,,,,,,,,,,,,,,,,"[+] in V79, CHO, CHL, TK6; [E] in Huly but [-] in HepG2 cells#Fowler et al 2012a",[+],,,,[+],[+] only where few cells could be scored (toxicity?),,,,[+],,,,,[-],,,,[-],,,,"[-] in male mice BM, ip single , 17 hrs ",,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,[+] borderline,,liver,#Uno et al 2015,[+]
182,Tetrakis(hydroxymethyl)phosphonium chloride/Tetrakis(hydroxymethyl)phosphonium sulfate,124-64-1/55566-30-8,AKXUUJCMWZFYMV-UHFFFAOYSA-M/ HFDZMBPIARIWLN-UHFFFAOYSA-M,[Cl-].OC[P+](CO)(CO)CO/ OC[P+](CO)(CO)CO.OC[P+](CO)(CO)CO.[O-]S(=O)(=O)[O-],,[-],,,,[-],"[-] in TA97, TA98, TA100, TA1535, TA1537; #[-] in TA97, TA98, TA100, TA1535, TA1537, sulfate form#Zeiger 1990",,,,,,"[-] in TA102#Kirkland et al 2016; #[-] including TA1538, sulfate form#Connor et al 1980",[-],,"[+] strong at 30% RTG, chloride form",,,[+]#Myhr et al 1990,[+],,,,for the two tetrakis salts no differences reported for NTP MLA data same article,[+],,,,,,,,,[+],#Anderson et al 1990,,[+],#Anderson et al 1990,,,,[+],,,,,[-] or [E] for MN  using via ip ,,,"[-] in mouse, sulfate form#Connor et al 1980",[E],,,,,,,"[-] in mouse, sulfate form#Connor et al 1980",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
183,"3,3',5,5'-Tetramethylbenzidine",54827-17-7,UAIUNKRWKOVEES-UHFFFAOYSA-N,Cc1cc(cc(C)c1N)c2cc(C)c(N)c(C)c2,"4,110",TC [-],#McCann et al 1975; #Zeiger et al 1988,,,[-],"[-] in TA97, TA98, TA100, TA1535",,,,,,"[-] in TA97, TA98, TA100, TA1535, TA102#ECVAM Review 2016; [-] in TA102#Makena and Chung 2007",[-],,[U],,,"[+] and [-] results, overall concluded [E]#Caspary et al 1988",[U],,,,"[-] to highly toxic concs, 4 hr treatments w/out#Oberly et al 1984; [-] in Hprt locus in CHO cells#Oberly et al 1996",[E],,,,,,,,,,,,,,,,[-] in CHO cells#Oberly et al 1996,[-],,[E],[-] no details #Salamone et al 1981;#Tsuchimoto and Matter 1981; [+] no details #Kirkhart 1981,,,,,,[E],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
184,Thioacetamide,62-55-5,YUKQRDCYNOVPGJ-UHFFFAOYSA-N,CC(=S)N,"-0,260",[-],,,,[-],"[-] in TA97, TA98, TA100, TA1535, TA1537",,,,,,"[-] in TA97, TA98, TA100, TA1535, TA1537, TA102 (with S9 only) and E. coli WP2#ECVAM Review 2016; [-] in TA102 and E. coli with S9#Dunkel et al 1984;#Watanabe et al 1998",[-],,[+],,,[+],[U],,,,[-] in Hprt locus#Augustine et al 1982,[I],,,,,,,,,[TC],[-] in CHL cells but only tested  without S9#Ishidate et al 1988,,,,,,,[I],,[+],,,,,,"[+] in mouse bone marrow, single oral dose#Chieli et al 1987; #Mirkova 1996; [-] in bone marrow and liver in 14 and 28-day dosing study#Sui et al 2015; [-] in liver of young rats#Takasawa et al 2010",[+],,,,,,,[+] for tetraploidy in rat liver cells#Clawson et al 1992,[+] (numerical),,,,,,,,,,,,,,,,,,,,,,,,,[+],,,[+],,"[+] in stomach, colon and bladder; [-] in liver, kidney, lung, brain and bone marrow of male mice, ip#Sasaki et al 2000","[+] in stomach; [-] in liver of rats, 3 oral doses#Beevers et al 2015",[+]
185,"4,4-Thiobis(6-tert-butyl-m-cresol)  (Santonox-R)",96-69-5,HXIQYSLFEXIOAV-UHFFFAOYSA-N,Cc1cc(O)c(cc1Sc2cc(c(O)cc2C)C(C)(C)C)C(C)(C)C,"7,069",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537#Zeiger et al 1987",[-],"[-] in TA98, TA100, TA1535, TA1537 and E. coli  WP2 uvrA, w/out S9#Benfenati DB",,,,,[-],,,,,,,,,,,,,,,,,,,,[-],,"[-] in CHL cells at 6-18, 24-0 or 48-0h treatment without S9 and at 6-18h tretament with S9.",[-],,,,,[-],,,,,,,,,,,,,,,,[-] in rat BM#US EPA OTS 2010,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
186,Tetrahydrofuran,109-99-9,WYURNTSHIVDZCO-UHFFFAOYSA-N,C1CCOC1,"0,460",[-],,[-],"[-] in 4 TA strains and E. coli WP2uvrA, up to 10 mg/plate, w/out S9.",[-],"[-] in TA97, TA98, TA100, TA1535, TA1537#Mortelmans et al 1986",,,,,,,[-],,TC,#Mitchell et al 1997,,,,,,,,[I],,,,,,,[-] in SHE embryo cells at 3000–4000 μg/ml and 3000 μg/ml and above without S9#Gibson et al 1997;#MAK Jan 2014,[-],[-],NTP,,[-],#Galloway et al 1987,,,,[-],,,,,,,,"[E] in male mouse, [-] in female mouse#Witt et al 2000",[E],,,,"[-] in male mouse  BM, ip single at 17-36 hrs, up to 2000 mg/kg",,,,[-],,,,,,,,,,,[-],#Madle et al 1994,,,,,[-] in rat#OECD SIAP 2000,[-],,,,,,,,,,,,,,
187,Tolterodine,124937-51-5,OOGJQPCLVADCPB-HXUWFJFHSA-N,CC(C)N(CC[C@@H](c1ccccc1)c2cc(C)ccc2O)C(C)C,"5,576",,,,,,,,,,,,"[-] in TA97, TA98, TA100, TA1535, TA1537 and in E.coli#Kirkland et al 2016",[-],,,,,,,,,,[-] up to 2160 ug/ml#Brambilla and Martelli 2009,[-],,,,,,,,,,,,,,,,[-] up to 506 ug/ml in human lymphocytes#Brambilla and Martelli 2009,[-],,,,,,,,"[-] in mouse BM cells up to 150 mg/Kg 2x oral, 24-48 hrs sampling#Brambilla and Martelli 2009",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
188,Toluene,108-88-3,YXFVVABEGXRONW-UHFFFAOYSA-N,Cc1ccccc1,"2,730",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537",[-],"[-] in TA98, TA100, TA1535, TA1537, up to 1000 µg/plate, w/out Aroclor 1254 ma, liquid preincubation procedure; [-] in TA98, TA100, TA1535, TA1537, TA1538, up to 2000 µg/plate, w/out S9;  [-] in E. coli WP2",,,,"[-] in TA98, TA100, TA1535, TA1537 and E. coli WP2A#WHO Report 2000",[-],,[+],,,[E],[E],"[-] in 2 different Tk assays, unpublished",,,,[E],[-],#Von der Hude et al 2000,,,,,[-] in V79 cells#Von der Hude et al 2000; [-] in human lymphocytes#Zarani et al 1999;#Gerner-Smidt and Friedrich 1978,[-],[-],NTP,,"[-] in CHO cells w/out S9, up to 1600 µg/mL",,,,,[-],,[+],,,"[-] in male mice, 3x gavage doses up to 2000 mg/kg/day",[-] in male mice after 2x ip doses up to 1000 mg/kg,,"[-] in male mouse bone marrow, 8 x 6hr inhalation exposures at 100 ppm over 15 days#Wetmore et al 2008; [-] in mouse blood after continuous 8-day inhalation#Bird et al 2010; [-] after 1 or 2 oral doses#Gad-el-Karim et al 1985; #Gad-el-Karim et al 1986; [+] in mouse bone marrow after 2 ip doses#Mohtashamipur et al 1985;#Mohtashamipur et al 1987; [+] in rat bone marrow after 2 ip doses#Roh et al 1987",[E],,,,,[-] in rat bone marrow after single and 5-day via ip up to 215 mg/kg,,"[+] in rat bone marrow, 12 days sc injection#Lyapkalo 1973; [+] repeated inhalation#Dobrokhotov and Enikeev 1976;[+] after 2x ip#Roh et al 1987; [-] in other inhalation studies#Aristov et al 1981; #Donner et al 1981; [-] in mouse bone marrow after oral dosing#Gad-el-Karim et al 1985; #Feldt et al 1985",[E],,,,,,,,,,,,,,,,,,,[-],#Plappert et al 1994,,,,,[-],[-],,,,"[-] in stomach, colon, liver, kidney, bladder, lung, brain and bone marrow of male mice via oral#Sasaki et al 2000","[-] in peripheral blood, bone marrow and liver of mice, 4 and 8 wks via inhalation#Plappert et al 1994",[-]
189,o-Toluenesulfonamide,88-19-7,YCMLQMDWSXFTIF-UHFFFAOYSA-N,Cc1ccccc1S(=O)(=O)N,"0,840",[-],,[-],[-] in 4 TA strains and E. coli WP2 uvrA up to 5 mg/plate w/out S9.,,,,,,,,,[-],,,,,,,,,,,,,,,,,,,,,,"[-] in CHL cells at 6-18, 24-0 or 48-0h treatment without S9 and at 6-18h tretament with S9.",,,,,,[-],,[-],#Eckhardt et al 1980,,,,,"[-] in mouse, po and ip#Eckhardt et al 1980#OECD SIDS 2002b",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
190,m-Toluidine/m-Toloudine hydrochloride,638-03-9/ 108-44-1,VDXZPXIEEVOGLV-UHFFFAOYSA-N,Cl.Cc1cccc(N)c1,,[-],,,,[-],"[-] in TA97, TA98, TA100, TA1535, TA1537",,,,,,"[-] in TA97, TA98, TA100, TA1535, TA1537#Mueller et al 1993; [-] in TA102 but in free base#Mueller et al 1993;#ECVAM Review 2016; [-] in TA102, free base#Jung et al 1992",[-],,,,,,,[-],"[-] in Hprt locus in V79 cells, w/out S9, two studies",,,[-],,,,,,,,,,,,,,[-] in CHL/IUL cells w/out S9,,,[-],,,,,,,,,,,,,,"[I] SCE in BALB/c mice bone marrow, no GLP",,,[I],,,,,,,,,,,,,,,"[-] inhibition in mouse testis, no GLP",,,[I],,,,,,,,,,,,,,
191,Toremifene/Toremifene citrate,89778-26-7/ 89778-26-8,XFCLJVABOIYOMF-QPLCGJKRSA-N,CN(C)CCOc1ccc(cc1)\C(=C(\CCCl)/c2ccccc2)\c3ccccc3,,[-],#Snyder 2009; #Williams et al 1998 ,,,,,,,,,,"[-] in TA98, TA100, TA1535, TA1538 and E. coli WP2#Williams et al 1998; #Snyder 2009",[-],,,,,,,,,,,,,,,,,,TC [+] in metabolically competent human lymphoblastoid cells#Styles et al 1994,[+],[+],,,,,,,[+] but no detail#Snyder 2009; [+] for polyploidy in SHE cells#Tsutsui et al 1997; [+] for numerical abs in MCL-5 cells#Styles et al 1997; [-] for structural abs in human lymphocytes#Williams et al 1998,[+] (numerical),,,,,,,,"[-] in mouse bone marrow, single oral dose#Williams et al 1998",[-],[+],[+] in liver#Snyder 2009,,,,,"[+] for numerical but not structural abs in female rat liver, single or 4 weeks oral dosing#Sargent et al 1996; #Styles et al 1997",[+] (numerical),,,,,,,"[-] citrate only, reported as #Davies et al 1997",[-] in liver of female rats (gavage),"[-] in liver and kidney of female gpt delta rats, 3-week gavage#Kawamura et al 2013; [-] in female Big Blue rats, 6 weeks gavage#Davies et al 1997",[-],,,,,,,,,,,,,,,,,,,,,,
192,"2,4,5-Trichlorophenoxyacetic acid",93-76-5,SMYMJHWAQXWPDB-UHFFFAOYSA-N,OC(=O)COc1cc(Cl)c(Cl)cc1Cl,"3,310",[-],TC [-]#Mortelmans et al 1984; TC [-]#Herbold et al 1982; [-] George et al 1992,,,[-],"[-] in TA98, TA100, TA1535, TA1537",,,,,,"[-] in TA98, TA100, TA1535, TA1537 and TA102#ECVAM Review 2016; [-] in TA102#Mersch-Sundermann et al 1988; [-] in TA104#George et al 1992",[-],,,,,,,,,,,,,,,,,,,,[+],,,"[+] in CHO cells  with S9, but with precipitation",,,,#Galloway et al 1987,[+],,[-],#Jenssen and Renberg 1976,,,,,"[-] in mouse bone marrow 1 and 7 days after single ip injection, but small numbers of animals and single dose level#Jenssen and Renberg 1976",[-],[+],#Ramel 1978,,,,,"weak [+] in mouse bone marrow, ip injection#Venkov et al 2000; [+] in bone marrow of rats and Mongolian gerbils, route not given#Ramel 1978",[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
193,Triethanolamine,102-71-6,GSEJCLTVZPLZKY-UHFFFAOYSA-N,OCCN(CCO)CCO,"-1,000",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537",,,,,,"[-] in TA98, TA100, TA1535, TA1537 and E. coli WP2#ECVAM Review 2016; [-] in E. coli#Dean et al 1985; #Inoue et al 1982",[-],,,,,,,[-] in Tk locus up to 1500 ug/ml,,,,[-],,,,,,,,,[-],,,"[-] in CHO cells w/out S9 up to 10,000 ug/ml",,,,"[-] in CHL cells, but without S9 only#Inoue et al 1982",[-],,[-],#IARC vol 77 2000,,"[-] in male and female mice, 90-day dermal up to 4 g/kg",,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
194,Trichlorofluoromethane,75-69-4,CYRMSUTZVYGINF-UHFFFAOYSA-N,FC(Cl)(Cl)Cl,"2,530",[-],,[-],"[-] in 4 TA strains and E. coli WP2uvrA, up to 50% gas exposure, w/out S9.",[-],[-] in M245#Zeiger et al 1987,,,,,,"[-]#Araki et al 1994; #Longstaff et al 1984

",[-],,,,,,,,,,[I] or [-] in Tk locus with S9 in AC246 cells#Seifried et al 2006; #Seifried et al 2008; [-] in Hgprt locus in CHO cells#Krahn et al 1980,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
195,Tricresyl phosphate,1330-78-5,IUJIYUAKFBGBCG-UHFFFAOYSA-N,Cc1ccc(OP(=O)(Oc2ccc(C)cc2)Oc3ccc(C)cc3)cc1.Cc4cccc(OP(=O)(Oc5cccc(C)c5)Oc6cccc(C)c6)c4.Cc7ccccc7OP(=O)(Oc8ccccc8C)Oc9ccccc9C,"5,110",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537",,,,,,"[-] in TA102, without details#Gee et al 1998;#ECVAM Review 2016",[-],,[-],#Mtitchell et al 1997,,,,,,,,[-],,,,,,,,,[-],,,[-] CA and SCE,,,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
196,Thiourea,62-56-6,UMGDCJDMYOKAJW-UHFFFAOYSA-N,NC(=S)N,"-1,080",[-],,[-],"[-] in 4 TA strains and E. coli WP2 uvrA/pKM101, up to 5 mg/plate, w/out S9.",[-],#Dunkel et al 1984; #Zeiger et al 1988,,,,,,,[-],,[E],,,[+]#Myhr et al 1988; [-]#Mitchell et al 1988,[U],,,,[-]#Wangenheim and Bolcsfoldi 1988,[E],,,,,,,[+] in V79 at >10 mM#Ziegler-Skylakakis et al 1998,[-],,,,,,,,,,,,,,,,,[-] in rat#CICAD 49 WHO 2003,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
197,Topiramate,97240-79-4,KJADKKWYZYXHBB-XBWDGYHZSA-N,CC1(C)O[C@H]2CO[C@]3(COS(=O)(=O)N)OC(C)(C)O[C@@H]3[C@H]2O1,"-1,204",,,,,,,,,,,,"[-] in TA98, TA100, TA1535, TA1537 and in E. coli#Kirkland et al 2016",[-],,,,,,,,,,[-] up to 5000 ug/ml#Brambilla and Martelli 2009; [-]#BfArM Doc,[-],,,,,,,,,,,,,,,,[-] in human lymphocytes up to 5000 ug/ml#Brambilla and Martelli 2009; #BfArM Doc,[-],,,,,,,,,,,,,,,,"[-] in rat BM up to 1000 mg/kg single oral dose, 6-24-48 hrs sampling#Brambilla and Martelli 2009",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
198,"1,2,4-trimethylbenzene",95-63-6,GWHJZXXIDMPWGX-UHFFFAOYSA-N,Cc1ccc(C)c(C)c1,"3,630",[-],,,,,,,,,,,"[-] in TA97a, TA98, TA100, TA102#Janik-Spiechowicz et al 1998",[-],,,,,,,,,,,,,,,,,,,,,,"[-] in CHL cells at 6-18, 24-0 or 48-0h treatment without S9 and at 6-18h tretament with S9.",,,,,,[-],,[-],#Janik-Spiechowicz et al 1998,,,,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
199,Triphenyltin hydroxide,76-87-9,BFWMWWXRWVJXSE-UHFFFAOYSA-M,O[Sn](c1ccccc1)(c2ccccc2)c3ccccc3,"3,530",[-],,,,[-],"[-] in TA97, TA98, TA100, TA1535, TA1537",,,,,,"[-] in TA97, TA98, TA100, TA1535, TA1537 and E.coli WP2#ECVAM Review 2016; [-] in E. coli WP2#Dunkel et al 1985",[-],,[+],,,[+],[E],,,,[-] in Hprt locus in CHO cells#Oshiro et al 1991,[E],[+],#Oshiro et al 1991,,,,,"weak [+] (<2-fold) in CHO cells w/out S9, but control MN frequencies high#Chao et al 1999; [+] in CHO cells  with S9#Oshiro et al 1991",[+],[-],NTP,,[-] in CHO cells ,,,,"[-] in CHO cells, tested without S9 only#Sasaki et al 1993",[-],,,,,,,,"Some increased MN in mouse peripheral blood by 1, 2 or 3 oral doses, less so by ip, but not dose-related and sampled early for blood MN#Chao et al 1999",[I],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
200,Tris(2-ethylhexyl)phosphate,78-42-2,GTVWRXDRKAHEAD-UHFFFAOYSA-N,CCCCC(CC)COP(=O)(OCC(CC)CCCC)OCC(CC)CCCC,"9,490",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537#Zeiger 1997",[-],"[-] in TA98, TA100, TA1535, TA1537 and E. coli WP2 uvrA, w/out S9#Study Report 1995",,,,,[-],,[-],,,[-]#Mitchell et al 1997,[U],,,,,[I],,,,,,,,,[-],NTP,"[-] in CHL cells at 6-18, 24-0 or 48-0h treatment without S9 and at 6-18h tretament with S9.",[-],,,,,[-],,[-],#Shelby and Witt 1995,,,,,,[-],[-],#Shelby and Witt 1995,,,,,,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
201,Turmeric oleoresin (79%-85% curcumin) - Curcuma longa extract has the same CAS No. but contains less curcumin,8024-37-1,,COc1cc(\C=C\C(=O)CC(=O)\C=C\c2ccc(O)c(OC)c2)ccc1O,"2,953",[-],,,,[-],"[-] in TA98, TA100, TA1535, TA1537",,,,,,"[-] in TA98, TA100, TA1535, TA1537, TA102 (ECVAM Review, 2016) ; [-] in TA102, for a turmeric essential oil identified by the same CAS nr (Liju et al 2013)   ",[-],,,,,,,,,,,,,,,,,,Curcuma longa extract [-] in CHO cells w/out S9 up to 2500 ug/ml#Velusami et al 2013,[-],[E],,,weak [+] in CHO cells,,,,Curcuma longa extract [-] in human lymphocytes w/out S9 up to 2500 ug/ml#Velusami et al 2013; turmeric [-]up to 500 ug/ml without S9 in CHO cells at different stages of cell cycle#Araujo et al 1999,[E],,,,,,,,"[-] in rat bone marrow, 2 weeks oral dosing up to 1000 mg/kg/day#Liju et al 2013; turmeric extract [-] in mouse bone marrow, 15 days dosing#Bhartiya et al 2010; curcumin [-] in rat bone marrow, 80 mg/kg gavage dosing every 2 days for 4 weeks#Celik et al 2013",[-],,,,,,,"[-] in rat bone marrow, 2 weeks oral dosing up to 1000 mg/kg/day#Liju et al 2013; turmeric [-] in mouse bone marrow after single ip dose or 7 days diet#Mukhopadhyay et al 1998",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"[-] in bone marrow, spleen and small intestine of rats, 2 weeks oral dosing up to 1000 mg/kg/day#Liju et al 2013; curcumin [-] in rat bone marrow, 80 mg/kg gavage every 2 days for 4 weeks#Celik et al 2013",[-]
202,Urea,57-13-6,XSQUKJJJFZCRTK-UHFFFAOYSA-N,NC(=O)N,"-2,110",[-],"[-] in TA98, TA100, TA1535, TA1537; [-] in E. coli#Shimizu et al 1985; TC [-]#Mortelmans et al 1986",,,,,[-],"[-] in TA98, TA100, TA1535, TA1537, TA1538 and E. coli WP2 uvrA, with/out S9#Benfenati DB",,,,,[-],,[E],[I]#Mitchell et al 1997; [+] only >200 mM#Wangenheim and Bolcsfoldi 1988,,,,,,,,[-],,,,,,,[-] in p53 deficient hamster and in human competent cells#Fowler et al 2012a,[-],TC,,,,,,,[+]^Ishidate and Odashima 1977; #Ishidate et al 1988 [+]^^,[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,[+],[+] only in alkaline comet at 600 msomol/kg#Zhang et al 2004,,,,,,,,,,,,[+]
203,Vinblastine sulphate,143-67-9,KDQAABAKXDWYSZ-JKDPCDLQSA-N,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1.OS(=O)(=O)O,"2,966",[-] ,"[-] in TA98, TA100, w/out S9; [-] in TA1537, without S9; [-] in E. coli WP2 hcr",,,,,,,,,,[-]#Bakshi et al 1985; [-]#Sakamoto et al 1985,[-],,,,,,,,,,[+] in Tk locus with L5178Y cells at 1ng/ml#Honma et al 2001,[+],,,,,,,"[+] in CHO cells at diff doses, six studies#Garriott et al 2002; [+] in CHL/IU cells#Matsushima et al 1999; [+] in V79 cells#Von der Hude et al 2000",[+],[+],[+] in CHL/UI cells#Matsushima et al 1999,,,,,,,[+],,,,,,,,[+] in bone marrow and blood#Vanparys et al 1990;#Miller et al 1991;#Grawe et al 1997;#Choudhury et al 2004;#Fiedler et al 2010; [+] in duodenum and colon#Coffing et al 2011,[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
204,Vanadium Pentoxide (Divanadium pentoxide),1314-62-1,GNTDGMZSJNCJKK-UHFFFAOYSA-N,O=[V](=O)O[V](=O)=O,"-1,161",[-],,,,[-],"[-] in TA97, TA98, TA100, TA1535, TA1537, TA1538, TA102",,,,,"[-] in TA98, TA100, TA1535, TA1537, TA102, w/out S9",,[-],,,,,,,[-] in Hprt locus in L5178Y cells,,,[-] in Tk locus even after re-evaluation#Seifried et al 2006; [-] in Hprt locus only without S9#Zhong et al 1994,[-],,,,,[+] in human lymphocytes and TK6 cells w/out S9,,"[+] in V79, aneuploidy#Zhong et al 1994; [-] in SHE cells#Gibson et al 1997",[+],[+] (hyperdiploidy),,,,,,,"[+] in HPLT, hyperdiploidy#Ramirez et al 1997; [+] polyploidy#Roldan and Altamirano 1990; [-] structural abs#Roldan and Altamirano 1990;#Rodriguez-Mercado et al 2010",[+] (numerical),,,,,"[-] in mature erythrocytes, male and female mice, 13 week inhalation at doses up to 4x top carc dose","[-] in BM of male rats, gavage, 1x dose at MTD",,[+] male but [-] female mice from 1 day to 4 wks inhalation aqueous aereosol#Rojas-Lemus et al 2014,[E],,,,,,,,,,,,,,,,[-] for cII and Kras mutations in lung of Big Blue mice at low dose used in carc study after 4 or 8 weeks inhalation,#Manjanatha et al 2015; #Banda et al 2015,[-],[+],#McGregor and Anderson 1999,,,,,,[+],,,,,[-] in female mouse lung 16 days via inhalation,,,,,,,"[-] female mouse lung 16 days via inhalation [-] same study as in ECHA; [+] mouse testis, liver, kidney, lung, spleen and heart, but [-] bone marrow via ip ","[+]#Altamirano-Lozano et al 1999; #Altamirano-Lozano et al 1996; #Schuler et al 2011
",[+]
205,Vinyl acetate,108-05-4,XTXRWKRVRITETP-UHFFFAOYSA-N,CC(=O)OC=C,"0,730",[-],,[-],"[-] in 4 TA strains and E. coli WP2 uvrA/pKM101, up to 5 mg/plate, w/out S9.",[-],"[-] in TA97, TA98, TA100, TA1535",,,,,,"[-] in TA98, TA100, TA1535, TA1537, TA1538#Lijinsky and Andrews 1980",[-],,,,,,,,,, [+] in Tk locus in TK6 cells w/out S9#Seifried et al 2006; [+] in Tk locus in TK6 cells#Budinsky et al 2013,[+],,,,,,,[+] in HPLT#Maki-Paakkanen and Norppa 1987; weak[+] in Tk locus and [-] in Hprt#Budinsky et al 2013,[+],,,,,,,,[+] in HPLT#Jantunen et al 1986; #Norppa et al 1985,[+],,[+],,,[+] in rat,,,"[+] mouse, ip, near lethal dose#Maki-Paakkanen and Norppa 1987; [-] in rat and mouse, drinking water#EU RAR 2008c; [-] in rat and mouse, inhalation#EU RAR 2008c",[E],,,,,,,[+] in rat#Nersesyan et al 1990,[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
206,4-vinylcyclohexene,100-40-3,BBDKZWKEPDTENS-UHFFFAOYSA-N,C=CC1CCC=CC1,"3,930",[-],,,,[-],"[-] in TA97, TA98, TA100, TA1535, TA1537, TA104",[-],"[-] in TA97, TA98, TA100, TA1535, TA1537 and in E. coli WP2",,,,"[-] in TA97, TA98, TA100, TA1535, TA1537 and E. coli WP2#ECVAM Review 2016",[-],,[+],,,[+],[U],,,,,[I],,,,,,,,,[-],,,[-] in CHO cells w/out S9 up to toxic concs,,,,,[-],,,,,[-],,,"[-] in mice and rats, inhalation for 2 days or 13 weeks#Bevan et al 2001",[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
207,Zafirlukast,107753-78-6,YEEZWCHGZNKEEK-UHFFFAOYSA-N,COc1cc(ccc1Cc2cn(C)c3ccc(NC(=O)OC4CCCC4)cc23)C(=O)NS(=O)(=O)c5ccccc5C,"5,466",,,,,,,,,,,,"[-] in TA98, TA100, TA1535, TA1537 and in E. coli WP2#Kirkland et al 2016",[-],,,,,,,,,,"[-] in Tk locus#Brambilla and Martelli 2009; [-] in Hprt locus in CHO cells up to 40 ug/ml, cytotoxicity at high [conc]#Brambilla and Martelli 2009",[-],,,,,,,,,,,,,,,,"[-] in human lymphocytes up to 200 ug/ml, limit of solubility#Brambilla and Martelli 2009; #BfArM Doc",[-],,,,,,,,[-] in 2 rat bone marrow MN studies: 1) up to 400 mg/kg 1x p.o. and 2) up to 2000 mg/kg 1 x p.o.#Brambilla and Martelli 2009,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
208,Zinc ethylenebisthiocarbamate (Zineb),12122-67-7,AMHNZOICSMBGDH-UHFFFAOYSA-L,[Zn+2].[S-]C(=S)NCCNC(=S)[S-],"1,300",[-],,,,[-],"[-] in TA97, TA98, TA100, TA1535, TA1537",,,,,,"[-] in TA97, TA98, TA100, TA1535, TA102, TA104#Franekic et al 1994; [-] in E.coli WP2#Simmon et al 1985;#ECVAM Review 2016",[-],,,,,,,,,,,,,,,,,,[+] in human lymphocytes#Soloneski et al 2002; [+] in CHO cells#Soloneski et al 2015,[+],,,,,,,,[+] in human lymphocytes#Soloneski et al 2001,[+],,,,,,,,,,,,,,,,"[+] in rat bone marrow, 6-day oral dosing repeated several times after recovery intervals#Kiryushin 1975; [+] in mouse bone marrow, single oral dose#Ryazanova and Gafurova 1980",[+],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
209,Zinc sulfate/Zinc heptahydrate,7733-02-0/ 7446-20-0,NWONKYPBYAMBJT-UHFFFAOYSA-L,[Zn+2].[O-]S(=O)(=O)[O-],,TC [-],#Gocke et al 1981; #Fujita et al 1988 ,,,,,,,,,,"[-] in TA97, TA98, TA100, TA1535, TA1537, TA102 and E. coli WP2 (E.coli only without S9)#ECVAM Review 2016; [-] in TA97, TA98, TA100, TA1535, TA1537#Gocke et al 1981; [-] in TA102 without S9#Marzin and Phi 1985; [-] in TA102 w/out S9#Fujita et al 1988; [-] in E. coli w/out S9#Moriya et al 1983",[-],,,,,,,,,,,,,,,,,,"[-] (reduced frequencies) for MN in WIL2-NS cells, without S9 only#Sharif et al 2011",[-],[+],,,,,[-] in WI-38 cells but ionly tested without S9,,[+] in human leukocytes without S9#Santra et al 2000,[+],,,,,,,,"[-] in mouse bone marrow, route not specified, single sampling time#Gocke et al 1981; [-] in mice, ip#EU RAR 2003b; though relevance of findings needs to be clarified",[I],,,,,"[-] in rats, 5 daily gavage doses",,,[-],,,,,,,,,,,,,,,,,,,[+],#Banu et al 2001,,,,,,,,,,,"[+] in mouse blood leukocytes, peak at 24 hrs after oral dosing#Banu et al 2001",[+]
210,Zonisamide,68291-97-4,UBQNRHZMVUUOMG-UHFFFAOYSA-N,NS(=O)(=O)Cc1noc2ccccc12,"0,506",,,,,,,,,,,,"[-] in TA98, TA100, TA1535, TA1537, and E. coli#Kirkland et al 2016",[-],,,,,,,,,,[-] in Tk locus up to 2120 ug/ml#EPAR Zonegran; [+] questionable in Hprt locus in V79 cells#EPAR Zonegran,[-],,,,,,,,,,,,,,,,[-] in human lymphocytes and upt to 2120 ug/ml in V79#EPAR Zonegran,[-],,,,,,,,,,,,,,,,[-] in mouse BM cells up to 900 mg/kg single oral dose with 8-24-48 hrs sampling#EPAR Zonegran,[-],,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
211,"Wyeth 14,643 (4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthio acetic acid)",50892-23-4,SZRPDCCEHVWOJX-UHFFFAOYSA-N,Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C,"2,991",,,,,,,,,,,"[-] in TA97, TA98, TA100, TA1535, TA1537, TA102, w/out S9",[-] in TA102#Glauert et al 1984; [-]#LeFevre et al 1994,[-],,,,,,,,,,,,,,,,,,[+]#Hwang et al 1993; [+]#LeFevre et al 1994; [-] in rat hepatocytes#Muller-Tegethoff et al 1995,[+],,,,,,,,[+]#Tsutsui et al 1993; #Hwang et al 1993; #LeFevre et al 1994,[+],,,,,[-] rats (28-day gavage) and mice (26 week diet and dermal),,,,[-],,,,,,,,,,,,,,,[+],[-] (gavage) and [+] (diet) results in liver of mice; [+] in liver but [-] in kidney of male and female mice (route unknown),#Trapp et al 2007; #Boerrigter 2004; #Singh et al 2001,[+],,,,,,,[-]#LeFevre et al 1994,[-],,,,,,,,,,,[+]#Suzuki et al 2010,"[+] in liver of rats via oral, sex not known",,[+]
